Regulation of transposable elements via histone modifications by Brunmeir, Reinhard
 
 
 
 
 
 
 
 
 
 
DISSERTATION 
 
 
 
 
Titel der Dissertation 
 
 
 
Regulation of Transposable Elements via Histone Modifications 
 
 
 
 
 
 
angestrebter akademischer Grad 
 
Doktor der Naturwissenschaften (Dr. rer. nat.) 
 
 
 
 
 
 
Verfasser: Mag. rer. nat. Reinhard Brunmeir 
Matrikel-Nummer: 9603618 
Dissertationsgebiet (lt. 
Studienblatt): 
091 441 Genetik 
Betreuerin / Betreuer: Univ.-Prof. Dr. Seiser / Univ.-Prof. Dr. Baccarini 
 
 
 
 
Wien, am 24. August 2008 
 
 

DANKE 
 
Diese Arbeit war nur möglich durch die Unterstützung anderer. Mein Dank gilt: 
 
Christian Seiser, meinem Betreuer, der mich durch das Projekt geleitet hat. 
 
Meinen Kollegen und Freunden im Labor: allen voran Lilli und Sabine! Ihr wart immer für 
mich da! Weiters Gordin, Reinsch, Stefan, Astrid, Jenny, Georg, Tom und Gerald. Es war 
eine Freude mit euch zu arbeiten. 
Den Mitarbeitern und Kollegen am Institut für die Hilfsbereitschaft und das gute Arbeitsklima. 
Natürlich auch meinen Freunden außerhalb des Labors, die mich durch die vier Jahre 
begleitet haben. 
 
Schlussendlich möchte ich auch meiner Familie danken, die immer ein Rückhalt für mich 
war: meinen Eltern, meinen Brüdern Didi und Dominik. 
 
 
 

ZUSAMMENFASSUNG 
 
Das Mausgenom besteht ungefähr zu 40% aus repetitiven Elementen (vor allem 
Transposons), die stillgelegt werden müssen, um die Integrität des Genoms aufrechterhalten 
zu können. Das wird durch verschiedene Mechanismen gewährleistet, wie zum Beispiel RNA 
Interferenz, Methylierung der DNA und Modulation der Chromatinstruktur. 
Die Fragestellung dieser Arbeit war, aufzuklären, inwieweit die Struktur des Chromatins an 
diesem Prozess beteiligt ist; im Detail sollte untersucht werden, welche Rolle die 
Azetylierung von Histonen bei der transkriptionellen Kontrolle von Transposons spielt. 
Histonazetylierung ist normalerweise mit transkriptionell aktivem Chromatin assoziiert und 
wird durch zwei antagonistisch wirkender Enzymklassen reguliert: Histonazetyltransferasen, 
die Azetylreste an die Histone anfügen, und Histondeazetylasen (HDAC), die sie wieder 
wegnehmen. Im Rahmen dieser Arbeit verwendeten wir HDAC-Hemmer bzw. Zellen ohne 
funktionelles Gen für das Enzym Histondeazetylase 1, um Histonazetylierungsmuster in der 
Zelle zu verändern. Anschließend wurden die transkriptionelle Aktivität von Transposons, 
Histonmodifikationsmuster auf Gesamthistonextrakten und Transposon-assoziiertem 
Chromatin überprüft. Dabei stellten wir eine erhöhte Histonazetylierung von transkriptionell 
aktivierten Transposons fest. Interessanterweise konnten wir mit dem LTR Retrotransposon 
VL30 (Virus-like 30S element) ein Transposon identifizieren, das nach Hemmung von 
Histondeazetylasen ein starke Expression aufwies. Eine Analyse von VL30 Transkripten 
ergab, dass sich für die erhöhte Transkription eine spezifische Untergruppe der VL30 
Elemente verantwortlich zeigte, die durch spezielle Merkmale in der regulatorischen Region 
gekennzeichnet war. Weiters wurde die transkriptionelle Aktivierung mithilfe von Stimuli (wie 
Serum oder Anisomycin), die zu einer Aktivierung von MAK Kinasen und zur 
Phosphorylierung von Histonen führen können, noch verstärkt. Tatsächlich konnten wir nach 
kombinatorischer Behandlung doppelt modifizierte (azetylierte und phosphorylierte) Histone 
Proteine am LTR von VL30 Elementen detektieren.  
Es wird ein Modell vorgeschlagen, wonach bestimmte Histonmodifikationen kooperieren, um 
ein volle transkriptionelle Aktivierung von VL30 Retrotransposons zu erreichen. 
 
ABSTRACT 
 
A large portion of the mouse genome (~40%) consists of repetitive elements which have to 
be silenced in order to maintain the integrity of the genome. This task is accomplished by 
different mechanisms, including RNA interference, DNA methylation and the modulation of 
chromatin structure. 
The aim of this work was to gain insight in how far the modulation of chromatin structure 
contributes to this process; in detail we wanted to clarify the role of histone acetylation in 
transcriptional control of transposable elements. Acetylation of histones is a post translational 
modification usually associated with open chromatin and transcriptionally active genes. It is 
regulated via the action of two antagonising enzyme families: histone acetyltransferases, 
which add acetyl-moieties to histone proteins and histone deacetylases (HDACs) which 
remove them. In the course of this work we took advantage of chemical inhibitors of HDACs 
and a cell system where a major histone deacetylase, HDAC1, was inactivated, to change 
histone acetylation patterns in the cell. Subsequently we analysed transcriptional activity of 
transposable elements, global histone modification patterns as well as histone acetylation of 
transposon-associated chromatin. We could detect increased histone acetylation levels of 
transcriptionally active transposable elements. Most interestingly we identified the LTR 
retrotransposon VL30 (Virus-like 30S element) to be highly inducible upon HDAC inhibition. 
Further analysis of VL30 transcripts revealed, that a distinct subgroup of VL30 elements, 
associated with a characteristic regulatory region, is mainly responsible for increased 
transcription. Moreover transcriptional activation was further increased by stimuli (such as 
serum and anisomycin) which lead to the activation of MAK kinase pathways and can cause 
phosphorylation of histones. Indeed we could detect double-modified (acetylated and 
phosphorylated) histone proteins at the LTR of VL30 elements upon combinatorial treatment 
with HDAC inhibitors and MAK kinase activators. 
A model is proposed, where two histone modifications cooperate to gain full transcriptional 
activity of VL30 retrotransposons. 
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1. Introduction 
 
During the 19th century major advances in microscopy techniques permitted novel insights 
into the architecture of the cell. It led to the discovery and description of cellular organelles, 
including the nucleus and structures therein i.e. the chromosomes. After the rediscovery of 
G. Mendel’s work on the laws of inheritance and T.H. Morgan’s experiments with flies in the 
beginning of the 20th century, chromosomes were recognised as the carrier of genetic 
information. A few decades later O. Avery established DNA (and not proteins) as 
“transforming principle” in bacteria and in 1953 J. Watson and F. Crick were able to solve the 
structure of the double helix, positioning the DNA molecule in the centre of genetics. 
Together with the development of techniques allowing the manipulation of DNA such as the 
discovery of restriction enzymes by W. Arber or the sequencing of DNA by F. Sanger, these 
discoveries were the basis for decades of fruitful research culminating in the creation of 
transgenic organisms and the sequencing of complete genomes. 
At the same time, it became clear that many biological phenomena cannot be fully 
understood and explained by the plain analysis of the DNA sequence. Phenotypic variation 
among genetically identical individuals and heritable changes without alterations in the DNA 
including phenomena such as genomic imprinting and paramutation required the 
development of novel concepts, summarised as “epigenetics”. 
Epigenetics postulates the existence of mechanisms that induce and maintain 
transgenerational changes (in gene expression) without affecting the DNA sequence, which 
is the primary carrier of genetic information. Only during the last years we learned what these 
mechanisms are and how they interact with each other to fulfil complex regulatory tasks. We 
begin to understand the impact of chromatin structure in the regulation and maintenance of 
gene expression patterns and how small RNA molecules contribute to epigenetic 
mechanisms. 
 
1.1. Chromatin 
 
The packaging of DNA with proteins into a higher order structure called chromatin is on the 
one hand a necessity to store almost two meters of linear DNA in an organelle of only 10µm 
diameter; on the other hand it is a means to organise the accessibility of DNA which is crucial 
for many biological processes such as replication, recombination, DNA repair and 
transcription. 
The basic unit of chromatin is the nucleosome, which consisting of 146bp of DNA wrapped 
around a histone octamer core particle containing one H3-H4 tetramer and two H2A-H2B 
dimers. 10-60bp of linker DNA connect thousands of nucleosomes on a continuous DNA 
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molecule constituting the famous beads-on-a-string structure (Butler, 1980; Allen, 1981). 
Higher levels of compaction are achieved by the binding of the linker histone H1 leading to 
the formation of the so-called 30nm fibre (Ramakrishnan, 1997).  
The core histone octamer builds a compact structure comprised of the C-terminal portions of 
the histone proteins, which are responsible for the assembly of nucleosomes by mediating 
histone-histone and histone-DNA interactions. In contrast, N-terminal tails of core histones 
are less structured protrude from the core and therefore can make secondary contacts with 
DNA, adjacent nucleosomes or proteins (Luger, 1997). They are also targets for a variety of 
site-specific posttranslational modifications, which will be discussed in detail the following 
sections. 
 
1.2. Chromatin Remodelling 
 
Compaction and close association with histone proteins conflict with many of the 
fundamental functions of DNA, where it has to be accessible as e.g. during recombination, 
transcription and replication. In the course of such processes nucleosomes have to be 
repositioned or even ejected in order to allow the binding of DNA binding factor, the 
recruitment of the transcription machinery or the passing of the replication machinery. Up to 
now we are aware of three distinct but interconnected mechanisms to control the 
accessibility of the DNA template. This task is mainly achieved by (1) the action of ATP-
dependent chromatin remodelling complexes, (2) posttranslational modifications of histone 
tails and (3) incorporation of histone variants. (Winter, 2007). 
 
1.2.1. Chromatin Remodelling Complexes 
 
Due to the numerous histone-DNA contacts (14 hydrogen bonds and salt linkers) 
nucleosomes are very stable protein-DNA complexes. Therefore their displacement requires 
a net-energy input, which is supplied by ATP-hydrolysis. Together with histone chaperones 
and DNA-binding transcription factors, ATP-dependent chromatin remodelling complexes 
facilitate the displacement of nucleosomes either by “sliding” of the DNA (Becker, 2002) or by 
nucleosome transfer (Korber, 2004; Lorch, 1999). Up to now five different classes of multi-
subunit ATP-dependent remodelling complexes have been identified, involved in distinct 
biological tasks. Specificity of the complexes is achieved via binding of sequence specific 
transcription factors as well as chromatin binding factors harbouring motifs, which favour the 
binding to chromatin associated with distinct protein modifications. Therefore it is not 
surprising that remodelling complexes act in concert with histone modifying complexes, like 
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histone acetyltransferase complexes (SAGA, NuA3, NuA4) or histone deacetylase 
complexes (Winter, 2007). 
All known ATP-dependent chromatin remodelling enzymes belong to the helicase 
superfamily 2 (SF2). The identity of the catalytic ATPase subunit, together with the 
composition of associated proteins and functional aspects led to the establishment of the 
following families: (1) the SWI/SNF (switch 2/sucrose-non-fermenting) complexes, 
comprising the yeast SWI2/SNF2 and RSC (remodels the structure of chromatin), the 
Drosophila BAP and PBAP and the mammalian BRM and BRG1 complexes. (2) The ISWI 
(imitation switch) family complexes, which are smaller and have fewer subunits, consisting of 
the Drosophila ACF (ATP-utilising chromatin assembly and remodelling factor), NURF 
(nucleosome remodelling factor) and CHRAC (chromatin accessibility complex) complexes. 
(3) The Mi-2 or CHD family complexes combine remodelling and histone modification 
activities as they contain the ATPase CHD4 (also known as Mi-2) as well as the histone 
deacetylases HDAC1 and HDAC2. The mammalian NURD (nucleosome remodelling and 
deacetylase) complex represents the most prominent member of this family. (4 and 5) The 
SWR1 as well as the INO80 complex were initially characterised in yeast but recently 
mammalian orthologues have been identified which are associated with proteins also found 
in histone acetyltransferase (HAT) complexes.  
Biological functions fulfilled by the different complexes include transcriptional activation, 
elongation, termination, repression, DNA repair, replication and chaperone activity (Winter, 
2007). 
 
1.3. Histone Modifications 
 
As already mentioned above, the N-terminal tails of histone proteins protrude from the 
nucleosomal surface. They are subjected to numerous posttranslational modifications 
(PTMs) like lysine acetylation, serine and threonine phosphorylation, lysine and arginine 
methylation, lysine ubiquitination, lysine sumoylation, lysine biotinylation, glutamatic acid 
ADP-ribosylation and others. These modifications may directly influence chromatin structure 
by changing the electrostatic constitution of histone tails: lysine acetylation leads to the 
neutralisation of positive charges and therefore may loosen the interaction between histone 
tails and the negatively charged DNA; serine and threonine phosphorylation may result in 
decondensation of the chromatin fibre via addition of negative charges (Turner, 2000). 
Alternatively they may serve as recognition sites for binding factors able to modulate 
chromatin structure (e.g. via ATP-dependent chromatin remodelling). 
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Different modifications are thought to act in a combinatorial or sequential fashion on one or 
more histone tails to specify downstream functions, strongly interrelating different 
modifications with each other. 
The modification patterns associated with defined regions exerting distinct biological 
functions can be interpreted as an additional layer of information on top of the genetic 
information stored within the DNA sequence. This idea was brought forward by the 
“epigenetic code” hypothesis (Strahl, 2000; Jeunuwein, 2001).  
 
1.3.1. Histone Acetylation 
 
Histone acetylation has already been described and linked to transcription in the 1960ies by 
V.G. Allfrey (Allfrey, 1964). However, only after the establishment of appropriate tools in the 
1980ies – the creation of antibodies specifically recognising acetylated histones – and the 
identification of enzymes responsible for acetylation and deacetylation of histones in the 
1990ies, major insights into the role of histone acetylation were rendered possible. The 
isolation of the first HAT (histone acetyltransferase) by J.E. Brownell (Brownell, 1996) and 
the first HDAC (histone deacetylase) by J. Taunton (Taunton, 1996) immediately re-linked 
histone acetylation to transcription since the isolated enzymes have already been described 
as transcriptional regulators.  
Since then, countless reports clearly demonstrated that hyperacetylation of histones is 
associated with transcriptional competent chromatin, while hypoacetylation is associated with 
transcriptional repression. 
On histone H3, acetylation sites include lysines 9, 14, 18 and 23 (Thorne, 1990), on histone 
H4, acetylation occurs on lysine residues 5, 8, 12 and 16 (Turner, 1993; Grunstein, 1997). 
Several reports suggest that various specific cellular processes are dependent on the 
acetylation state of distinct lysine residues. In yeast, acetylation of H3K14, H4K8 and H4K16 
correlates with transcriptional activation whereas acetylation of H3K9, H4K5 and H4K12 
plays a role in histone deposition (Allis, 1985; Sobel, 1995). In Drosophila, H4K5 and H4K8 
acetylation is observed in euchromatic, H4K12 in heterochromatic regions. Acetylation of 
H4K16 is associated with different biological functions, depending on the organism: in yeast 
it is involved in the formation of boundary elements at telomeres preventing Sir2 spreading 
(Suka, 2002), in Drosophila it is important for dosage compensation (Akhtar, 2000) and in 
mammals it is has a function in normal transcriptional control (Lee, 2007).  
Recently, reports based on high resolution mapping of histone modification patterns 
somehow challenge the aforementioned model, that distinct acetylation events are highly 
specific for certain biological functions, as they find many acetylation marks co-occurring and 
therefore emphasise the cooperativity and interdependency of acetylation events (Liu, 2005). 
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1.3.1.1. Histone Acetyltransferases 
 
Histone acetyltransferases are grouped in two major families, the GNAT (GCN5-related N-
acetyltransferase) and the MYST (MOZ, YBF2/SAS3, SAS2, Tip60) family. A common 
feature of all HATs is a highly conserved acetyl-CoA binding site and the fact that they are all 
part of large multiprotein complexes in vivo (Narlikar, 2002; Kimura, 2005; Lee, 2007)). 
Association with other proteins seems to be crucial for substrate specificity. That way distinct 
complexes with specificity for certain lysines/histones can fulfil different biological functions 
(see chapter above).  
Data coming from in vitro studies, recently also from in vivo studies, report that there is a 
directionality in the acetylation process. For instance histone H4 is acetylated in the following 
C- to N-terminal order: H4K16 ? H4K12 ? H4K8 ? H4K5 (Sarg, 2004; Jiang, 2007). 
However, both substrate specificity and the acetylation sequence are far from being 
completely understood and additional analyses are needed to dissect the exact modes of 
action as well as their biological functions. 
Another important feature of many HATs is a protein domain, which is able to preferentially 
bind to chromatin carrying certain histone modifications. For instance HATs, but also the 
ATPase subunit of certain chromatin remodelling complexes can contain a bromodomain 
(binds preferentially to acetylated lysine residues), a chromodomain (recognising histones tri-
methylated at lysine 4), WD40 repeats, PHD fingers (binding other methylated lysine 
residues) or tudordomains (recognising methylated lysine and arginine residues) (Winter, 
2007). This links histone acetylation to several other histone modifications and sets the 
playground for a variety of cross-regulatory mechanisms. 
 
1.3.1.2. Histone Deacetylases 
 
Deacetylation of histone proteins is accomplished by members of two different enzyme 
families: (1) the NAD+-dependent Sir2-like proteins (sirtuins) and (2) the Rpd3/Hda1-like 
lysine deacetylases. Ad (1) The founding member of this class of deacetylases is the yeast 
Sir2 (Silent information regulator protein 2) protein which is involved in the transcriptional 
silencing of several loci, including the mating type locus, telomeres and the rDNA locus. Sir2 
activity is dependent on the ratio of NAD+/NADH, therefore it is suggested that Sir2 might be 
a sensor of the cellular metabolic and energy rate. Strikingly it is involved in lifespan 
expansion upon caloric restriction in a wide range of organisms. In mammals seven Sir2 
homologues (SIRT1-7) have been identified so far. The proteins display differential specificity 
toward acetylated substrates (including histones but also other proteins), diverse cellular 
locations, affect a broad range of cellular functions and appear to divide the functions 
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originally fulfilled by the common ancestor (Haigis, 2006; Inoue, 2007). Ad (2) The 
Rpd3/Hda1-like deacetylases utilise a zinc-catalysed mechanism (Finnin, 1999) to 
deacetylase histones and other proteins. Mammalian HDACs are grouped into 3 subfamilies 
according to their homology to yeast proteins: class I enzymes comprise HDAC1, 2, 3 and 8 
and show homology to the yeast RPD3 (Reduced potassium dependency 3) protein. They 
are ubiquitously expressed, therefore thought to fulfil general cellular functions and are 
crucial for basic cellular processes such as transcription, replication and DNA repair. Its 
prime substrates seem to be histones; however they also can deacetylase other proteins as 
for example p53, E2F1 and YY1.  HDAC1 and HDAC2 are close homologues originating 
from a gene duplication event in vertebrates. They share more than 80% sequence identity 
and are found in the multiprotein complexes SIN3, NuRD and CoREST. HDAC1 and HDAC2 
have overlapping functions, but knock out studies revealed that they also have distinct and 
non-redundant biological functions (Lagger, 2002; Montgomery, 2007; Yang, 2008; Brunmeir, 
2008). In a wide range of organisms HDAC1 and HDAC2 are important co-regulators of 
development, differentiation and cell cycle progression. In contrast to HDAC1 and HDAC2, 
which are located exclusively in the nucleus, HDAC3 has the ability to shuttle between 
nucleus and cytoplasm. HDAC3 is also found in multiprotein complexes where it delivers the 
enzymatic activity for the N-CoR / SMRT complex. It is involved in numerous biological 
processes including differentiation, cell cycle progression and DNA repair (Knutson, 2008; 
Bhaskara, 2008). HDAC8 is the evolutionary youngest member of the class I HDAC family. It 
is only found in vertebrates and its function is largely unknown. Class II HDACs are 
distinguished by a large C-terminal (yeast) or N-terminal (mammals) extension in addition to 
the deacetylase domain homologous to the corresponding domain of its yeast ancestor 
Hda1. The N-terminus of HDAC4, 5, 7 and 9 contains multiple MEF and 14-3-3 binding sites 
crucial for regulation of subcellular localisation and nucleo-cytoplasmic shuttling. 
Interestingly, enzymatic activity of HDAC4 and HDAC7 is dependent on the class I enzyme 
HDAC3, linking class I and class II HDAC function. Biological functions of HDAC4, 5, 7, and 
9 include tightly regulated differentiation processes such as muscle differentiation and 
cardiac development. Another member of class II HDACs is HDAC6, which is unusual in its 
architecture as it carries two deacetylase domains. It is mainly localised in the cytoplasm and 
regulates multiple cytoplasmic processes such as cytoskeleton dynamics (via α-tubulin 
deacetylation), heat shock response (via HSP90 deacetylation) and ubiquitin-dependent 
pathways. The last member of class II HDACs, HDAC10 seems to be vertebrate specific; 
little is known about its function. Finally there is one more class of HDACs, class IV (class III 
is constituted by the sirtuins in this classification system), which consists of a single protein 
exhibiting equidistance to Rpd3 and Hda1: HDAC11. It is highly conserved, found from 
___________________________________________________________________________ 
  17 
bacteria to mammals and therefore thought to play a fundamental role in diverse organisms. 
However, little is known about its function so far (Yang, 2008). 
 
1.3.2. Histone Phosphorylation 
 
Phosphorylation of histones, especially on serine 10 and 28 of histone H3, plays an 
important role in two opposing biological processes. On the one hand, phosphorylation is 
crucial for chromosome condensation during mitosis (mitotic histone H3 phosphorylation), on 
the other hand it is involved in chromosome decondensation during transcriptional induction 
(stimulus-induced histone H3 phosphorylation). Thus, the same mark serves as a signal for 
antithetic functions. A functional discrimination is possible through the different contexts 
where the identical histone mark occurs and the action of different signalling cascades. 
 
1.3.2.1. Mitotic Histone H3 Phosphorylation 
 
During the entry into mitosis, chromatin becomes condensed and phosphorylated at serine 
10 and 28 of histone H3. Histone phosphorylation starts at pericentric heterochromatin in 
early prophase and subsequently spreads throughout the whole chromosome, peaking at 
metaphase (Bradbury, 1992; Koshland, 1996; Goto, 1999). It is suggested, that 
phosphorylation is required for proper recruitment of the condensin complex and the mitotic 
spindle (Giet, 2001). The enzymes controlling reversible H3 phosphorylation are Ipl1/AIR-2 
kinases (mammalian homologue: AuroraB) and type 1 phosphatases (PP1), respectively. 
 
1.3.2.2. Stimulus-induced Histone H3 Phosphorylation 
 
In contrast to mitotic phosphorylation, which occurs throughout the whole genome, serine 10 
phosphorylation during interphase is associated with a minute fraction of the genome. It is 
restricted to a limited number of genomic loci including intergenic and genic regions (E. 
Simboeck, PhD thesis, 2008) and appears only transiently. Histone phosphorylation is the 
result of signalling cascades triggered by external or internal stimuli. It is conferred by signal 
transduction pathways, which involve phosphorylation cascades, perfectly suited to rapidly 
propagate and amplify signals. This ensures that the cell can quickly respond to changed 
conditions and adapt its gene expression patterns accordingly.  
The best-studied example of genes regulated by histone phosphorylation is the so-called 
“nucleosomal response”, where immediate early (IE) genes such as c-fos and c-jun are 
transcriptionally activated upon mitogen treatment (Mahadevan, 1991). Recently also other 
genes have been found to be regulated by a mechanism involving phosphorylation of H3S10 
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(Hauser, 2002). A common feature for all genes identified so far is the phosphorylation of 
H3S10 via the Rsk2 (ribosomal S6-kinase) or the MSK1/2 (mitogen- and stress-activated 
protein kinase) effector kinase (Thomson, 1999). Rsk2 is activated by the ERK (extra-cellular 
signal-regulated kinase) MAP kinase signalling pathway which responds to growth signals 
such as EGF (epidermal growth factor), bFGF (basic fibroblast growth factor) and TPA (12-
O-tetradecanoylphorbol 13-acetate). Activation of this pathway results in p42/p44 
(ERK1/ERK2) signalling through Ras and Raf, usually linked to proliferation. In contrast, 
MSK1/2 can be activated through the p38 as well as the ERK signalling pathway (Soloaga, 
2003). The p38 signalling pathway is a sensor of external and internal stress signals and is 
activated by toxins such as anisomycin or UV. Notably, another MAP kinase cascade, the 
JNK (c-Jun aminoterminal kinase) pathway is not involved in phosphorylation of chromatin, 
but histone acetylation (Cano, 1995). In addition to MAP kinase cascades, other pathways 
were also shown to induce H3 phosphorylation in mammals. Viral infection induces 
upregulation of the INFβ gene (Agalioti, 2002); cytokine induction leads to the activation of 
NFκB responsive genes (Yamamoto, 2003); both events are accompanied with serine 10 
phosphorylation. Finally, induction of progesterone target genes requires MSK1 mediated 
histone H3 phosphorylation. 
Up to now, it is not completely understood, how H3 phosphorylation affects gene expression. 
It could act similarly as histone acetylation, i.e. weaken the interaction between the N-
terminal histone tails and the DNA backbone, thereby rendering the DNA more accessible for 
interacting factors. Moreover, phosphorylated histones could serve as recognition sites for 
factors activating transcription. In vitro experiments showed that the HAT Gcn5 exhibits a 
preference for histones phosphorylated at serine 10 (Cheung, 2000). More recently 14-3-3 
proteins have been identified to specifically bind to histones modified in such a way 
(Macdonald, 2005) and influence the phosphorylation-dependent activation of target genes 
(Winter, 2008; Walter, 2008). Another interesting feature of phosphorylated histones is their 
special susceptibility for additional histone modifications. It was shown that especially the 
neighbouring lysines 9 and 14 are highly likely to become acetylated (Cheung, 2000; 
Clayton, 2000) leading to double modified (“phosphoacetylated”) histones. The “synergistic 
coupled phosphoacetylation” model considers phosphorylation as facilitator for sequential 
acetylation events. This is in opposition to another model, the “independent dynamic 
phosphoacetylation” model, which suggests an independent regulation of phosphorylation 
and acetylation. There are examples for genes regulated according to the predictions of both 
models; therefore it might be that different genes are regulated by distinct mechanisms, with 
the emergence of phosphoacetylation as a common feature. 
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1.3.3. Histone Methylation 
 
Another histone modification extensively studied is histone methylation. It occurs at lysines, 
where carboxyl groups become methylated or at arginines where methyl groups are 
covalently bound to nitrogen atoms. This difference in the chemistry accounts for several 
distinctions in lysine and arginine methylation. Whereas lysines can be mono-, di- or tri-
methylated, arginine is mono- or di-methylated (symmetrically or asymmetrically). Lysines 
are methylated by histone methyltransferases (HMTs), arginines by protein arginine 
methyltransferases (PRMTs) (Bannister, 2005). 
Methylation of histones bears some specific features distinguishing this epigenetic mark from 
acetylation and phosphorylation: (1) methylation of histones does not influence the charge of 
lysine and arginine residues. Therefore it is unlikely that histone methylation does 
significantly affect the interaction between DNA and the histone protein and directly alter 
chromatin structure. It rather creates binding epitopes for regulatory proteins that specifically 
recognise the methylated histone tail by distinct binding domains such as chromo- and 
tudordomain (Fischle, 2003; Dormann, 2006).  (2) Histone methylation is considered to be a 
rather stable mark. For a long time no lysine specific demethylases were known and lysine 
methylation was thought to be a real epigenetic mark responsible for the propagation of 
epigenetic information over generations. This view has been put into perspective by the 
recent identification of several demethylases (Shi, 2004; Trewick, 2005). However, compared 
to other posttranslational modifications (e.g. acetylation) the half-life of histone methylation is 
significantly longer (Fodor, 2006). (3) PRMTs and HMTs are strictly site specific and act on 
distinct arginine and lysine residues (see Table 1). (4) Several proteins can be necessary to 
act in a defined order to fully methylate lysine residues; e.g. Suvar3-9 proteins only convert 
di-methylated into tri-methylated lysine 9. The first two methyl-groups have to be delivered by 
other HMTs. (5) Methylation of distinct residues is clearly associated with distinct biological 
functions. The scope of the epigenetic information is further refined by the association of 
different biological functions with mono- di- or tri-methylated residues. 
The biological processes, where histone methylation plays a role, range from transcriptional 
regulation to epigenetic silencing via heterochromatin assembly. Methylation of lysine 4 on 
histone H3 is correlated with transcription and strongly enriched at active promoters. 
Remarkably LSD1, an H3K4 specific demethylase is found in the HDAC containing CoREST 
complex (Lee, 2005) and HDAC inhibition not only leads to enhanced histone acetylation but 
also increased lysine 4 methylation (Lee, 2006; Jiang, 2007), functionally linking histone 
acetylation and lysine 4 methylation. Histone 3 lysine 9 methylation is linked with 
heterochromatin maintenance, especially H3K9met3, which is a hallmark of constitutive 
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Histone/residue Methyltransferase Demethylase Function 
H3 R2 CARM1 (Hs, Mm)  
PADI4 (Hs) 
 
H3 K4 SET1 (Sc) 
SET7/9 (Hs) 
MLL (Hs) 
Smyd3 (Hs) 
Ash1 (Dm) 
 
 
 
 
 
LSD1 (Hs) 
JMJD2A 
Activator 
Activator 
Activator 
Repressor 
Activator 
Repressor 
Repressor ?? 
H3 R8 PRMT5  
PADI4 (Hs) 
Repressor 
H3 K9 SUV39h1 (Hs, Mm) 
SUV39h2 (Hs) 
Clr4 (Sp) 
Dim5 (Nc) 
Kryptonite (At) 
G9a (Hs, Mm) 
Eu-HMTase1 (Hs) 
ESET/SETDB1 (Hs, Mm) 
E(z)/EZH2 (Hs, Dm) 
Ash1 (Dm) 
 
 
 
 
 
 
 
 
 
 
LSD1 (Hs) 
JHDM2 (Hs) 
JMJD2A-D (Hs) 
DNA methylation, Heterochromatin, 
Repressor 
DNA methylation, Heterochromatin 
Heterochromatin, Repressor 
DNA methylation 
DNA methylation 
Imprinting, Repressor 
Repressor 
DNA methylation, Repressor 
Repressor 
Activator 
Activator 
Activator 
Activator, Repressor 
H3 R17 CARM1 (Hs, Mm)  
PADI4 (Hs) 
Activator 
H3 R26 CARM1 (Hs, Mm)  
PADI4 (Hs) 
 
H3 K27 E(z)/EZH2 (Hs, Dm) 
Ezh2 (Mm) 
 Heterochromatin, Repressor 
X-Chromosome inactivation, 
Heterochromatin, Repressor 
H3 K36 Set2 (Sc) 
NSD1 (Mm) 
 
 
JHDM1 (Hs) 
JMJD2A/C (Hs) 
Activator 
 
Repressor 
Activator, Repressor 
H3 K79 Dot1/DOT1L (Sc, Hs)  Repressor, DNA damage, Activator 
H4 R3 PRMT1  
PADI4 (Hs) 
Activator 
H4 K20 SET9 (Sp) 
SET7/8 (Hs, Dm) 
SUV4-20 (Hs) 
Ash1 (Dm) 
NSD1 (Mm) 
 DNA damage 
Repressor 
Heterochromatin 
Activator 
H1 K26 EZH2 (Hs)   
 
Table 1.  Methylation sites and responsible enzymes (adapted from (Bannister and Kouzarides, 2005))  
Hs – Homo sapiens, Mm – Mus musculus, Dm – Drosophila melanogaster, Sc – S. cerevisiae, Nc – 
Neurospora crassa; H3, H4, H1 – histones, K – lysine, R – arginine 
 
heterochromatin (Peters, 2001). In contrast, mono- or di-methylated lysine 9 residues are 
found predominantly in euchromatic regions, where they serve as marks for transcriptional 
silenced genes. Lysine 27 methylation is a repressive mark associated with defined forms of 
facultative heterochromatin: it is highly enriched at the silenced X chromosome as well as 
genes targeted by the Polycomb silencing machinery (Rougeulle, 2004; Ringrose, 2004). 
Methylation at lysine 20 of histone H4 is another repressive mark (Schotta, 2004) and the tri-
methylated species of histone H4 lysine K20 is associated with constitutive heterochromatin. 
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Interestingly, hyperacetylation of H4 is able to prevent efficient lysine 20 tri-methylation 
(Sarg, 2004), again linking two different epigenetic marks. 
 
1.4. Transposable Elements 
 
One of the most stunning features of genomes of higher eukaryotes is the fact that only a tiny 
fraction of the DNA sequence is containing coding information. In mammals about 3% of the 
genome encodes translated sequences, whereas the rest contains intronic, intergenic or 
interspersed repetitive sequences. The latter ones contribute about 46% of the human and 
39% of the murine genome (Lander, 2001; Waterston, 2002). The bulk of interspersed 
repeats are remnants of once active transposable elements (TEs) having accumulated 
numerous sequence alterations. 
Some time ago, TEs were considered as “junk DNA” without any benefit for the host; they 
were regarded as paradigmatic example for “selfish genes”, using the host as a parasite 
solely for the propagation of itself. Nowadays this one-sided view has been modified and the 
prevailing view is much more ambiguous since recent findings disclosed numerous instances 
where the host profits from the presence of TE or TE-derived sequences. 
 
1.4.1. Dangers and Benefits 
 
The dangers arising from the presence of TE are obvious: via transposition into genes or into 
the proximity of genes they can act as a mutagen. When inserted into exons, the reading 
frame might get interrupted leading to premature termination of the transcript. Insertion in 
intronic or neighbouring regions can cause incorrect splicing events resulting in termination 
of the transcript or in the creation of fusion transcripts. In some cases the regulatory 
cassettes of nearby TEs stimulate ectopic expression of genes. LINE elements have the 
ability to transduce 3’ genomic sequences, thereby bringing coding or regulatory sequences 
into novel genomic contexts resulting in changes in gene expression patterns or exon 
shuffling. Based on observations in human and mouse, there are estimations that 0.1% and 
10-15%, respectively, of all spontaneous mutations are caused by such events (Maksakova, 
2006). Another source of potential harm comes from an intrinsic feature of dispersed repeats: 
their repetitive nature makes them a susceptible target for homologous recombination events 
(Prak, 2000) causing deletions or inversions.  
All those TE-induced changes may have fatal consequences for the affected individual, 
however from an evolutionary point of view, TE-mediated alterations are an important source 
of variation. Only a fraction of TE-induced changes causes phenotypic consequences, the 
majority is phenotypically neutral. Therefore it is not surprising that there is significant 
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variability between populations (Xing, 2007) and strains (Takabatake, 2008). Recently, 
Muotri and colleagues (Muotri, 2005) could show that during neuronal development LINE 
elements are actively transposing, leading to genetic variation between neurons within the 
brain of a single individual, possibly contributing to its uniqueness. 
Differences in TE localisation patterns clearly can have consequences for the regulation of 
host genes. Peaston and colleagues identified numerous fusion-transcripts in the murine 
oocyte driven by TE-derived regulatory sequences and a recent publication demonstrated 
that strain specific TEs can be the source of strain specific fusion-transcripts (Peaston, 2004; 
Horie, 2008). This suggests that novel regulatory sequences – as delivered by TEs – are 
readily incorporated into the arsenal of the host to control endogenous genes. 
Not only regulatory sequences are co-opted by the host: there are several examples of host 
genes descending from TEs now fulfilling essential functions (a process, called “molecular 
domestication”). For instance, the RAG proteins, similar to DNA transposons, mediate the 
site-directed DNA rearrangement of immunoglobulin gene segments (V(D)J recombination) 
and telomerase, the enzyme crucial for telomere length maintenance, might also originate 
from a TE (Eickbush, 1997; Miller, 1999).  
In summary TEs are one of the driving forces of genome evolution; they shape the genome 
by introducing a range different alterations; from large genome rearrangements to subtle 
modulation of gene expression patterns. 
 
1.4.2. Classification 
 
Generally, TEs can be divided into two classes, with major differences in their mode of 
propagation: DNA transposons move as pieces of DNA, cutting and pasting themselves into 
new genomic locations. In contrast, the genomic expansion of retrotransposons occurs by a 
replicative mechanism, where a RNA transcript is reversely transcribed into DNA and 
integrates into a new genomic location (“copy and paste” mechanism) (Prak, 2000). In 
mammals no active DNA transposons have been identified so far; they are only present as 
remnants of once active elements, occupying 0.8% (mouse) or 3.0% (human) of the genome. 
The bulk of TEs comprise retrotransposons, covering 37.3% of the genome in mice and 
43.1% in humans (Lander, 2001; Waterston, 2002). They are subdivided into 3 major 
classes: (1) long interspersed nucleotide elements (LINEs), (2) short interspersed nucleotide 
elements (SINEs) and long terminal repeat (LTR) elements. For the structure of TEs, please 
see Figure A. 
(1) More than half a million LINE elements, covering roughly 20%, reside in the murine and 
human genome. Most of them are 5’ truncated or rearranged (Smit, 1999). Several 
thousands are full length (roughly 7kb), and of these an estimated 50 (human) or 3,000 
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(mouse) are active. In humans, LINE elements are the most active autonomous TEs in the 
present day genome. Several instances of LINE insertions causing diseases have been 
reported (Kazazian, 1998). 
(2) SINEs are non-autonomous, non-coding transposable elements with the length of only a 
few hundred basepairs. They are derived from the 7SL RNA or tRNAs and represent the 
most abundant class of TEs. In humans, SINEs are represented by Alu elements (1.1 million 
copies, 13.6% of the genome), in mice by B1, B2, ID and B4 elements (1.4 million copies, 
8.2% of the genome) (Waterston, 2002). As they do not contain an ORF, SINEs entirely 
depend on other mobile elements for their mobility. Transposition occurs by utilisation of the 
LINE L1 enzymatic machinery in trans. 
(3) The third class of retrotransposons, LTR elements, is structurally similar to retroviruses. 
According to the current view, the earliest infectious retrovirus originated from endogenous 
retroviral-like (ERV) elements that acquired mechanisms for horizontal transfer. In turn, many 
current endogenous retroviral elements have probably arisen from infectious retroviruses 
which have lost their capability for horizontal transfer due to mutations in the env gene. 
Therefore, the classification into three sub-classes is based on their similarity to retroviruses. 
Interestingly, the different sub-classes show a markedly dissimilar evolutionary history in 
human and mouse. Whereas ERVs are nearly extinct in human, all three sub-classes have 
active members in the mouse (Waterston, 2002). Insertional mutagenesis caused by LTR 
element is responsible for ~10% of all spontaneous mutations in the mouse. Prominent 
members of the three subclasses in mice are VL30, MuRVY, MuRRS elements (Class I / 
MLV-like / typeC / gammaretroviruses), IAP, ETn, MusD elements (Class II / MMTV-like / 
typeB / betaretrovirus) and MERVL, MT, ORR1 elements (Class III). Altogether LTR 
elements occupy 9.9% and 8.6% of the genome in mouse and human, respectively, of which 
a considerable number is internally deleted. 
 
1.4.3. Intracisternal A-type Particle 
 
Intracisternal A-type Particle (IAP) retrotransposons are among the best-studied LTR 
retroelements in the mouse. The name comes from their ability to assemble virus like 
particles into the cisternae of the endoplasmatic reticulum, which can not leave the cell 
because the lack of a functional env protein. Recently, an infectious progenitor (IAP-E) with 
an intact env gene that can pass through a complete retroviral life cycle has been identified 
(Ribet, 2008). Whereas this extracellular variant is at the edge of extinction with only a single 
active copy left, the intracellular variant is highly active with around 300 functional and 700 
non-functional copies. A full length IAP element is about 7.2kb in length, but several 
subfamilies exist which carry characteristic internal deletions exist. The most prominent 
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subfamily is the IAP I∆1 with a 1.9kb deletion in the gag-pol region (Kuff, 1988). As already 
mentioned, IAP elements are highly active; they are responsible for numerous germ line as 
well as somatic mutations (Ishihara, 2004; Howard, 2008). Interestingly the I∆1 subtype is 
the predominant variant expressed in myeloid leukaemia cells and I∆1 elements are 
responsible for virtually all germ line mutations. Loss of silencing (see next chapter) also 
leads to preferential expression of this subtype. Recent models suggest a role for the 
truncated translation product in binding the I∆1 RNA and recruiting the full length IAP protein 
for efficient transposition (Saito, 2008). 
 
1.4.4. Virus-like 30S Elements 
 
The Virus-like 30S (VL30) retrotransposon has been identified at the end of the 1970ies. 
During the propagation of MLV virus particles on mouse cells it was noticed that in addition to 
the 35-38S MLV RNA, virus particles contained a smaller RNA species sedimenting at 
around 30S. In subsequent studies this RNA was recognised as derived from genomic VL30 
retrotransposons, packed into MLV particles for transmission into heterologous cells (French, 
1997). Estimations of genomic copy numbers predict the existence of 150-200 VL30 
elements, but so far no element with intact open reading frames has been reported. 
Therefore VL30 elements are regarded as non-autonomous retrotransposons relying on the 
enzymatic machinery of other elements for successful retrotransposition. An unusual feature 
of this class of LTR elements is that its transcription can be efficiently induced by a wide 
range of agents and stimuli, among them oncogenic (SV40, Ha-ras, N-ras, TPA), growth 
(FCS, EGF), hormone (progesterone, estradiol) stress (ionising radiation, ischemia, 
vanadium) and differentiation (retinoic acid) signals (French, 1997; Tzavaras, 2003; 
Nousopoulos, 2007). Furthermore the regulation seems to be cell line specific and also 
depend on the enhancer design of individual elements. So far four different subtypes of VL30 
elements have been characterised with marked differences in the U3 region of the LTR, 
which seem to determine differential responsiveness to signals (Nilsson, 1994). 
The physiological role of VL30s is largely unknown. Recent findings showed that their 
expression enhanced the metastatic potential of human melanoma cells (Song, 2002) and 
VL30 RNA formed a complex with PSF (Song, 2004), a class of repressor proteins, thereby 
de-repressing the expression of multiple oncogenic genes in human cells (Song, 2005). In 
mouse, cerebral ischemia induced neuronal expression of VL30 RNA bound to 
polyribosomes (Costain, 2006). Thus, VL30s seem to play an important regulatory role in 
reverse gene expression and translation (Nousopoulos, 2007). 
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1.4.5. Silencing of transposable elements 
 
It has been a long-standing enigma what the mechanisms are that keep TEs in check. The 
way, how the host recognises TEs and how it mechanistically achieves comprehensive 
silencing of a multitude of TEs during different stages of development is only recently 
becoming clearer. 
The initial observation that genomic DNA associated with TEs is heavily methylated was one 
of the most important findings, raising the idea that DNA methylation might restrict the activity 
of TEs. The use of inhibitors of DNA methylation (Jaenisch, 1985; Davis, 1989) and finally 
the genetic inactivation of DNA methyltransferases indeed demonstrated the crucial role of 
DNA methylation in TE silencing (Li, 1992; Walsh, 1998; Okano, 1999; Liang, 2002; 
Bourc’his, 2004; Gaudet, 2004). Also other proteins involved in the establishment, 
maintenance or the read-out of DNA methylation patterns have been identified to be involved 
in transcriptional repression of TEs (Yu, 2001; Huang, 2004; Sharif, 2007). The mode of 
action how DNA methylation represses TE expression seems to involve the binding of 
proteins recognising methylated DNA (MBDs, methyl binding domain proteins) and the 
subsequent recruitment of enzymes and complexes converting the associated chromatin into 
heterochromatin. Alternatively the DNA methyltransferases can directly interact with histone 
modifying enzymes. Deacetylation as well as methylation of histones via HDAC complexes 
and HMTs is thought to be essential for the process of heterochromatinisation; this is 
supported by the finding that loss of the lysine 9 specific HMT Suvar3(9) is sufficient to partly 
release TE repression in murine ES cells (Martens, 2005). Interestingly silencing via DNA 
methylation is not a strictly hierarchical process, starting with DNA methylation and followed 
by changes on the chromatin level; heterochromatinisation rather seems a self amplifying 
process, due to the numerous interactions and feedback loops between the different proteins 
involved. DNA methylation appears to be the top layer of a multilayered silencing process. In 
accordance to this, de novo silencing of retroviruses can also occur in the absence of de 
novo DNA methyltransferases (Pannell, 2000). 
Loss of DNA methylation was demonstrated to be sufficient to release the repression of IAP 
elements in germ cells as well as in somatic cells and LINE elements in germ cells (Walsh, 
1998; Bourc’his, 2004). However, reports about transcriptional reactivation of other TEs have 
been elusive so far. Therefore it is not clear to which degree other TEs can also be 
reactivated by the loss of DNA methylation. Relieving one layer of repression might not be 
sufficient to induce transcription. Furthermore many TE intrinsic promoters only act in a cell 
type or stage specific manner (Branciforte, 1994; Dupressoir, 1996; Seifarth, 2005). 
Whereas the mechanisms necessary to repress TE expression – heterochromatinisation via 
DNA methylation, histone deacetylation and methylation – have been disclosed throughout 
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the last two decades, it has been unclear how silencing is specifically directed to TEs. Only 
recently, with the discovery of small interfering RNAs (siRNAs) and RNA interference (RNAi), 
this problem started getting solved; the observation that the introduction of double stranded 
RNA (dsRNA) leads to the silencing of homologous genomic sequences, sparked the idea 
that nucleic acid pathogens (viruses, viroids) and parasites (TEs) might distinguish 
themselves by producing dsRNA. The latter could be detected by a specialised machinery to 
trigger silencing. Although it turned out that different organisms have developed slightly 
varying pathways and the initial model has undergone some adaptations, the major concept 
proved to be correct: small RNAs trigger the silencing of TEs, either by cleavage of the 
transcript, translational inhibition or by transcriptional repression with the mechanisms 
described above. 
The current model for RNAi dependent TE silencing in animals (Figure B) distinguishes 
between two pathways: the piRNA pathway (Girard, 2008), where 24-27 nucleotide long so-
called piRNAs (because of their association with Piwi-like proteins) are processed from long 
RNA precursors transcribed from defined loci called piRNA clusters. These clusters are rich 
in TE-derived sequences, with a bias for TEs oriented in the antisense orientation. Thus, 
antisense piRNAs are loaded onto Piwi proteins, which target transposon transcripts. This 
complex can be either targeted to genomic transposons and trigger silencing via DNA 
methylation and histone modifications, or the transposon transcript is sliced by the PIWI 
protein initiating an amplification cycle (Figure B). The alternative pathway is the short 
interference RNA (siRNA) pathway (Birchler, 2008), where TE-derived dsRNAs are 
processed by a Dicer protein into 21-23 siRNAs and loaded into Argonaute proteins. The 
RNA directs the complex to transposon mRNA which is cleaved or targeted to genomic DNA 
where it initiates silencing. An amplification step as for the piRNA pathway has not been 
described in animals (although it exists in plants and yeast) (Figure B). 
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Figure A. Structures of transposable element types. (A) DNA transposons consist of a single ORF that 
encodes the transposase. The transposase has a DNA-binding domain and conserved DDE motif, the catalytic 
core, resembling a retroviral integrase. The ORF is flanked by inverted repeats (IR), sometimes also with direct 
repeats (DR). (B) Full length LINE elements consist of a 5’ untranslated region (5’UTR) that has promoter activity; 
two open reading frames (ORF1 and ORF2) that are separated by an intergenic spacer; followed by a 3’UTR and 
a poly A tail ((A)n). ORF1 encodes a 40kDa protein that binds nucleic acids, whereas ORF2 contains reverse 
transcriptase (RT), an endonuclease domain (EN) and a cysteine-rich region. (C) SINEs derived from tRNAs 
(such as B2, B3, ID, B4) consist of a tRNA-related region (tRNA), a non-tRNA region (L1 3’UTR) often resembling 
the 3’UTR of LINE elements, and a poly A tail ((A)n). SINEs derived from 7SL RNA (such as Alu, B1) are 300bp 
intron-less sequences that consist of two GC-rich fragments, the left (L-Alu) and right (R-Alu) monomer, 
connected by an A-rich linker, and that end in a poly A tail ((A)n). Transcription is driven by an internal Pol III 
promoter. (D) Full length LTR retrotransposons consist of partly overlapping coding regions for group-specific 
antigen (gag), protease (prt), polymerase (pol) and envelope genes, flanked on both ends with long terminal 
repeats (LTRs) with promoter activity. The pol gene contains domains for reverse transcriptase (RT), RNaseH 
and endonuclease (EN). ? … target site duplication. Adapted from Prak, 2000. 
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Figure B. RNAi mediated silencing of animal TEs. (A) The piRNA pathway in animals involves the generation 
of piRNAs from a piRNA cluster, association of the RNA with Piwi proteins and slicing of the transposon 
transcript. Alternatively genomic loci containing TEs are turned into heterochromatin. (B) The siRNA pathway in 
animals. Here, dsRNAs serve as substrate for Dicer which processes the dsRNA into short siRNAs. Subsequent 
loading of the antisense siRNA onto Argonaute proteins leads to cleavage of the transposon transcript or 
silencing of genomic TEs. Adapted from Girard, 2008. 
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2. Materials and Methods 
 
2.1. Work with DNA 
 
Plasmid DNA preparation from bacteria 
Plasmid DNA from E.coli was prepared using the Wizard® Plus SV Minipreps DNA 
Purification System from Promega or the QIAGAN® Plasmid Midi Kit. 
 
Isolation of genomic DNA eukaryotic cells 
Genomic DNA from eukaryotic cells was isolated with the help of the PUREGENE® DNA 
Isolation Kit from GentraTM. 
 
Agarose gel electrophoresis 
50x TAE: 
Tris/acetate pH 5.2 2M 
EDTA 100mM 
 
DNA Loading buffer: 
Urea 4M 
Sucrose 50% (w/v) 
EDTA pH 8.0 1mM 
Bromphenol blue 0.1% 
Storage at -20°C 
 
TAE Agarose gels: 
 2% Agarose Gel 0.8% Agarose Gel 
Agarose 1g 0.4g 
1x TAE 50ml 50ml 
Ethidiumbromid 0.5mg/l 0.5mg/l 
 
For separation and characterisation DNA fragments were loaded with DNA loading buffer on 
agarose gels and separated according to their size by electrophoresis. Gels were run with 1x 
TAE, 2-8 V/cm and the DNA was visualised on an UV screen.  
λ DNA digested with HindIII and different DNA ladders were used as size markers. 
 
Elution of DNA fragments from agarose gels 
To isolate DNA fragments for agarose gels the Wizard® Plus SV Gel and PCR Clean up 
System from Promega was used. 
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Cloning of PCR amplified DNA fragments 
To clone DNA fragments amplified with PCR, the pGEM®-T Vector System from Promega 
was utilised following the manufacturers instructions. 
 
PCR analysis 
For conventional PCR analysis we used the GoTaq® Colorless/Green Master Mix from 
Promega. For semi-quantitative analysis of ChIP experiments, the linear range of the PCR 
reaction was determined empirically by using increasing amount of DNA template and 
adapting the number of cycles for each primer pair. PCR products were resolved on 2% 
agarose-TAE gels. 
Reaction mix per sample: 
2x Master Mix  12.5µl 
Primer F (10pmol/µl)    0.5µl 
Primer R (10pmol/µl)    0.5µl 
DNA template       xµl 
H2O       xµl 
Total volume  25.0µl 
 
PCR conditions: 
Temp Time  
95°C 4’  
AT* 4’  
72°C 45’’  
95°C 60’’ 
AT 45’’ 
72°C 45’’ 
C# 
72°C 4’  
4°C ∞  
AT: annealing temperature (see primer table); C#: number of cycles  
 
Real Time PCR analysis 
SYBER green Real Time PCR was performed with the Bio-rad iCycler iQ system and Taq 
DNA Polymerase (recombinant) from Fermentas to quantify PCR assays. Reactions were 
always performed in doublets or triplicates and quantified according to a dilution series 
included within the run. 
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Reaction mix per sample: 
10x taq buffer   2.5µl 
10mM dNTP each   0.5µl 
25mM MgCl2   2.5µl 
TaqDNA polymerase (5U/µl)   0.2µl 
Primer F (10pmol/µl)   0.25µl 
Primer R (10pmol/µl)   0.25µl 
FITC Flourescein Calibration 
Dye (1µM)   0.9375µl 
10x Syber Green   1 
H2O   11.8625µl
Template   5.0µl 
total volume 25.0µl 
             
Real Time PCR conditions 
Temp Time 
95°C 3’  
95°C 20’’ 
AT 25’’ 
72°C 25’ 
40x 
95°C 
60°C 
MC  
20°C ∞  
  MC: melting curve; AT: annealing temperature 
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2.2. Work with RNA 
 
Total RNA isolation 
For the isolation of total RNA from tissue culture cells the TRIzol® Reagent (Invitrogen) was 
used according the manufacture’s protocol. To avoid degradation of RNA, RNAse Inhibitor 
was added to isolatied RNA (1u RiboLockTM RNAse Inhibitor / µl sample; Fermentas). 
Remaining DNA contamination was removed by DNAse treatment. Therefore 1-2u of 
TurboTM DNase from Ambion was added to each sample followed by incubation for 15min at 
37°C and 15min at 85°C to inactivate the enzyme. 
RNA concentration was determined by absorbance at 260nm. 
E260nm x (dilution)-1 x e-1 = concentration µg/ml   
e-1 = 40 for single stranded RNA 
To ensure equal loading and integrity of the RNA, aliquots (1µg) were diluted in RNA sample 
buffer containing ethidium bromide and run on MOPS/EDTA agarose gels. The amount of 
loaded RNA was controlled by visualisation on an UV screen.  
 
RNA separation on MOPS/EDTA agarose gels 
10x MOPS/EDTA: 
MOPS 200mM 
Na-acetate 50mM 
EDTA 10mM 
adjust to pH 7.0 
 
RNA sample buffer: 
Formamide 15ml 
10x MOPS 3ml 
37% Formaldehyde 4.8ml 
H2O, RNAse free 2ml 
Glycerol 2ml 
10% (w/v) Bromphenol blue 1.6ml 
Optional: 5µl ethidium bromide (1mg/ml) 
Storage at -20°C 
 
MOPS/EDTA gel: 
 50ml 100 ml 
Agarose 0.6g 1.2g 
H2O 42.5ml 85ml 
10x MOPS 5ml 10ml 
37% Formaldehyde 2.5ml 5ml 
 
To resolve secondary structures in the RNA, the RNA samples supplemented with sample 
buffer were heated up to 65°C for 5 min, cooled on ice and loaded on a 1.2% MOPS/EDTA 
gel. 
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cDNA Synthesis 
For preparation of cDNA from total RNA, the iScriptTM cDNA Synthesis Kit (Bio-rad) 
containing a mixture of oligo d(T) primers and random hexamer nucleotides was used. 
Reaction mix per sample: 
5x iScript reaction mix 4µl 
iScript reverse transcriptase 1µl 
Nuclease free H2O xµl 
RNA template 1µg of total 
RNA 
xµl 
total volume 20µl 
 
Reaction condition: 
Temp Time 
25°C 5’ 
42°C 30’ 
85°C 5’ 
4°C ∞ 
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2.3. Work with Proteins 
 
Isolation of whole cell extracts 
Cells were harvested by trypsination and resuspended in complete DMEM. After 
centrifugation (1000 rpm, five minutes), the cell pellet was washed in 5ml 1x PBS and 
transferred to an Eppendorf tube. Alternatively, cells were washed with 1x PBS, scratched 
from the petri-dish with a rubber policeman in 5ml 1x PBS, collected in a Falcon tube, 
pelleted by centrifugation (1000rpm, five minutes) and transferred to an Eppendorf tube. 
Then, cells were pelleted again by centrifugation at full speed for 10 seconds and the 
resulting pellet (without supernatant) was frozen in liquid nitrogen and thawed again at RT. 
Cells were resuspended in 2x pellet volume extraction buffer and again immediately frozen in 
liquid nitrogen. The extracts were thawed at 37°C for five minutes and refrozen in liquid 
nitrogen. Slow thawing on ice for 15 minutes, followed by centrifugation at full speed at 4°C 
for 10 minutes, resulted in a supernatant, which directly could be used for Western blot 
analysis. If cells were pretreated with chemical inhibitors, 1xPBS and extraction buffer was 
supplemented with appropriate HDAC or phosphatase inhibitors. 
Extraction buffer (Hunt Buffer): 
Tris-HCl pH 8.0 20mM 
NaCl 100mM 
EDTA pH 8.0 1mM 
NP-40 0.5% 
Protease inhibitors (Complete; Roche) 
 
Deacetylase inhibitors 
Na-Butyrate 100 × Stock 1M 
10mM final concentration 
 
Phosphatase inhibitors 
Inhibitor Stock Final conc. 
NaF - 0.21g/100ml lysis buffer 
Tetra-Sodium-pyrophosphate - 0.9g/100ml lysis buffer 
Na-orthovanadate 100× 0.184g/10ml 50mM Tris pH7.5 
Β-glycerphosphate 100× 2.16g/100ml H2O 
 
Histone isolation 
Cells were harvested, washed and pelleted as described above. After washing with cold PBS 
and repeated centrifugation (full speed, 10 seconds) the pellet was resuspended in 1ml ice-
cold lysis buffer by vortexing or pipetting and then centrifuged. Three further wash steps with 
lysis buffer and one with Tris/ EDTA wash buffer, each followed by centrifugation, resulted in 
a nuclear pellet, which was incubated with 100 µl ice cold H2O supplemented with H2SO4 to a 
final concentration of 0.4 N for at least 1 hour on ice. Then the samples were centrifuged 
___________________________________________________________________________ 
  35 
(4°C, full speed, 10 minutes). The supernatant was mixed with 10x volume acetone and the 
histones were precipitated from 1h to overnight at -20°C. Precipitates were collected by 
centrifugation (4°C, full speed, 10 minutes). The pellet was air-dried and resuspended in a 
suitable volume of H2O. If cells were pretreated with chemical inhibitors, 1xPBS, lysis and 
wash buffer was additionally supplemented with appropriate HDAC or phosphatase 
inhibitors. 
Lysis buffer: 
Tris 10mM 
Na-bisulfite 50mM 
MgCl2 10mM 
Na-butyrate 10mM 
Triton X-100 1% 
Sucrose 8.6% 
adjust to pH 6.5 
 
Wash buffer: 
Tris 10 mM 
Na3EDTA 13 mM 
adjust to pH 7.4 
 
Determination of protein concentration 
The concentration of total protein was determined using a Biorad Protein Assay reagent. The 
extract was diluted 1:1000 in a 1:5 dilution of the reagent, mixed well and the spectroscopic 
absorption was measured at 595nm. Total protein concentration was estimated with help of 
standard curve built for known concentrations of protein vs. OD595 values. 
 
SDS-Gel-Electrophoresis 
Acrylamide stock: 
acrylamide  30%  
N,N´-methylene-bisacrylamide 0.8% 
 
Separating gel buffer: 
Tris-HCl pH 8.8 1.5M  
 SDS 0.4% 
 
Stacking gel buffer: 
Tris-HCl pH 6.8 0.5M  
SDS 0.4%  
 
___________________________________________________________________________ 
  36 
SDS Sample buffer: 
Tris-HCl pH 8.8 100mM 
glycerol 20%  
bromphenol blue 0.01% 
DTT 200mM  
SDS 4%  
 
10x Running buffer: 
Tris  50mM  
glycine 500mM  
SDS  0.2% 
 
Western blot analysis 
After proteins were separated on an SDS-gel, the stacking gel was removed and the 
separation gel was transferred to distilled water. 3MM filter paper and a nitro-cellulose 
membrane (Schleicher & Schuell, Nr. BA 83) were cut to the size of the gel and soaked in 
Harlow buffer. The support pads of the transfer unit were also soaked in Harlow buffer. The 
sandwich was assembled in the following order: support pad, 2 sheets of 3MM paper, gel, 
nitrocellulose membrane, 2 sheets of 3MM paper and again support pad. The sandwich was 
placed in the electrotransfer unit (Hoefer), filled with transfer buffer. The transfer was 
performed at a constant current of 200mA (1 or 2 gels) in a cold room for 1.5 hours under 
stirring with a magnet bar. The quality of the transfer was checked by staining the membrane 
with 1x Ponceau for one minute. The excess Ponceau was removed by rinsing the 
membrane with distilled water. 
Harlow 2 transfer buffer: 
Tris  25mM 
glycine 190mM 
methanol 20% 
 
10x Ponceau S: 
Ponceau S 2%  
trichloroacetic acid 30%  
sulfosalicylic acid 30%  
 
Antibody Incubation 
In order to block any unspecific reactions of the antibodies, the membrane was incubated 
with blocking solution for one hour at RT under gentle agitation. 
The incubation with the primary antibody (diluted in blocking solution) was carried out at 4°C 
overnight or at room temperature for at least one hour. 
After three washing setps with 1x PBS, containing 0.1% Tween-20, 15 minutes each, the blot 
was incubated with the secondary (peroxidase-coupled) antibody, diluted in 1x PBS, 0.1% 
Tween 20, for one hour at RT followed by another three washes. 
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Western blocking solution: 
PBS 1x 
PVP 1%  
non fatty dried milk 1% 
Tween 20 0.1%  
NaN3 0.01%  
 
Immunodetection by ECL (Enhanced Chemo-Luminescence) 
Equal amounts of ECL solution 1 and 2 (Amersham) were mixed, poured over the blot and 
incubated for one minute. The excess of ECL solution was removed and the membrane was 
packed into saran wrap and exposed to X-ray films. 
 
Western blot stripping 
Western blots that have been used for ECL could be re-used after stripping. The blot was 
washed three times in PBS, 0.1% Tween 20. After incubation with stripping buffer at 50°C for 
30 minutes, the blot was washed again three times with PBS, 0.1% Tween 20 and was then 
ready for a new incubation with a different antibody. 
Stripping buffer (100 ml): 
20% SDS 10ml 
1 M Tris-HCl pH 6.7 6.25ml 
ß-mercaptoethanol 700µl 
H2O 83.05ml 
 
The following antibodies were used in this study: 
Antibody Name Dilution  Source Company Cat. Nr. 
histone H3 c-H3 1:50000 r Abcam ab1791 
pan-acetyl-histone H3 H3ac 1:5000 r Upstate 06-599 
pan-acetyl-histone H4 H4ac 1:5000 r Upstate 06-598 
acetyl (lys9)-histone H3 H3K9ac 1:5000 r Upstate 07-352 
acetyl (lys14)-histone H3 H3K14ac 1:5000 r Upstate 06-911 
acetyl (lys5)-histone H4 H4K5ac SAT247 1:5000 r Upstate 06-759 
acetyl (lys8)-histone H3 H4K8ac SAT198 1:5000 r C. Seiser  
acetyl (lys12)-histone H3 H4K12ac SAT44 1:5000 r C. Seiser  
acetyl (lys16)-histone H3 H4K16ac SAT53 1:5000 r C. Seiser  
mono-methyl-(lys9)-histone H3 H3K9met1 1:5000 r T. Jenuwein  
di-methyl-(lys9)-histone H3 H3K9met2 1:5000 r T. Jenuwein  
tri-methyl-(lys9)-histone H3 H3K9met3 1:5000 r T. Jenuwein  
mono-methyl-(lys27)-histone H3 H3K27met1 1:5000 r T. Jenuwein  
di-methyl-(lys27)-histone H3 H3K27met2 1:5000 r T. Jenuwein  
tri-methyl-(lys27)-histone H3 H3K27met3 1:5000 r T. Jenuwein  
mono-methyl-(lys20)-histone H4 H4K20met1 1:5000 r T. Jenuwein  
di-methyl-(lys20)-histone H4 H4K20met2 1:5000 r T. Jenuwein  
tri-methyl-(lys20)-histone H4 H4K20met3 1:5000 r T. Jenuwein  
di-methyl-(arg17)-histone H3 H3R17met2 1:2000 r Upstate 07-214 
di-methyl-(arg3)-histone H4 H4R3met2 1:2000 r Upstate 07-213 
tri-methyl-(lys4)-histone H3 H3K4met3 1:5000 r Upsate 07-473 
tri-methyl-(lys4)-histone H3 H3K4met3 1:5000 r Abcam ab8580 
histone deacetylase 1 HDAC1 10E2 1:2000 m C. Seiser  
histone deacetylase 2 HDAC2 3F3 1:100 m C. Seiser  
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histone deacetylase 3 HDAC3 1:10000 r Abcam ab16047 
DNA methyltransferase 1 DNMT1 1:2000 m Abcam ab13537 
ß-actin ACTIN 1:5000 m Sigma A5316 
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2.4. Work with Bacteria 
 
Solutions and media 
Antibiotic stock solutions 
Ampicillin 100 mg/ml 
Kanamycin 50 µg/ml 
 
Luria-Bertani liquid medium (LB-medium) 
Bacto-Trypton (Difco) 10 g/l 
Bacto-Yeast Extract (Difco) 5 g/l 
NaCl 5 g/I 
 
Top agarose 
Bacto-Trypton (Difco) 10 g/l 
NaCl 8 g/I 
Agarose 6 g/l 
 
All media were sterilized by autoclaving and stored at 4°C. For the selection of transformed 
bacteria the autoclaved media were supplemented with the appropriate antibiotics. 
Solid bacteria media were prepared by adding 1.5% w/v Bacto-Agar (Difco) to liquid media 
before autoclaving. After cooling the medium to 50°C, antibiotic stock solutions were added 
to the proper final concentrations and poured into petri dishes. LB plates were stored at 4°C. 
For blue/white selection of bacteria, LB plates were supplemented with IPTG (5.5mM) and X-
Gal (= 5-bromo-4-chloro-3-indyl-β-D-galactoside) 80µg/ml. 
 
Growth of bacteria 
Liquid cultures were inoculated either with frozen bacterial stocks or with bacterial colonies 
from agar plates stored at 4°C. Single colonies were picked with sterile toothpicks, 
transferred into the appropriate liquid medium and incubated at 37°C under agitation 
overnight. 
 
Freezing of bacteria 
For long-term storage, 2x freezing buffer and overnight bacteria culture were mixed 1:1 and 
stored at -80°C.  
2x Freezing buffer 
K2HPO4 12.60 g/l 
KH2PO4   3.60 g/l 
Na citrate   0.90 g/l 
MgSO4 •7 H2O   0.18 g/l 
(NH4)2SO4   1.80 g/l 
Glycerol 88.00 g/l 
storage at 4°C 
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Transformation of bacteria 
Heat shock competent bacteria (DH5α) were thawed on ice, DNA (~5ng) was added and 
bacteria were incubated for another 20min on ice. After a heat shock of 45sec at 42°C, 500µl 
of SOC medium was added and bacteria were rotated for ½ - 1h at 37°C before they were 
plated on appropriate LB plates and incubated O/N at 37°C. 
SOC medium 
Bacto-Trypton 2% 
Bacto-Yeast Extract 0.5% 
NaCl 10 mM 
Kcl 2.5 mM 
MgSO4 10 mM 
MgCl2 10 mM 
Glucose 20 mM 
storage at -20°C 
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2.5. Cell Culture 
 
Solutions and media 
10x Phosphate buffered saline (PBS): 
NaCl 80g/l 
KCl 2g/l 
Na2HPO4 16.5g/l 
KH2PO4 2g/l 
Adjust pH to 7.4 
 
100x Antibiotic stock solution (AB): 
Penicillin G potassium salt 6g/l 
Streptomycin sulfate 10g/l 
Dissolved in 1x PBS 
 
100x Antibiotic stock solution plus glutamine (AB + G): 
Glutamine 5.8g/l 
Dissolved in 100x AB 
 
Trypsine/EDTA solution (TE): 
Trypsine 2.2U/mg 700mg 
10x PBS 25ml 
1% Na-EDTA, pH 7.4 5ml 
Add water to a final volume of 250ml 
 
Dulbecco’s modified eagle medium (DMEM) 
DMEM (Sormed) powder was dissolved in bidestilled water, supplemented with 3.7g/l 
NaHCO3 and sterilised by filtration (pore size 0.2µm). The DMEM was stored at 4°C. Before 
use 450ml DMEM were supplemented with 5ml AB and fetal calf serum (FCS, Gibco BRL) 
stored in 50ml aliquots at -20°C.  
 
Medium for murine embryonic stem cell (ESC) cultivation (M15) 
ES cell qualified high-glucose DMEM containing 4500 mg/l glucose (Sigma) was 
supplemented with 15% FCS (HyClone), 1x AB + G, 1x  ß-mercaptoethanol and ESGRO LIF 
(103 units / ml medium). The medium was stored at 4°C and prewarmed at 37°C before use. 
 
100x ß-Mercaptoethanol stock solution (0.01M) 
72µl of 14M ß-mercaptoethanol were added to 100ml 1x PBS, the solution was sterilized by 
filtration, aliquoted and stored at – 20°C. Once in use, the solution was stored at 4°C. 
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0.1% (w/v) Gelatine solution 
10g gelatine were added to 1l dH2O, the solution was mixed on a rotator and autoclaved for 
30 minutes at 120°C. After cooling down to room temperature, the working solution was 
prepared by diluting the 1% gelatin in sterile water. Gelatine solution was stored at 4°C. 
 
2x Freezing medium for ESCs 
2x Freezing Medium for ESCs contained 20% DMSO, 20% FCS (HyClone) in high-glucose 
DMEM (GibcoBRL). 
 
Cell culture and splitting of fibroblast and osteosarcoma cells 
Cells were cultured in petri-dishes with DMEM medium at 37°C and in an atmosphere of 
7.5% CO2. After reaching a critical density (sub-confluent), the cells were split and supplied 
with fresh medium. Therefore, cells were washed twice with 1x PBS and incubated with TE 
at 37°C for several minutes. When cells detached from the surface they were taken up with 
an appropriate amount of medium, resuspended carefully and split to fresh petri-dishes in 
adequate dilutions.  
 
Cell culture and splitting of ESCs 
ES cells were cultured on pre-gelatinised tissue culture dishes: therefore petri-dishes were 
covered with 0.1% gelatine solution and incubated for at least 10min at room temperature. 
Prior to use excess of gelatine was removed. Cells were incubated at 37°C in a 5% CO2-
atmosphere. 
Established ES cell lines required to be subcultured every third day. When reaching 
confluence, ES cells were split 1:3 - 1:5. For this purpose, cells were washed twice with 1x 
PBS and trypsinised with TE in HBBS w/o Ca&Mg (Gibco) twenty minutes at 37°C. 
Trypsinisation was stopped by adding at least two volumes of M15. Cells were disaggregated 
by carefully pipetting up and down with a glass or a Gilson pipette to generate a single-cell 
suspension, before being replated at optimal density onto fresh gelatinised petri-dishes. 
Medium had to be changed every day. 
 
Freezing of fibroblast and osteosarcoma cells  
Logarithmically growing cells were trypsinised, taken up with 10ml medium and collected by 
centrifugation at 1200 rpm for 5 minutes. The resulting cell pellet was dissolved in 90% FCS 
and 10% DMSO, mixed well and transferred into a freezing-ampoule (cryo tube, Nunc). After 
30 minutes of incubation on ice, the freezing-ampoule was cooled to -80°C for one day and 
finally transferred to liquid nitrogen for long time storage. 
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Thawing of fibroblast and osteosarcoma cells  
Cells stored in liquid nitrogen were quickly thawed at 37°C in a water bath for 2-3 minutes. 
Then cells were transferred in a fresh petri-dish containing a 10 ml CO2 saturated DMEM 
medium. When cells attached to the surface, fresh medium was supplied to remove the 
DMSO contained in the freezing medium. 
 
Freezing of ESCs  
After 2x washing with 1x PBS, trypsinisation and neutralization with the appropriate medium, 
one volume of 2x freezing medium was added to the cells, drop by drop, under gentle 
agitation.  
If the cell suspension to be frozen had a volume larger than 0.9-1 ml, cells were collected by 
centrifugation and resuspended in 0.5 ml cell culture medium before dropwise addition of the 
same volume of freezing medium. Freezing vials were stored at –80°C at least overnight 
before being transferred into liquid nitrogen for long-term storage.  
 
Thawing of ESCs 
After quick thawing in a 37°C waterbath, cells were transferred into a Falcon tube. 10 to 15 
ml of appropriate cell culture medium was added dropwise under gentle shaking. To avoid 
any contamination by DMSO, cells were collected by centrifugation at 1000 rpm for 7 
minutes. The supernatant was discarded, cells were resuspended in a suitable volume of 
medium and seeded onto tissue culture dishes. 
 
Cell lines used in this study 
Mouse fibroblasts 3T3 Swiss (ATCC: CCL-92) 
The mouse fibroblast cell line 3T3 Swiss was cultured by G. Todaro and H. Green and 
derived from Swiss Albino mouse embryos. This hypotetraploid cell line was cultured in 
DMEM + AB + 10% FCS and was arrested in G0 by reducing FCS to 0.2% for 48-72 hours. 
 
Mouse fibroblasts NIH/3T3 (ATCC:  CRL-1658) 
NIH/3T3 is a fibroblast cell line established from NIH Swiss mouse embryo cultures. Culture 
conditions are similar to 3T3 Swiss cells. 
 
Mouse fibroblasts PM 
This mouse fibroblast cell line was established by Y. Zhang from the laboratory of P. 
Matthias at the FMI, Basel. Cells were derived from E13.5 129SV/BL6 mouse embryos 
carrying two floxed alleles of the HDAC1 gene and immortalised via the 3T3 protocol. Cells 
are aneuploid and carry a mutation in the p53 tumour suppressor gene (see J. Jurkin, 
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Diploma thesis, 2006). Cultivation conditions are similar to 3T3 Swiss cells. Several 
subclones of this cell line have been established: PM1/1, PM1/2, PM1/3 and PM1/4 
subclones were transiently transfected with an EGFP carrying plasmid, GFP+ cells were 
FACS sorted into 96-well plates and raised for further use as wildtype control cell lines. 
PM4/1, PM4/2, PM4/3 and PM4/4 subclones were transfected with a plasmid carrying EGFP 
and the cre recombinase gene. GFP+ cells were FACS sorted into 96-well plates, raised, and 
served as HDAC1 knock out fibroblast cell lines (Deletion of exon 6 of the HDAC1 gene was 
verified via PCR, Western Blot and Immunoflourescence). 
 
Mouse embryonic stem cells 3A1R 
This embryonic stem cell line was created by blastocyst outgrowth experiments from G. 
Weitzer at the MFPL, Vienna in collaboration with our laboratory. The ES cell line carries one 
wildtype and one floxed allele of the HDAC1 gene, corresponding to a wildtype genotype; the 
genetic background is 129SV/BL6. Cells are cultivated on gelatinised petri-dishes in M15 ES 
cell medium with LIF. 
 
Human osteosarcoma cells U2OS (ATCC: HTB-96) 
This cell line was derived from a moderately differentiated sarcoma of the tibia of a 15 year 
old girl in 1964 by J. Ponten and E. Saksela. Cells are hypertriploid and are maintained in 
medium containing DMEM + AB + 10% FCS. 
 
Drugs, inhibitors and reagents 
The following drugs were used in this study: 
Trichostatin A (TSA) (66nN or 166nM; Wako Pure Chemical Industries) 
5’-Aza-2’-deoxycytidine (Aza-dC) (1µM or 100µM; Sigma) 
Anisomycin (Aniso) (189nM; Sigma) 
Okadaic acid (OA) (50nM; Sigma) 
all-trans-Retinoic acid (RA) (10nM; Sigma) 
H89 (10µM; Alexis Biochemicals) 
G-418 (500µg/ml; Sigma) 
 
Transfection of U2OS cells 
To transfect U2OS cells with plasmid DNA, the LipofectamineTM reagent from Invitrogen was 
used according the manufactorers instruction. Shortly, 1µg and 5µl of LipofectamineTM was 
incubated in 250µl OptiMEM®  (Invitrogen) each for 5min at RT. Then the content of both 
eppis was joined, incubated for another 15min at RT and put on a 6well plate which 
contained logarithmically growing U2OS cells in 2ml DMEM + AB + 10% FCS. Therefore, the 
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cells were split 24h prior to the transfection procedure and 100,000 cells were seeded per 
6well. 5-6h after transfection the medium was removed and replaced by 2.5ml DMEM + AB + 
10% FCS. If desired, 66nM of TSA was added for 24h after transfection. To monitor 
expression levels of the transfected DNA constructs, cells were lysed 24h after transfection 
with 500µl TRIzol® reagent from Invitrogen and RNA was isolated as described above. For 
quantification of RNA levels, cDNA was prepared as described earlier and subjected to Real 
Time PCR analysis. For analysis of transposition frequency, cells were trypsinesed 24h post 
transfection and transferred to a 10cm dish where they were grown till ~80% confluency 
(~6days). Then, cells were again trypsinesed, cell numbers were determined using the 
CASY®1 cell counter and 500,000 cells were seeded per 10cm dishes. Selection for neo+ 
cells was started 24h later by adding 500µg/nl G418 to the medium and maintained for 10-
14days till all neo- cells detached from the surface and neo+ positive cells were growing in 
visible clones of at least 1mm diameter. To quantify the number of neo+ positive clones, cells 
were washed with 1x PBS prior to fixation with 70% EtOH for 10min, washed again with 1x 
PBS, stained with Methylenblue-Solution for 10min to visualise the colonies and finally the 
plates were rinsed with H2O to remove the remaining background staining. 
Methylenblue-solution: 
Methylenblue 0.1% w/v 
NaAc 0.5M 
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2.6. Chromatin Immunoprecipitation (ChIP) 
 
Buffers 
Wash buffer I 
Triton X-100 0.25% 
EDTA pH 8.0 10mM 
EGTA pH 7.5 0.5mM 
Hepes pH 7.5 10mM 
 
Wash buffer II 
NaCl 0.2M 
EDTA pH 8.0 1mM 
EGTA pH 7.5 0.5mM 
Hepes pH 7.5 10mM 
 
SDS lysis buffer 
SDS 1% 
EDTA 10mM  
Tris-HCl pH 8.1 50mM 
 
Dilution buffer 
SDS 0.01% 
Triton X-100 1.1% 
EDTA 1.2mM 
Tris-HCl pH 8.1 16.7mM 
NaCl 167mM 
 
RIPA wash 
NaCl 150mM 
Tris-HCl pH 8.0 50mM 
SDS 0.1% 
NaDoc 0.5% 
NP-40 1% 
 
High salt wash 
NaCl 500mM 
Tris-HCl pH 8.0 50mM 
SDS 0.1% 
NP-40 1% 
 
LiCl wash 
LiCl 250mM 
Tris-HCl pH 8.0 50mM 
NaDoc 0.5% 
NP-40 1% 
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TE 
Tris-HCl pH 8.0 10mM 
EDTA pH 7.5 1mM 
 
Elution Buffer 
SDS 2% 
NaHCO3 0.1M 
DTT 10mM 
 
Preparation of sepharose bead suspension 
Solid A-beads were pre-swollen in TE on ice for 30 minutes. A-beads were then washed 
three times with TE. G-beads, which are provided by the manufacturer as a suspension, 
were re-buffered in TE by washing the beads three times with TE. Then the beads were 
blocked by adding the following solutions per ml swollen beads: 
sonicated Salmon Sperm DNA (10mg/ml) 20µl 
BSA (10mg/ml) 100µl 
NaAzid 2% 50µl 
TE 830µl 
 
Finally the beads were rolled for one hour at 4°C. Beads were stored at 4°C. 
 
Formaldehyde fixation and preparation of soluble chromatin 
Chemical cross-link of chromatin was performed by addition of formaldehyde for 10 minutes 
at 37°C directly to the medium in the culture-dish at a final concentration of 1%. A 
subsequent incubation with glycine at a final concentration of 125mM for 5 minutes at room 
temperature stopped the formaldehyde fixation. After washing the cells twice with 1x PBS 
they were scraped with a rubber policeman in PBS containing 1mM PMSF. The cells were 
then pelleted at 1200 rpm at 4°C for five minutes. The cell pellet was washed with wash 
buffer I containing 1mM PMSF, protease inhibitors (Complete; Roche) and when desired 
10mM sodium butyrate, 10mM β-glycerophosphate and 10mM orthovanadate. After 10 
minutes incubation on ice, nuclear extracts were pelleted at 1200 rpm at 4°C for five minutes. 
The nuclear pellet was washed with wash buffer II containing the same inhibitors and 
incubated on ice of 10 minutes. Finally, washed nuclear extracts were pelleted at 1200 rpm 
at 4°C for five minutes and the washed nuclear pellet was resuspended in lysis buffer at a 
concentration of 107 cells/ml containing inhibitors as indicated above. The lysate was 
incubated 30 minutes on ice or stored up to two months at 4°C. Chromatin was sheared to 
an appropriate size for ChIP (approximately 500bp) by sonication of the nuclear lysate. The 
Bandelin UW 70 sonotrode, which was equipped with a 2mm tip, was used setting the output 
signal to 40% and the duty cycle to 90%. After each sonication step for 15 seconds the lysate 
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was kept on ice for two minutes. Sonication steps were repeated up to 6 times. To pellet 
cellular debris, the cell lysate was centrifuged for 10 minutes at 4°C at full speed. 
 
Chromatin immunoprecipitation and isolation of precipitated DNA 
The remaining supernatant, which comprises the soluble chromatin fraction, was then 
aliquoted for different chromatin immunoprecipitations using approximately 106 cells in 100µl 
per IP and diluted 10-fold in dilution buffer containing the specific inhibitors as mentioned 
above. One aliquot was kept for isolation of DNA fragments and is referred to as input DNA. 
The chromatin samples were pre-cleared by addition of 20µl of protein A/G Sepharose beads 
and rocked at 4°C for at least one hour. After centrifugation for three minutes at 4°C at 1500 
rpm the supernatant was combined with the antibody of interest (2-8µg, depending on the 
antibody) or with an unspecific IgG (1µg) and immuno-complexes were formed while rocking 
over night at 4°C. 
Chromatin antibody complexes were isolated by incubation with 30µl of protein A/G 
Sepharose beads and rocked at 4°C for at least one hour. The beads were harvested by 
centrifugation at 4°C for three minutes at 1500 rpm and were then washed one to two times 
with 900µl of each RIPA, high salt and LiCl buffer and two to four times with 900 µl TE buffer 
by rocking for 10 minutes at 4°C. Immuno-complexes were eluted from the Sepharose beads 
by addition of 400µl elution buffer and vigorous rocking at room temperature for 30 minutes. 
Cross-link of immunoprecipitated chromatin and input aliquots was reversed by addition of 
0.05 volume of 4M NaCl to the eluted samples and incubation at 65°C over night. Next day 
Proteinase K digestion was performed (0.025 volume of 0.5M EDTA pH 7.5, 0.05 volume of 
1M Tris pH 6.5 and proteinase K (final concentration 0.1mg/ml)). DNA was recovered by a 
phenol-chloroform-isoamylalcohol (PCI) extraction and precipitated by addition of 0.1 volume 
of 1M sodium acetate pH 5.2, 20µg glycogen and 2.5 volumes of ethanol. 
Immunoprecipitated and input DNA was dissolved in 200µl water. For quantification via Real 
Time PCR or semi-quantitative conventional PCR, 5µl of the DNA or 5µl of a 1:40 dilution of 
input DNA was used as template. 
 
Antibodies 
The following antibodies were used in this study: 
Antibody Name µl  Source Company Cat. Nr. 
unspecific IgG UN 1 r Ch. Seiser - 
histone H3 c-H3 6 r Abcam ab1791 
pan-acetyl-histone H3 H3ac 5 r Upstate 06-599 
pan-acetyl-histone H4 H4ac 5 r Upstate 06-598 
phospho (ser10)-acetyl 
(lys14)-histone H3 
H3S10p/H3K14ac 10 r Upstate 07-081 
phospho (ser10)-acetyl 
(lys14)-histone H3 
H3S10p/H3K14ac 
GP3 
2 r Ch. Seiser 
 
- 
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2.7. Primers used in the study 
 
Primers for ChIP analysis 
Gene Name Sequence Temp.
actb_prom_f GCCAGCACCCATCGCCAAAACTC 
actb_prom_r TTGGCTCCGCGTCGCTCACTCA ß-actin 
PL: promoter 
59° 
mPrss11 (-500) F CAAGTTCACAGCCACAGTCC 
mPrss11 (-500) R GGCACTTAACAGAGGGAAACC 
Prss11 / 
HtrA1 
PL: mPrss11 (-500) F: -401 of 1exon1; mPrss11 (-500) R: -256 of exon1; PS: 146bp 
59° 
L1-ORF2-for TTTGGGACACAATGAAAGCA 
L1-ORF2-rev2 CTGCCGTCTACTCCTCTTGG LINE1 
PL: ORF2; PS: ~200bp; RE: Martens, 2006 
59° 
Sine_B1_for GTGGCGCACGCCTTTAATC 
Sine_B1_rev GACAGGGTTTCTCTGTGTAG SINE B1 
PS: 122bp; RE: : Martens, 2006 
59° 
Sine_B2_for GAGATGGCTCAGTGGTTAAG 
Sine_B2_rev CTGTCTTCAGACACTCCAG SINE B2 
PS: 132bp; RE: : Martens, 2006 
59° 
mVL30-for CCTTTGTTGCCCAGGTAAGTC 
mVL30-rev CACTGTAGCCAGTTGTGACCAG VL30 int 
PL: pol; PS: ~380bp; RE: Puschendorf, 2006 
59° 
VL30_LTR/UTR_for ACAGCGCGACCACCCAGAGG 
VL30_UTR_rev GTCCCTGATCCTCCCCTGTTCCT VL30 LTR 
PL: 5'LTR/UTR; PS: ~240bp 
59° 
IAPgagIDI_for GAGATTGGACTTTTGACTTGT 
IAPasen TGTGGCTTGCTCATAGATTAG IAP int 
PL: gag region; PS: ~270bp 
59° 
IAP_LTR_chip_I/III_for AC AAG ATG GCG CTG ACA GCT  
IAP_LTR_chip_I/II_rev G AGC ATT CTC CTT CGC CTC  IAP LTR 
PL: LTR; PS: ~170bp 
59° 
ETn-for CAGGCTTTGGAGACAATAGGG 
ETn-rev TCTCTCAGGGAACTCAGAAACG ETn 
PS: ~280bp; RE: Puschendorf, 2006 
59° 
MuERVL-for CCCATCATGAGCTGGGTACT 
MuERVL-rev CGTGCAGATCCATCAGTAAA MERVL 
PS: ~280bp; RE: Puschendorf, 2006 
59° 
MT-for ATGTCTTGGGGAGGACTGTG 
MT-rev AGCCCCAGCTAACCAGAACT MT 
PS: ~250bp; RE: Puschendorf, 2006 
59° 
ORR1-for CTTTAGTTGATGGCCCAGGA 
ORR1-rev CCAACTCTGCCCTCTGTAGC ORR 
PS: ~250bp; RE: Puschendorf, 2006 
59° 
Tigger_for GTGTCAGGAGGTTTCAAAGGCTC 
Tigger_rev CGCTCTCTTGAAGGCAAGGACTC Tigger 
PS: 352bp; RE: based on homology to human Tigger; Martens, 2006 
59° 
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Primers for gene expression analysis 
Gene Name Sequence Temp. Org. 
RT-HPRT-fo GCTGGTGAAAAGGACCTCT 
RT-HPRT-rev CACAGGACTAGAACACCTGC HPRT 
  
59° m 
Actin-for TGG CAC CAC ACC TTC TAC AAT GAG 
Actin-rev CAA GAA GGA AGG CTG GAA AAG AG ß-actin 
  
59° m 
RT-Prss11for TCG GAG GAT GGA CTG ATT GT 
RT-Prss11rev GTT TGG CTT TGC TAG ATG TGA G 
Prss11 / 
HtrA1 
  
59° m 
L1-ORF2-for TTTGGGACACAATGAAAGCA 
L1-ORF2-rev2 CTGCCGTCTACTCCTCTTGG LINE1 
PL: ORF2; PS: ~200bp; RE: Martens, 2006 
59° m 
Sine_B1_for GTGGCGCACGCCTTTAATC 
Sine_B1_rev GACAGGGTTTCTCTGTGTAG SINE B1 
PS: 122bp; RE: Martens, 2006 
59° m 
Sine_B2_for GAGATGGCTCAGTGGTTAAG 
Sine_B2_rev CTGTCTTCAGACACTCCAG SINE B2 
PS: 132bp; RE: Martens, 2006 
59° m 
 RLTR1b_for GAGAGGCGAGAGGCAGAAGAAAG 
 RLTR1b_rev GTCGCCAACCTAGGTATCCAGAG RLTR1b 
  
59° m 
RLTR6_for CCCCCTGAGGAGCGGTGT 
RLTR6_rev AGTAAGCATCCCCTGTCGTTTCA RLTR6 
  
59° m 
mVL30-for CCTTTGTTGCCCAGGTAAGTC 
mVL30-rev CACTGTAGCCAGTTGTGACCAG VL30 
PS: ~380bp; RE: Puschendorf, 2006 
59° m 
IAPsen ACTAACTCCTGCTGACTGG 
IAPasen TGTGGCTTGCTCATAGATTAG IAP 
PL: IAPsen: gag region;pos. ~890; IAPasen: gag region; pos. ~1310; PS: ~420bp 
59° m 
ETn-for CAGGCTTTGGAGACAATAGGG 
ETn-rev TCTCTCAGGGAACTCAGAAACG ETn 
PS: ~280bp; RE: Puschendorf, 2006 
59° m 
MuERVL-for CCCATCATGAGCTGGGTACT 
MuERVL-rev CGTGCAGATCCATCAGTAAA MERVL 
PS: ~280bp; RE: Puschendorf, 2006 
59° m 
MT-for ATGTCTTGGGGAGGACTGTG 
MT-rev AGCCCCAGCTAACCAGAACT MT 
PS: ~250bp; RE: Puschendorf, 2006 
59° m 
ORR1-for CTTTAGTTGATGGCCCAGGA 
ORR1-rev CCAACTCTGCCCTCTGTAGC ORR 
PS: ~250bp; RE: Puschendorf, 2006 
59° m 
Tigger_for GTGTCAGGAGGTTTCAAAGGCTC 
Tigger_rev CGCTCTCTTGAAGGCAAGGACTC Tigger 
PS: 352bp; RE: based on homology to human Tigger; Martens, 2006 
59° m 
mHDAC1 RT-F AAGCAGCAGACG GACATCG 
mHDAC1 RT-R GCCTCTTCCACGCCATCG HDAC1 
  
59° m 
neo_for_N ATCAGACAGCCGATTGTCTG 
neo_rev CAGTTCCGCCCATTCTCCG neo 
PS: ~250bp 
59° h 
RT_hGAPDH_for TCTTCTTTTGCGTCGCCAG 
RT_hGAPDH_rev AGCCCCAGCCTTCTCCA GAPDH 
RE: Fraga, 2005 
61° h 
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Primers for genotyping 
Gene Name Sequence Temp.
WT-fo GGCCTTGTGTCTTGGAAGAGCACC 
WT-rev GCTGAAGGAAGGTGGAAGAGTGGC HDAC1 wt 
PL: WT-fo/rev: exon 5; PS: 319bp 
54  
KO-fo CCTCCCATTGAGTTGGCAGGGCAA 
Lac-out AACCCGTCGGATTCTCCGTGGGAA HDAC1 ko 
PL: KO-fo: intron 4; Lac-out: LacZ gene; PS: 490bp 
 54 
HDAC1-lox-for GGTAGTTCACAGCATAGTACTT 
HDAC1-lox-rev CTGTGTCATTAGAATCTACTT HDAC1 lox 
  
 54 
HDAC1-lox-for GGTAGTTCACAGCATAGTACTT 
HDAC1-delta-rev GTTACGTCAATGACATCGTCTT HDAC1 delta 
  
 54 
DNMT1-delta-for AGAGGCTAGGGGGTTGGCATTGG 
DNMT1-delta-rev  AAAGGCGTGAAAGCAGCATCGTGT DNMT1 
  
54  
Cre-for TAATCGCCATCTTCCAGCAG 
Cre-rev  CAATTTACTGACCGTACA cre 
  
54  
 
Primers for cloning 
Gene Name Sequence Temp.
IAPgagCON_for   
IAPgagCON_rev   IAP 
PL: IAPgagCON_for/rev: gag region; PS: ~ 500bp; ET: 50sec; C#: 40x 
56° 
VL30con_for2   
VL30con_rev2   VL30 
PL: VL30con_for2: 5' of 3' LTR; VL30con_rev2: R region of LTR; PS: ~ 500bp; ET: 1min; C#: 35x 
62° 
 
PL: Primer Location; PS: Product Size; ET: Extension Time; C#: Cycle Number; RE: Reference; Org.: 
Organism: human (h), mouse (m); Temp.: Annealing Temperature 
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3. Aims of the Work 
 
Activation of transposable elements (TEs) in somatic cells can potentially lead to mutations 
resulting in pathological relevant changes of gene expression patterns. Therefore, restriction 
of transposon activity is crucial for maintaining genomic integrity of a cell. 
So far, DNA methylation, RNAi pathways and histone methylation have been implicated in 
the silencing of TEs in eukaryotic cells. The role of another epigenetic modification known to 
be involved in the regulation of transcriptional control – histone acetylation – has not been 
analysed in detail. Therefore we wanted to survey TE expression in murine somatic cells with 
altered histone acetylation states. This was achieved either by chemical inhibition of all class 
I and II histone deacetylases (HDACs) or genetic inactivation of the major class I deacetylase 
HDAC1. That way we tried to identify TEs regulated by histone acetylation and in subsequent 
experiments to gain further insight into molecular mechanisms relevant for activation of this 
class of TEs. 
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4. Results 
 
4.1. Influence of HDAC1 inactivation, HDAC inhibition and reduced DNA methylation on 
global histone modification patterns and IAP DNA methylation levels in fibroblasts 
 
To monitor the influence of histone acetylation on various biological processes, our lab is on 
the one hand utilising chemical inhibitors of HDACs, on the other hand we established ESCs 
and fibroblast cell lines lacking a functional copy of the Hdac1 gene.  
In collaboration with the laboratory of P. Matthias (FMI, Basel), a fibroblast cell line derived 
from a BL6/129Sv mouse carrying two floxed alleles of Hdac1 was established and 
immortalised following the 3T3 immortalisation protocol. Four subclones were transfected 
with a vector expressing the cre recombinase leading to the deletion of exon 6 encoding the 
catalytic core of the HDAC1 protein. Four additional subclones were transfected with a 
control vector. That way we obtained four cell lines lacking a functional copy of Hdac1 
(referred to as HDAC1-/-) and four cell lines with a functional copy of the gene serving as 
wildtype control cell lines (HDAC1+/+). Some aspects of proliferation, cell cycle regulation, 
gene expression profile and HDAC complex formation connected to the loss of Hdac1 in this 
cell system have been analysed by others (J. Jurkin, diploma thesis, 2006; Y. Zhang, FMI 
Basel).  
To extend the analysis and monitor the influence of other HDACs beside Hdac1, we also 
treated HDAC1+/+ fibroblast cell lines with trichostatin A (TSA), a compound efficiently 
inhibiting all class I and class II HDACs. Furthermore, HDAC1+/+ fibroblast cell lines were 
treated with 5’-Aza-2’-deoxycytidine (Aza-dC), a compound leading to a reduction in DNA 
methylation. 
In a first step, levels of the class I HDACs HDAC1, HDAC2, HDAC3 and of the maintenance 
DNA methyltransferase DNMT1 were monitored via Western blot analysis using specific 
antibodies. As visible in Figure 1A, loss of HDAC1 lead to upregulation of its closest 
homologue, HDAC2. This compensatory mechanism may buffer some of the effects caused 
by the loss of HDAC1, but still total cellular HDAC activity was diminished by about 30% 
when HDAC1 was depleted (Figure 1B), underlining its dominant role in this cell type. 
HDAC3 and DNMT1 protein levels remain unchanged. General HDAC inhibition via TSA 
treatment does not change steady-state levels of HDAC1, 2 and 3, whereas DNMT1 levels 
are slightly decreased (Figure 1A). Reduction of DNMT1 levels after HDI treatment has 
previously been reported in Jurkat T and cervix cancer cells and seems to result from 
reduced mRNA expression (You, 2008) or decreased mRNA stability, respectively 
(Januchowski, 2007). Treatment of fibroblasts with Aza-dC does not influence HDAC levels, 
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whereas DNMT1 protein levels are slightly diminished which is consistent with reports that 
Aza-dC can lead to the proteasomal degradation of DNMT1 (Goshal, 2005). 
Having monitored expression levels of proteins directly targeted by chemical or genetic 
inhibition, we went on to evaluate effects on the biological targets of HDACs and DNMT1, i.e. 
histone modification patterns and the methylation status of CpG dinucleotides. To examine 
DNA methylation levels, we employed the Ms-SNuPE technique (Gonzalgo, 1997) and 
analysed the methylation of CpG sites within the regulatory region of IAP retrotransposons, 
which are normally highly methylated (collaboration with G. Egger, Norris Comprehensive 
Cancer Center, University of Southern California, USA). The use of differential primers 
allowed us the analysis of distinct subgroups of IAP elements; locating both PCR primers 
within the LTR of the retrotransposon resulted in the amplification of DNA derived from 
multiple genomic loci and therefore mirrored the average DNA methylation of multiple IAP 
elements. This approach was used to quantify DNA methylation levels of two subgroups of 
IAP elements. Figure 1C shows the average methylation of canonical IAP elements including 
elements which are still capable of retrotransposition (Dewannieux, 2004) and Figure 1D 
shows average DNA methylation of a heterochromatic Y chromosome specific subgroup of 
IAP elements (Fennelly, 1996). To investigate DNA methylation of defined single copy 
elements, one PCR primer was located in the genomic region flanking the 5’ LTR and 
therefore the amplified DNA corresponds to a distinct genomic IAP retroelement. Figure 1E 
shows the DNA methylation levels of a full length IAP element harbouring all features 
necessary for autonomous retrotransposition and exhibiting 100% LTR-LTR homology, a 
signature of recent integration. It served as paradigm for an evolutionary young retroelement. 
In contrast to this, Figure 1F shows DNA methylation levels of an IAP element representing 
an evolutionary old member of this retroelement family with only 86% LTR-LTR homology.  
Despite the different features of the IAP retrotransposons tested, DNA methylation in all four 
cases showed a characteristic pattern: loss of HDAC1 did not influence CpG methylation 
(compare black and grey bars) demonstrating that HDAC1 is not necessary for the 
maintenance of proper DNA methylation patterns of transposable elements. Inhibition of the 
enzymatic function of all class I and II HDACs with TSA for 24h also did not change DNA 
methylation. Only when cells were treated with Aza-dC, which directly targets DNA 
methyltransferases, CpG methylation levels were reduced to 30-60% of the normal values. 
Next we wanted to characterise histone modification patterns upon HDAC1 knock out or TSA 
and Aza-dC treatment of cells. Therefore logarithmically growing cells were treated with TSA 
or Aza-dC and histone acetylation and methylation patterns were monitored via Western blot 
analysis. Histone modification patterns in fibroblast cells lacking functional HDAC1 protein 
were only slightly influenced. Loss of HDAC1 in fibroblasts was selectively enhancing 
acetylation of lysine 8 at histone H4 (H4K8ac) as compared to wildtype cells (Figure 2A). All 
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other histone modifications examined, including active marks such as acetylation of H3K9, 
H3K14, H4K5, H4K12, H4K16, tri-methylation of H3K4, di-methylation of H3R17m2, 
H4R3m2 and repressive marks such as mono-, di-, and tri-methylation of H3K9, H3K27, 
H4K20 remained unaffected. When cells were treated with TSA, major changes in the 
histone modification landscape were induced: as expected all lysine residues examined were 
hyperacetylated; remarkably lysine residues proximal to the N-terminal end of the histone 
exhibited a higher increase in acetylation than lysine residues further distal to the N-terminus 
(Figure 2A). Other histone modifications were also altered in response to HDI treatment: the 
active mark H3K4m3 was enriched as well as the repressive mark H3K27m3. Decreased 
signals for H4K20m3 could be due to loss of this repressive mark or originate from the 
property of the antibody to recognise the epitope less efficiently, when nearby lysine residues 
are hyperacetylated (see Figure 3). This could also be valid for H3R17m2 and H4R3m2; 
however we do not know the features of these antibodies concerning or with respect to 
epitope recognition upon hyperacetylation. Loss of DNA methylation has severe effects on 
genomic integrity and gene expression patterns (Jackson-Grusby, 2001) and numerous 
reports showed physical and functional interaction between the DNA methylation machinery 
and histone modifying enzymes. Therefore we evaluated histone modification patterns after 
inducing reduced DNA methylation levels. We found two opposing effects caused by Aza-dC 
treatment: on the one hand, active marks correlating with gene transcription such as H3ac, 
H3K9ac, H4ac, H4K5ac, H4K8ac, H4K12ac and H3K4m3 were increased, on the other hand 
histone modifications usually considered as repressive marks and associated with 
heterochromatin showed marked enrichment, notably H3K9m3, H3K27m3, H4K20m2 and 
H4K20m3. 
The data presented so far, show that interfering with single aspects of epigenetic regulatory 
pathways also had consequences on several other, not directly targeted pathways. 
In detail, genetic inactivation of HDAC1 in fibroblasts lead to a 30% decrease in total HDAC 
activity, albeit the upregulation of its close homologue and interaction partner, HDAC2. Work 
from others demonstrated that in immortalised fibroblasts the activity of HDAC1/HDAC2 
containing multiprotein-complexes was altered (J. Jurkin, diploma thesis, 2006) and a small 
number of genes was deregulated (Y. Zhang, FMI, Basel). Here we show that global histone 
modification patterns were only modestly and specifically changed, i.e. H3K8ac was 
increased, while all other modifications examined remained equal. This finding is in contrast 
to recent findings from embryonic stem cells (ESCs), where loss of HDAC1 lead to a more 
pronounced hyperacetylation detectable with antibodies against pan-acetylated histones H3 
and H4 (Lagger, 2002) and a reduction of H3K9m3. Furthermore up to seven percent of all 
genes were found deregulated (Zupkovitz, 2006), suggesting that in less committed ESCs 
histone deacetylation may play a more dominant role in gene silencing than in fully 
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committed fibroblasts, where more stable marks might take over this task. Another finding 
was that the HDAC1 protein was not necessary for proper maintenance of DNA methylation 
patterns of transposable elements. This is interesting, since HDAC1 and DNMT1 physically 
interact (Fuks, 2000) but it is still unclear, whether this interaction is essential for DNMT1 
function. Additionally there are reports linking HDAC inhibition with loss of DNA methylation 
in cancer cells (Ou, 2007; Milutinovic, 2007). However, these reports suggest a mechanism 
involving active demethylation rather than passive loss of DNA methylation and HDACs 
acting indirectly. Nevertheless, we did not observe changes in DNA methylation levels of IAP 
retrotransposons when cells were treated with TSA for 24h. HDAC inhibition caused a global 
increase of histone acetylation, most prominent at lysine residues within the proximity of the 
N-terminus. So far we cannot fully explain this phenomenon; possible reasons could be that 
(i) HDACs preferentially deacetylate lysines proximal to the N-terminus leading to low levels 
of steady state acetylation near the N-terminus (ii) HATs preferentially acetylate lysine 
residues distal to the N-terminus, or if different HATs have distinct specificities, those which 
preferentially acetylate distal lysines are dominant. To answer this question we need more 
insight into the specificity of HDACs and HATs on native substrates. Data obtained in vitro 
may support a model where HATs deliver specificity and HDACs unspecifically remove 
acetyl-moieties from lysines and thereby maintain a silenced ground state. Other histone 
modifications altered upon TSA treatment were increased tri-methylation of H3K4 and 
H3K27. While H3K4m3 was most likely enriched because the H3K4 specific demethylase 
LSD1 removes methyl-groups less efficiently from hyperacetylated histones (Shi, 2005; Lee, 
2006), the reason for H3K27m3 enrichment remains unclear. Although it is well established 
that HDAC1 and HDAC2 are components of certain PcG complexes (van der Vlag, 1999), 
which deliver H3K27 tri-methylation, functional data on the influence of histone acetylation on 
K27 methylation are lacking. A speculative model may interpret the increase in H3K27m3 as 
compensatory mechanism counteracting the possible release of PcG target gene expression 
upon hyperacetylation. An alternative is the involvement of HDACs in H3K27 demethylation 
by recently discovered JmjC-domain containing proteins. 
Aza-dC treatment of fibroblasts had severe and complex consequences on several 
epigenetic modifications. In accordance with previous work, DNA methylation levels were 
decreased as exemplified with the analysis of several IAP LTR retrotransposon subtypes. 
Furthermore there was an increase in histone acetylation; interestingly we detected a 
preference for lysine residues proximal to the N-terminus what is reminiscent of the changes 
induced by TSA treatment, although Aza-dC has more subtle effects. The interplay between 
DNA methylation and histone acetylation is well established and additionally to the physical 
interaction between HDAC1 and DNMT1, methyl CpG binding domain (MBD) proteins are 
integral components of the NuRD complex and thought to target HDAC1/HDAC2 containing 
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complexes to methylated DNA (Denslow, 2007). Therefore the increase in histone 
acetylation could be a direct consequence of diminished HDAC recruitment to target genes 
and consequently lead to increased H3K4m3 levels. Explanations for the enrichment of the 
repressive marks H3K9m3, H3K27m3, H4K20m2 and H4K20m3 are less obvious; one might 
regard it as a compensatory mechanism for the loss in repression caused by reduced DNA 
methylation; however this does not throw light on possible mechanisms involved in this 
process. 
In summary we uncovered a combination of direct and indirect effects mediated by the 
application of chemical inhibitors, some of them already described and analysed, others 
novel and waiting to be elucidated. 
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Figure 1. Genetic inactivation of HDAC1, chemical inhibition of class I and II HDACs or DNA methylation 
leads to changed protein levels of targeted genes, total HDAC activity and DNA methylation of IAP 
retrotransposons.  
(A) Logarithmically growing HDAC1+/+ and HDAC1-/- fibroblasts were treated with 166nM TSA for 24h, with 1µM 
Aza-dC for 24h followed by incubation without inhibitor for another 24h or incubated with vehicle DMSO 
(untreated), harvested and subjected to Western blot analysis. Protein levels were determined with specific 
antibodies. Loss of HDAC1 lead to the upregulation of HDAC2; TSA and Aza-dC treatment to a slight reduction in 
DNMT1 levels. ACTIN served as loading control. 
(B) Total histone deacetylase activity was determined from equal amounts of protein extracts isolated from 
HDAC1+/+ (black bar) and HDAC1-/- (grey bar) fibroblasts incubated with [3H]acetate labelled chicken erythrocyte 
histones. Counted radioactivity corresponds to the amount of released acetyl moieties per hour and 10µg protein 
and reflects relative deacetylase activity. Values correspond to the average of four independent experiments. 
Inactivation of HDAC1 resulted in a 30% reduction of total HDAC activity. 
(C) – (F) DNA methylation levels of HDAC1+/+ (black bars) and HDAC1-/- (grey bars) fibroblast cells, treated as in 
(A). Methylation of the LTR region of IAP retrotransposons was determined employing the Ms-SNuPE technique 
as described recently (Gonzalgo, 1997). (C) Average methylation status of two CpG sites within the LTR of 
multiple copies of retrotransposition competent IAP elements (Dewannieux, 2004). (D) Average methylation of 
two CpG sites of a multi-copy Y chromosome specific species of IAP elements (Fennelly, 1996). (E) DNA 
methylation of the LTR region of a retrotransposition competent IAP element exhibiting 100% LTR homology 
(Dewannieux, 2004). Values correspond to the average methylation of 3 CpG sites. (F) Methylated CpG sites 
within the LTR of an IAP element, which shows 86% LTR homology and is therefore considered as evolutionary 
old. Values represent the average methylation of 3 CpG sites. All classes of IAP elements examined in (C) – (F) 
showed decreased DNA methylation upon Aza-dC treatment, but levels remained constant upon loss of HDAC1 
or treatment with TSA. 
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Figure 2. Histone modification patterns are altered upon HDAC1 knock out, HDAC inhibition and decrease 
in DNA methylation. 
(A) Logarithmically growing HDAC1+/+ and HDAC1-/- fibroblast cells were treated with 166nM TSA for 3h or with 
1µM Aza-dC for 24h followed by incubation without inhibitor for another 24h or incubated with vehicle, harvested, 
histones were extracted and subjected to Western blot analysis. Antibodies recognising pan-acetylated histone 
proteins H3 (H3ac) and H4 (H4ac) were used as well as antibodies recognising acetylation marks at defined 
lysine residues (H3K9ac, H3K14ac, H4K5ac, H4K8ac, H4K12ac, H4K16ac). An antibody directed against the c-
terminal part of histone H3 (c-H3) served as loading control.  
(B) To monitor histone lysine methylation patterns after HDAC1 knock out, TSA or Aza-dC treatment, cells were 
treated as in (A) with the exception that TSA was applied for 24h. Antibodies used were directed against either 
mono-, di- or tri-methylated lysine residues; the antibody against the c-terminus of H3 served as loading control. 
(C) Methylation status of arginine residues. Cells were treated as in (B). 
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Figure 3. Characterisation of antibodies recognising specifically modified histone proteins. 
To test the influence of acetylation of neighbouring lysine residues on epitope recognition, hyperacetylated 
histone proteins were incubated with recombinant HDAC1 and the cofactor RbAp48 leading to deacetylation of 
histone proteins at multiple lysine residues as detected with antibodies against H3K9ac, H3K14ac, H4K12ac and 
H4K16ac. Addition of TSA to the reaction inhibited deacetylation (left lane). While antibodies directed against 
trimethylated K9 and K27 were not influenced in their ability to recognise their epitopes by differential acetylation 
state of neighbouring lysine residues, the antibodies against H4K20m2 and H4K20m3 were disturbed in their 
epitope recognition. To demonstrate equal loading of histones, an antibody recognising the N-terminus of histone 
H3 was included in the analysis. 
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4.2. Histone acetylation of transposable elements 
 
Having monitored general changes in chromatin and DNA methylation patterns upon HDAC1 
inactivation, HDAC inhibition and reduction in DNA methylation, we went on to specifically 
address the role of histone acetylation in the regulation of transposable elements. Therefore 
we wanted to know the acetylation status of chromatin associated with transposable 
elements. HDAC1+/+, HDAC1-/-, TSA treated and Aza-dC treated fibroblasts were harvested; 
chromatin was isolated and subjected to chromatin immunoprecipitation (ChIP) experiments. 
Antibodies recognising pan-acetylated histones H3 and H4, were used to monitor the 
acetylation status, antibodies recognising the c-terminal part of histone H3 to survey the 
nucleosome density and unspecific rabbit IgGs served as controls for the specificity of the 
immunoprecipitation reaction. Real Time PCR analysis allowed the quantification of histone 
acetylation levels of the transposable elements listed in Table 1. Additionally two single copy 
genes were included as examples for not repetitive sequences: Pde10a, encoding 
phosphodiesterase 10A, located on chromosome 17 and Gsn, encoding gelsolin, located on 
chromosome 2. Both genes are not or only weakly expressed in untreated fibroblasts and the 
latter one can be transcriptionally induced by TSA treatment. As seen in Figure 4 HDAC1 
deletion in fibroblasts did not change H3ac, H4ac and nucleosome density at any of the loci 
investigated. In contrast to this, TSA treatment for 3h (Figure 5) or 24h (Figure 6) was 
perturbing histone acetylation levels associated with transposable elements. As apparent in 
Figures 5A and 6A, H3ac was enriched at SINE B1, SINE B2 and VL30 transposable 
elements as well as the promoter of the Gsn gene, whereas H4ac was highly induced at all 
transposable elements analysed as well as both single copy control regions (Figure 5B and 
6B). Thus, hyperacetylation of histone H3 upon HDAC inhibition seems to be restricted to 
specific sequences while hyperacetylation of H4 seems to be a phenomenon common to all 
kinds of transposable elements as well as at least some single copy genes. Figure 7 shows 
H3 and H4 histone acetylation levels upon Aza-dC treatment, which were enriched at specific 
sequences including SINE B1, SINE B2, VL30 and IAP elements. Noteworthy H3ac and 
H4ac levels were equally enriched at both histones, with the exception of SINE B2 elements, 
where only H4ac was increased. 
A fact, one should take into consideration when interpreting these data is the restricted 
specificity when using consensus primers for quantification. This is relevant especially for 
SINE elements, which are highly abundant short sequences found throughout the genome 
including intergenic regions, introns and promoters. Therefore the chromatin status of 
numerous SINEs might closely depend on the genomic environment rather than on SINE 
specific factors and increased histone acetylation as detected with consensus primers might 
mirror enriched acetylation of a subgroup of elements located e.g. in the proximity of 
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promoters and not a general increase in acetylation of SINE elements. When focusing on 
LTR elements this objection might be less relevant, since LTR retrotransposons are bigger 
and therefore do not represent integral parts of regulatory regions of other genes to the same 
degree. 
 
 
 
 
Figure 4. Histone acetylation states of transposable elements in HDAC1+/+ and HDAC1-/- fibroblasts. 
ChIP experiments with chromatin from HDAC1+/+ and HDAC1-/- were performed and acetylation levels were 
determined via Real Time PCR. Values are presented as relative enrichment of acetylation compared to 
HDAC1+/+ cells and each bar represents the average of at least three independent experiments. HDAC1 deletion 
does not influence H3 and H4 acetylation of chromatin associated with transposable elements (A and B) or 
nucleosome density (C). ± SEM. n=3. 
 
 
 
 
 
 
Figure 5 and 6. Histone acetylation states of transposable elements are altered upon TSA treatment. 
HDAC1+/+ fibroblasts were treated with 166nM TSA for 3h (Figure 5) or 24h (Figure 6), chromatin was isolated 
and ChIP experiments were performed. For quantification Real Time PCR was employed. Values represent the 
average of at least three independent experiments and are given as relative enrichment based on the values 
obtained in untreated cells. Apart from some minor differences, 3h and 24h TSA treatment leads to similar 
changes in histone acetylation; H3ac is specifically enriched in SINE B1, SINE B2, VL30 elements and Gsn (Fig. 
5A and 6A) while H4ac is enriched at all studied sequences (Fig. 5B and 6B). Nucleosome density is not 
influenced as assayed via ChIP using an antibody against c-term H3 (Fig. 5C and 6C). ± SEM. n=3. 
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Figure 7. Histone acetylation states of transposable elements are altered upon Aza-dC treatment. 
HDAC1+/+ fibroblasts were treated with 1µM Aza-dC for 24h followed by incubation without inhibitor for another 
24h, then chromatin was isolated and ChIP experiments were performed. For quantification Real Time PCR was 
employed. Values represent the average of at least three independent experiments and are given as relative 
enrichment based on the values obtained in untreated cells. H3ac and H4ac are similarly enriched at SINEs, 
VL30 and IAP elements (A and B) whereas nucleosome density shows no major changes (C). ± SEM. n=3. 
 
 
 
 
    PCR Amplicons 
Class Sub-Class Element Copy Number Expression ChIP 
LINE   L1 599000* ORF2 (2400-2600) ORF2 
SINE 7SL RNA B1 564000* - - 
  tRNA B2 348000* - - 
DNA   Tigger 24000* internal (250-550) internal 
LTR ERV Class I VL30 150-200+ pol (3700-4100) 5'LTR (600-840)/pol 
 ERV Class II IAP 1000+ gag (1000-1300) 5'LTR (30-200)/gag 
 ERV Class II ETn 300-400+ - - 
 ERV Class III MERVL 200+ pol (3900-4200) pol 
 MaLR (III) MT 13000-50000°° internal (450-700) internal 
  MaLR (III) ORR1 10000-38000°° internal (1400-1600) internal 
 
Table 1. List of Transposable elements analysed. Classification of transposable elements, copy number and 
approximate location of primers used to survey the expression and histone modification status of TEs. *Waterston 
2002; +Maksakova 2006; °°Smit 1993; note that the last Reference is out-dated and might underestimate the 
actual number of MT and ORR1 elements.  
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4.3. Expression of transposable elements 
 
To test whether the changes in histone acetylation mediated by TSA and Aza-dC mirrored 
changes in the biological activity of the TEs, we monitored expression levels of the elements 
listed in Table 1. RNA from HDAC1+/+, HDAC1-/-, TSA treated and Aza-dC treated fibroblasts 
was isolated, reversely transcribed and subjected to Real Time PCR analysis. Figure 8 
summarises the results of HDAC1-/- (Fig. 8A), TSA treated (Fig. 8B) and Aza-dC (Fig. 8C) 
treated fibroblasts compared to untreated HDAC1+/+ cells. Loss of HDAC1 did not influence 
TE expression, what was not surprising, since acetylation levels of histones associated with 
TEs in HDAC1-/- fibroblasts were not affected. As shown in Fig. 8A treatment with TSA lead 
to a modest increase in the expression of some transposable elements (LINE1, SINE B1, 
SINE B2, IAP, ETn, MERVL). Strikingly, expression levels of VL30 elements were highly 
induced. Aza-dC treatment strongly enhanced the expression of VL30 as well as IAP 
elements, corroborating earlier reports (Davis, 1989; Tzavaras, 2003). To confirm that the 
results obtained do not mirror the behaviour of a particular fibroblast cell line, we additionally 
tested TE expression levels in the two widely used fibroblast cell lines Swiss 3T3 and 
NIH/3T3. As summarised in Table 2, TSA and Aza-dC treatment had similar effects on TE 
expression with a significant enrichment of VL30 transcripts in TSA and Aza-dC treated cells 
and enrichment of IAP transcripts upon Aza-dC application. Interestingly, in embryonic stem 
cells VL30 elements could not be induced by TSA or Aza-dC. Instead ETn elements showed 
elevated mRNA levels, indicating cell type specific regulation of transposable elements. Of 
further interest was the accumulation of IAP but not VL30 transcripts in DNMT1 knock out 
brains, although reduction of DNA methylation via the chemical inhibitor Aza-dC lead to 
activation of VL30 elements in fibroblasts (Table 2). This discrepancy could be due to (i) the 
lack of factors promoting VL30 expression in neuronal cells or (ii) DNMT1 independent 
activation of VL30 expression in Aza-dC treated cells. We favour the second alternative for 
the following reasons: first, others could show that VL30 expression could be induced by 
certain stimuli in neuronal cells (Costain, 2006) and second, Aza-dC might have additional 
effects besides the reduction of DNA methylation (e.g. DNA damage) which could be the 
causative reason for VL30 induction.  
Having established the regulation of VL30 and IAP retrotransposons via histone acetylation 
and DNA methylation in fibroblasts, we went on to compare TE expression data with the 
acetylation status upon inhibitor treatment. Thereby, three major points became evident: (i) 
expression levels of LTR retroelements correlated with the acetylation status of histone H3, 
when cells were exposed to TSA. As described before, H4 acetylation was increased 
unspecifically. (ii) Upon Aza-dC treatment H3ac as well as H4ac was specifically enriched at 
LTR elements showing enhanced expression. (iii) Hyperacetylation of SINEs as induced by 
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TSA (SINE B1, SINE B2) and Aza-dC (SINE B1) was accompanied by only minor increases 
in mRNA, if at all. Obviously, there is a discrepancy between the behaviour of LTR elements 
on the one hand and SINEs on the other hand; the reason for this might be similar to the 
reason for enriched histone acetylation found at SINEs after TSA treatment: these short 
sequences are integral parts of numerous genes and therefore the modest increase in 
transcript abundance might originate from increased transcription of genes harbouring SINE 
sequences within the gene body rather than from weak induction of SINE expression itself. 
However, although we favour this model, we cannot rule out the second alternative. In 
contrast to this, high activation of the LTR elements VL30 and IAP is more likely to originate 
from activation of the element itself. 
In summary, we could not only show a correlation between TE expression and histone 
acetylation states but also identified a class of LTR elements (VL30) which can be 
transcriptionally activated by HDAC inhibition. 
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Figure 8. Expression levels of transposable elements are altered upon TSA and Aza-dC treatment. 
Cells were left untreated, grown in medium containing 166nM TSA for 24h or supplemented with 1µM Aza-dC for 
24h followed by growth for 24h in inhibitor free medium. mRNA levels of different TEs were analysed via Real 
Time PCR. Values were normalised to the housekeeping gene HPRT, and shown as relative values compared to 
untreated wildtype fibroblasts. Bars represent the average of at least three independent experiments. ± SD. (A) 
HDAC1 knockout does not influence TE expression. (B) Upon TSA treatment, expression of the LTR 
retrotransposon VL30 is increased more than thirty times. (C) Aza-dC has the ability to highly induce expression 
of VL30 as well as IAP retrotransposons. 
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4.4. Single locus versus multi copy origin 
 
Whenever working with transposable elements, one should be aware of a specific feature of 
repetitive elements: they exist in multiple copies distributed all over the genome and 
therefore individual elements are different in respect of genomic environment influencing 
chromatin status and potential transcriptional activity. Furthermore, TEs are under high 
selective pressure and mutation mediated by host or TE-intrinsic factors leads to the 
generation of a pool of elements with individual sequence specificities. Therefore a class of 
elements is a collection of similar, but heterogeneous individuals, differing in external and 
internal features.  
Increased transcript levels upon external signals could originate from upregulation of all 
transposable elements within a class, of a subgroup of elements exhibiting specific features 
or even a single copy with unique intrinsic or positional properties. In order to distinguish 
between these different scenarios we analysed VL30 and IAP derived transcripts arising 
upon TSA and Aza-dC treatment and compared them to transcripts present in untreated 
cells. mRNA from three independent biological samples each (fibroblasts; TSA, Aza-dC, 
untreated) was collected, reversely transcribed and subjected to PCR amplification in 
doublets. To amplify IAP derived transcripts, primers annealing in the highly conserved gag 
region were used, for VL30 transcript amplification primers within the 3’ UTR and 3’LTR R 
region were chosen. The six PCR products derived from each condition were pooled to 
exclude a bias due to individual PCR reactions, PCR products were cloned and sequenced. 
As control, the same procedure was also performed with genomic DNA as template for PCR 
amplification. Each sequenced clone corresponding to an individual transcribed (or genomic) 
TE was then subjected to further analysis: first, sequences were aligned to scan if the pool of 
transcripts contained identical sequences emerging repeatedly, what would indicate 
preferred expression of unique TEs or of a specific subgroup of TEs with high similarity.  
This analysis revealed that IAP sequences were heterogeneous, even upon induction of 
expression with Aza-dC. VL30 sequences lost the heterogeneity existing when left untreated, 
upon induction of high expression with TSA or Aza-dC. This indicated that IAPs were 
transcribed from multiple genomic loci, while VL30 elements were transcribed from a limited 
number of loci when induced. Second, sequences were blasted against the annotated 
murine genome (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) to identify genomic TEs serving 
as potential sources of transcription. Genomic sequences showing at least 98% homology to 
the cloned sequences were considered to show sufficient homology to be regarded as 
potential source of transcription. If more genomic sequences showed homology >98%, the 
sequence with the highest E-value was chosen. That way ~90% of the cloned sequences 
could be assigned to distinct genomic TEs (IAP: 115 of 127 clones; VL30: 64 of 72 clones). 
___________________________________________________________________________ 
  72 
The complete sequence of these genomic transposons was used to classify the expressed 
IAP and VL30 elements. As summarised in Table 3, IAP elements expressed under different 
conditions were full length (44 – 65% of all expressed elements) or belonged to the I∆1 
subgroup (delta I; 12 – 26%), a non autonomous subpopulation of IAP elements carrying a 
1.9kb internal deletion and responsible for most of the described insertional mutations. The 
rest consisted of IAPs carrying miscellaneous other deletions (10 – 30%). Strikingly the 
proportion in untreated and TSA treated cells was grossly similar to the composition of 
genomic IAP elements as amplified within the control experiment, when genomic DNA was 
used as template for the PCR reaction (Figure 11A). This indicates that under those 
conditions none of the three subtypes is preferentially expressed. Only upon Aza-dC 
treatment, we noticed a reduced contribution of IAP elements carrying internal deletions to 
the pool of expressed IAPs, which seemed to be non-random (Χ2 = 0.025). Next we analysed 
the regulatory regions of the sequenced IAP elements, the long terminal repeats (LTRs). 
Comparing the 5’ LTR to the 3’ LTR of given IAP elements demonstrated that with the 
primers used, we amplified exclusively evolutionary young IAP elements, as the majority of 
the 5’ LTRs showed 100% identity with the corresponding 3’ LTRs (78%), a signature for 
recent integration. The remaining 22% still exhibited at least 97.8% 5’ LTR – 3’ LTR 
homology (Table 3). Alignment and phylogenetic analysis of the LTRs revealed no significant 
difference between genomic copies, elements expressed under non-inducing conditions 
(untreated, TSA) and elements expressed upon induction of high expression (Aza-dC) (Tree 
1). However, comparison of the LTR length disclosed a marked peculiarity of IAP elements 
expressed after Aza-dC treatment: the average length of the LTR was 375bp in contrast to 
350, 352 or 356bp for genomic IAPs, elements expressed when cells were untreated or TSA 
treated (Figure 11B, Table 3). This increment in length was caused by the presence of 
additional nucleotides in the highly variable CT-rich R region. The region encoded of varying 
numbers of the 17bp or 15bp tandem repeat sequences CTCTCTCTTGCTTCTTG or 
CTCTCTTGCTTCTTG (identified with the Tandem Repeat Finder Program 
http://tandem.bu.edu/trf/trf.html using default settings; Benson, 1999), containing a binding 
site for the CCAAT/enhancer-binding protein alpha (C/EBPalpha) transcription factor 
(identified with the Alibaba2.1 transcription factor binding site prediction program using the 
TRANSFAC 4.0 database). IAP elements expressed upon Aza-dC treatment comprised 2 – 3 
binding sites, the others 1 – 2, indicating that expression of IAP elements was strongly 
enhanced by the presence of additional C/EBPalpha binding sites when restricting DNA 
methylation was lost. 
Analysis of VL30 elements revealed that the main fraction of genomic elements was 
associated with LTRs containing a type III U3 region (Tree 2). It was demonstrated earlier 
(French, 1997) that the U3 region is crucial for transcriptional regulation and so far, four 
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subtypes have been classified (Nilsson, 1994). Elements expressed in untreated fibroblasts 
showed similar characteristics concerning the U3 region, indicating that under those 
conditions, many of the genomic copies are transcribed and there is no preference towards 
the expression of specific subtypes. When VL30 expression was induced by HDAC or DNMT 
inhibitors, the composition of transcribed subtypes exhibited major changes. The majority of 
the cloned sequences contained U3 regions of the subtype IV, the remaining ones of the 
subtype I, but no sequences encoding U3 subtype III regions were identified (Figure 11C, 
Table 4). Phylogenetic analysis of the U3 sequences showed, that the U3 subtype IV regions 
were almost identical and possibly were derived from a single genomic copy (Tree 2). 
Screening the murine genome with BLAST identified only one genomic locus with significant 
similarity supporting the hypothesis that these sequences may stem from a single VL30 
element. Detailed analysis of this VL30 element gave rise to a surprising finding: whereas the 
3’ LTR contained a subtype IV U3 region, the 5’ LTR contained a subtype I U3 region. The 
source of transcription might therefore be a hybrid element whose expression is driven by a 
5’ LTR subtype I U3 regulatory region. That way, all transcripts cloned upon TSA or Aza-dC 
treatment might originate from elements driven by a type I U3 region; the majority from a 
single locus, some additional transcripts from several other U3 subtype I controlled elements 
(Figure 11D).  
In summary we revealed a differential behaviour of two particular LTR elements: whereas 
loss of DNA methylation leads to high expression of multiple genomic IAP elements (with a 
preference for IAPs with additional transcription factor binding sites at the R region), HDAC 
inhibition or loss of DNA methylation is specifically inducing the transcription of VL30 
elements associated with LTRs of a specific subtype. 
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Figure 11. Characterisation of IAP and VL30 elements expressed upon different stimuli in 3T3 fibroblasts. 
(A) IAP elements expressed under different conditions were either full length (white bars), belonged to the I∆1 
subgroup (delta I, grey bars) or carried different other internal deletions (other, black bars). 
(B) The average length of the LTRs driving IAP expression upon Aza-dC treatment was increased due to an 
extension of a CT rich stretch within the R region. 
(C) When untreated, 3T3 fibroblasts expressed mostly VL30 elements associated with a type III U3 region within 
the 3’ LTR (grey bars); when cells were treated with TSA or Aza-dC, only elements with a type I or IV U3 region 
were detected. 
(D) VL30 elements potentially serving as genomic sources of transcription mainly were associated with a type III 
subtype 5’ LTR in untreated cells, whereas 5’ LTRs of VL30 elements induced with TSA and Aza-dC exclusively 
belonged to the type I subgroup. 
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  IAP element  LTR 
  Homology Chromosome bp Type Nested  bp Homology CT bp
G 01 99,7 10 5223 I∆1  374 100,0 75 
G 02 99,3 11 4339 other  352 99,7 53 
G 03 99,7 3 4427 other LX 341 100,0 45 
G 04 99,6 17 7067 full length  337 98,2 38 
G 05 99,9 6 7106 full length L1 337 100,0 38 
G 06 99,9 6 5163 I∆1  337 100,0 38 
G 07 99,9 10 7123 full length  366 100,0 68 
G 08 99,6 13 5092 I∆1  354/389 99,2 55 
G 09 98,7 8 7085 full length  352 100,0 53 
G 10 99,7 7 6578 other  336 100,0 38 
G 11 98,6 14 7146 full length  338 99,7 38 
G 12 98,1 6 5168 I∆1 L1 338 100,0 39 
G 13 99,7 3 5212 I∆1  335 100,0 36 
G 14 99,7 X 7119 full length  368 99,7 68 
G 15 100,0 4 5337 I∆1  336 100,0 38 
G 16 98,5 11 7092 full length L1 352 100,0 53 
G 17 99,6 17 5369 I∆1 IAP 419 100,0 121 
G 18 100,0 2 7103 full length  354 100,0 55 
G 19 100,0 4 7089 full length  350 100,0 51 
G 20 99,6 14 7080 full length  352 100,0 53 
G 21 99,7 17 7106 full length  338 100,0 40 
G 22 99,6 1 5862 other L1 353 100,0 53 
G 23 99,6 7 5019 other  338 99,4 38 
G 24 99,9 12 6962 other  352 100,0 53 
G 25 99,9 8 5150 other  339 100,0 40 
G 26 99,8 8 7160 full length  355 100,0 56 
G 27 99,9 17 6864 other    336/- - 38 
0 01 99,0 4 7060 full length L1 339 100 39 
0 02 98,6 12 3979 other  359/357 98,9 61 
0 03 99,9 2 6592 other  382 100,0 82 
0 04 99,5 1 1551 other  - - - 
0 05 99,6 7 7091 full length  336 99,7 38 
0 06 99,2 9 7076 full length  352 99,7 53 
0 07 98,2 14 7192 full length  366 100,0 68 
0 08 99,6 18 6575 other  337 99,7 38 
0 09 99,7 8 7126 full length  371 100,0 72 
0 10 99,6 2 6020 other  338 100,0 40 
0 11 100,0 16 7164 full length  381 99,7 81 
0 12 99,0 18 4238 other IAP 338 99,7 38 
0 13 98,4 17 7132 full length L1 352 99,7 54 
0 14 99,0 19 7050 full length  322 100,0 38 
0 15 99,9 4 4862 other L1 350/351 99,7 52 
0 16 99,3 2 7123 full length RSINE 371 100,0 70 
0 17 99,2 17 7076 full length  336 99,4 38 
0 18 99,5 10 5584 I∆1 LX 337 100,0 38 
0 19 99,9 11 4311 other  337 100,0 38 
0 20 99,7 3 5313 I∆1  389 100,0 90 
0 21 98,4 14 7192 full length  366 100,0 68 
0 22 99,9 12 7079 full length  352 99,7 53 
0 23 99,1 14 7107 full length  337 99,7 39 
0 24 98,8 X 7071 full length L1 337 100,0 38 
0 25 99,2 12 5212 I∆1 RMER 368 100,0 70 
0 26 99,1 X 7132 full length  351 100,0 53 
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  IAP element  LTR 
  Homology Chromosome bp Type Nested  bp Homology CT bp
T 01 98,8 X 7071 full length L1 337 100,0 38 
T 02 99,2 17 6015 other  369 100,0 70 
T 03 99,3 7 7080 full length  352 100,0 53 
T 04 99,3 17 7068 full length  352 100,0 0 
T 05 99,1 18 7117 full length  367 100,0 68 
T 06 100,0 12 6961 other charlie 352 100,0 53 
T 07 98,6 7 7080 full length  353 99,4 53 
T 08 99,9 2 7103 full length  337 100,0 38 
T 09 98,6 10 5223 I∆1  374 100,0 75 
T 10 99,9 19 4875 other  337 99,7 38 
T 11 98,1 X 7193 full length  365 100,0 67 
T 12 99,4 9 5180 I∆1 L1 353 100,0 54 
T 13 99,9 6 5334 I∆1  376 100,0 77 
T 14 99,7 4 4507 other  338 100,0 38 
T 15 99,6 6 4701 other  338 100,0 38 
T 16 98,7 16 5284 I∆1  406 100,0 107 
T 17 99,5 1 7105 full length  337 100,0 38 
T 18 100,0 14 7080 full length  352 100,0 53 
T 19 99,9 2 7103 full length  337 100,0 38 
T 20 100,0 6 7064 full length LX 337 100,0 38 
T 21 98,6 12 7150 full length  352 100,0 53 
T 22 99,9 16 7074 full length  337 99,7 38 
T 23 99,5 5 4344 other  352 100,0 53 
T 24 99,5 13 7086 full length  352 100,0 53 
T 25 98,8 X 5203 I∆1  382 100,0 83 
T 26 99,3 3 5308 I∆1  366 100,0 67 
T 27 99,9 1 7082 full length  354 99,4 55 
T 28 98,9 13 5349 I∆1  398 100,0 118 
T 29 99,9 10 5223 I∆1  374 100,0 75 
T 30 100,0 5 4344 other  352 100,0 53 
T 31 99,6 11 5790 other    337 100,0 38 
A 01 100,0 15 7127 full length  372 100,0 74 
A 02 98,4 14 5460 I∆1  456 100,0 157 
A 03 99,5 8 5418 I∆1 L1 415 100,0 117 
A 04 99,5 10 4948 other L1 337 100,0 38 
A 05 99,5 17 7107 full length  367 100,0 68 
A 06 99,6 1 7179 full length  367 100,0 68 
A 07 100,0 X 7119 full length  368 99,7 53 
A 08 99,4 3 7064 full length  351 100,0 53 
A 09 99,7 8 7102 full length  353 100,0 106 
A 10 98,4 8 5315 I∆1  405 100,0 106 
A 11 99,9 2 7154 full length L1 399/397 99,6 98 
A 12 99,9 19 7201 full length  413 100,0 114 
A 13 99,3 17 7068 full length  352 100,0 103 
A 14 99,1 10 4308 other  401 100,0 53 
A 15 99,9 6 7089 full length  353 100,0 53 
A 16 99,7 16 7104 full length  354 100,0 67 
A 17 99,9 2 5260 I∆1  366 100,0 50 
A 18 99,7 2 5306 I∆1 L1 349 100,0 50 
A 19 99,6 14 7079 full length  337 99,1 38 
A 20 99,0 9 7159 full length  367 100,0 68 
A 21 100,0 13 7092 full length  352 100,0 53 
A 22 99,5 7 5137 I∆1  421 100,0 123 
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  IAP element  LTR 
  Homology Chromosome bp Type Nested  bp Homology CT bp
A 23 99,5 3 7376 full length  416 100,0 118 
A 24 100,0 7 5137 I∆1  421 100,0 123 
A 25 99,7 8 4320 other LX 337 100,0 38 
A 26 98,3 7 7329 full length ORR1 405 97,8 107 
A 27 99,7 8 5153 I∆1  337 100,0 38 
A 28 98,8 X 7214 full length  351 100,0 52 
A 29 99,2 10 7145 full length  386 100,0 87 
A 30 100,0 14 7087 full length    353 100,0 53 
         
         
         
      IAP element  LTR 
      bp Type Reference  bp Homology CT bp
M17551  7096 full length Mietz, 1987 338 100,0 38 
AB099818  7309 full length Ishihara, 2004 443 100,0 145 
AC012382  7084 full length Dewnnieux, 2004 354 100,0 55 
AC087891  7155 full length Dewnnieux, 2004 353 100,0 55 
AC090431  7126 full length Dewnnieux, 2004 354 100,0 53 
AL590616  7070 full length Dewnnieux, 2004 337 100,0 38 
X04120  5059 I∆1 Ymer, 1985 337 100,0 38 
AxinFu     5195 I∆1 Whitelaw E  338 100,0 38 
 
 
Table 3. Characterisation of cloned IAP elements. Summary of characteristic features of cloned IAP elements. 
Clones G 01 to G 27 correspond to IAP elements amplified from genomic material, 0 01 to 0 26 to IAP elements 
expressed in untreated cells, T 01 to 31 and A 01 to 30 to IAPs expressed upon TSA or Aza-dC treatment, 
respectively. Given is the homology of the cloned sequence to the most homologous genomic sequence 
(Homology), genomic location of the corresponding sequence (Chromosome), length of the genomic IAP element 
(bp), affiliation to one of the three subgroups: full length, I∆1 deletion type or IAP carrying another deletion (Type). 
If the genomic IAP is inserted into another TE, the identity of the TE is given as determined with the Repbase TE 
database (http://www.girinst.org/censor/; Jurka, 2005) (Nested); Finally, the LTR is characterised in terms of 
length (bp), homology of the 5’ LTR to the 3’LTR (Homology), and length of the CT rich hypervariable region in 
the R region (CT bp). The list is further extended by the characterisation of eight IAP elements published earlier 
(M17551, AB099818, AC012382, AC087891, AC090431, AL590616, X04120, AxinFu). 
___________________________________________________________________________ 
  78 
 
  VL30 element  LTR 
  Homology Chromosome bp Nested  bp Homology U3 5' U3 3' 
G 01 99 7 5346 IAP 584 100,0 III III 
G 02 99 17 4826 LX 628 100,0 III III 
G 03 100 2 5316 RMER 603 100,0 III III 
G 04 100 9 5208  585 100,0 III III 
G 05 100 13 4237 B2 558 99,8 IV IV 
G 06 99 8 5248 LX 564/565 99,8 IV IV 
G 07 99 15 5468  646 99,8 III III 
G 08 99 10 4610  600 100,0 III III 
G 09 100 18 5310 ORR1 588 100,0 III III 
G 10 100 6 4964  561 100,0 I I 
G 11 99 13 5526 ORR1 568 99,8 I I 
G 12 100 8  IAP / VL30 553 100,0 III III 
G 13 99 2 5495  649 99,7 III III 
G 14 99 8  IAP / VL30 553 100,0 III III 
G 15 98 17 5521  605 100,0 III III 
G 16 99 17 5226 MTA / L1 555 100,0 III III 
G 17 99 18 5130    544 100,0 III III 
0 01 100 8  IAP / VL30 553 100,0 III III 
0 02 99 6 4964  561 100,0 I I 
0 03 100 18 5130  544 100,0 III III 
0 04 99 2 5316 RMER 603 100,0 III III 
0 05 100 2 4843 B3 569/575  I IV 
0 06 100 18 5410  600 100,0 III III 
0 07 100 8 5441  605/606 99,8 III III 
0 08 100 13 5139 MT2A 534 100 I I 
0 09 100 2 5316 RMER 364/645  III III 
0 10 98 8  IAP / VL30 553 100,0 III III 
0 11 99 13 4857  602 100,0 III III 
0 12 99 X 4807    589 100,0 III III 
T 01 99 2 4843 B3 569/575  I IV 
T 02 100 2 4843 B3 569/575  I IV 
T 03 100 2 4843 B3 569/575  I IV 
T 04 100 17 4954 RMER 535 100,0 I I 
T 05 99 2 4843 B3 569/575  I IV 
T 06 100 2 4843 B3 569/575  I IV 
T 07 100 2 4843 B3 569/575  I IV 
T 08 99 2 4843 B3 569/575  I IV 
T 09 100 2 4843 B3 569/575  I IV 
T 10 100 2 4843 B3 569/575  I IV 
T 11 99 2 4843 B3 569/575  I IV 
T 12 99 2 4843 B3 569/575  I IV 
T 13 98 6 4964  561 100,0 I I 
T 14 99 2 4843 B3 569/575  I IV 
T 15 100 2 4843 B3 569/575  I IV 
T 16 99 2 4843 B3  569/575   I IV 
A 01 100 2 4843 B3 569/575  I IV 
A 02 99 2 4843 B3 569/575  I IV 
A 03 100 2 4843 B3 569/575  I IV 
A 04 100 2 4843 B3 569/575  I IV 
A 05 99 2 4843 B3 569/575  I IV 
A 06 99 2 4843 B3 569/575  I IV 
A 07 99 6 4964  561 100,0 I I 
A 08 98 6 4964  561 100,0 I I 
A 09 98 6 4964  561 100,0 I I 
A 10 98 6 4964  561 100,0 I I 
A 11 100 2 4843 B3 569/575  I IV 
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  VL30 element  LTR 
  Homology Chromosome bp Nested  bp Homology U3 5' U3 3' 
A 12 98 6 4964  561 100,0 I I 
A 13 98 6 4964  561 100,0 I I 
A 14 100 2 4843 B3 569/575  I IV 
A 15 100 2 4843 B3 569/575  I IV 
A 16 99 6 4964  561 100,0 I I 
A 17 100 2 4843 B3 569/575  I IV 
A 18 100 2 4843 B3  569/575   I IV 
 
 
Table 4. Characterisation of cloned VL30 elements. Summary of characteristic features of cloned VL30 
elements. Clones G 01 to G 17 correspond to VL30 elements amplified from genomic material, 0 01 to 0 12 to 
VL30 elements expressed in untreated cells, T 01 to 16 and A 01 to 18 to elements expressed upon TSA or Aza-
dC treatment, respectively. Given is the homology of the cloned sequence to the most homologous genomic 
sequence (Homology), genomic location of the corresponding sequence (Chromosome) and length of the 
genomic VL30 element (bp). If the genomic VL30 is inserted into another TE, the identity of the TE is given as 
determined with the Repbase TE database (http://www.girinst.org/censor/; Jurka, 2005) (Nested); The LTR is 
characterised in terms of length (bp) and homology between 5’ LTR and 3’LTR (Homology). Finally, the affiliation 
of the 5’ and 3’ U3 region to one of the four described subgroups (I-IV) is specified. 
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Tree 1. Phylogenetic Relationship between the LTR regions of IAP elements. LTR sequences of IAPs 
showing high similarity to cloned IAP fragments, together with previously characterised IAPs (see Table 3) were 
aligned with ClustalV using default settings. If necessary, the alignment was manually adjusted. Construction of a 
neighbour-joining tree was performed in Megalign. 
___________________________________________________________________________ 
  81 
 
 
Tree 2. Phylogenetic Relationship between U3 LTR regions of VL30 elements. Sequences of the 3’ U3 
regions of genomic and expressed VL30 elements were aligned with ClustalW. Additionally U3 sequences of 
elements described earlier (French, 1997; Nilsson, 1994; Costain, 2006) were included. VL3 and NVL3 are 
representatives of the subgroup I, Tlev1, VM1 B1 and VM1 B2 constitute the subgroup II, VL30x1, ELM5, BVL1 
VL11 PA2 and PB10 are members of the subgroup III, and finally mVL30 1, RVL3, NVL1, NVL2 and MEL ELM 
were included as representatives of the subgroup IV. Cloned U3 regions from genomic and expressed VL30 
elements could be clearly assigned to three of the four subgroups (I, III and IV). Note that all U3 sequences 
derived from cells treated with TSA or Aza-dC within subgroup IV are nearly identical, indicating a single genomic 
copy as source of transcription. 
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4.5. A dual histone modification mark regulates the expression of VL30 elements 
 
Transcriptional regulation of VL30 elements has already been in the focus of research since 
the 1990s. Contributions from numerous laboratories showed that VL30 elements could be 
activated by a plethora of stimuli (French, 1997; Tzavaras, 2003; Noutsopoulos, 2007). 
Interestingly, many of the stimuli can be summarised as internal or external stress in the 
broadest sense and a considerable number among them is able to trigger signalling 
cascades such as the ERK or p38 pathways. Signalling via these pathways ultimately leads 
to activation of several transcription factors but also to phosphorylation of histone proteins. 
Phosphorylation of serine 10 at histone H3 (H3S10p) during interphase is a rare event that 
correlates with the activation of specific target genes (Mahadevan, 1991; Thompson, 1999). 
The presence of S10-phosphorylated histone H3 (H3S10p) marks at promoter-associated 
chromatin coincides with acetylation of neighbouring lysines K9 and K14 leading to a dual 
histone modification termed phosphoacetylation (Cheung, 2000; Clayton, 2000; Li, 2001). 
Histone H3 phosphoacetylation correlates with the activation of the so called “immediate 
early” genes c-fos and jun-B as well as late inducible genes such as HDAC1 (Hauser, 2002). 
Recently, it was shown that the dual histone modification mark H3S10pK14ac serves as a 
binding epitope for 14-3-3 proteins (Winter, 2008; Walter, 2008).  
The finding that the HDAC inhibitor TSA was sufficient to highly induce VL30 expression in 
logarithmically growing fibroblasts (where ERK pathways are activated through the action of 
growth factors) prompted us to ask if both stimuli, histone acetylation and histone 
phosphorylation were required for full VL30 activation. To test this model, we had to switch 
the cell system from proliferating to serum-arrested fibroblasts (3T3 Swiss). Arrest in G0 upon 
serum withdrawal eliminates mitotic H3 phosphorylation, a modification that targets the 
majority of histone H3 molecules associated with chromatin condensation during mitosis. 
This system also allows to selectively activate specific signalling cascades in the absence of 
serum-dependent activity of different kinase pathways. Cells arrested for 48–72h were 
treated with TSA, serum (FCS) to activate the ERK pathway, anisomycin (Aniso) to activate 
the p38 stress pathway or retinoic acid (RA) as a compound able to induce VL30 expression 
without direct link to histone phosphorylation. Figure 12A shows the effect of the different 
compounds on histone H4 acetylation and histone H3 phosphoacetylation as detected with 
an antibody directed against H3S10p/K14ac in G0 arrested 3T3 Swiss fibroblast. As expected 
TSA lead to the accumulation of hyperacetylated histones; phosphoacetylation was absent in 
untreated arrested cells, upon TSA, RA and RA/TSA treatment, detectable in very low 
abundance upon Aniso treatment, clearly detectable in logarithmically growing cells and cells 
incubated with FCS. Combined treatment with Aniso/TSA or FCS/TSA finally lead to the 
efficient formation of phosphoacetylated histones.   
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Earlier reports demonstrated that the fraction of phosphoacetylated histone H3 is only 
minute, even upon Aniso/TSA treatment (Winter, 2008) and the mark is localised to a 
restricted number of genomic loci (Simboeck, PhD thesis, 2008). Therefore we were 
interested, if phosphoacetylated histones were associated with VL30 elements. We 
performed ChIP experiments with untreated, TSA, Aniso and Aniso/TSA treated resting 3T3 
Swiss fibroblasts using an antibody against H3S10ph/K14ac double modified histones and 
surveyed phosphoacetylation levels via semi-quantitative PCR of the VL30 5’LTR regulatory 
region. Strikingly, we could detect phosphoacetylated histones at VL30 elements, when cells 
were treated with Aniso/TSA, but not upon single treatment with Aniso or TSA (Figure 12B). 
Additional ChIP experiments from cells treated with FCS/TSA demonstrated the presence of 
phosphoacetylation also upon activation of the ERK pathway together with induction of 
hyperacetylation. Retinoic acid together with TSA did not lead to the formation of such a 
histone mark (Figure 12C). In summary, activation of the p38 or ERK pathway together with 
induction of hyperacetylation results in the establishment of a phosphoacetylation mark at 
VL30 LTRs. Next we were interested in the influence of the different stimuli on VL30 
expression. We isolated mRNA from arrested 3T3 Swiss fibroblasts exposed to the 
aforementioned chemicals, reversely transcribed them and quantified VL30 levels with Real 
Time PCR. Whereas single treatment of cells with TSA, Aniso, FCS or RA lead to a modest 
increase in expression, combined treatment of Aniso, FCS or RA with TSA revealed a 
synergistic effect between p38, ERK, retinoic acid receptor activation and histone acetylation 
(Figure 13). As presented above, Aniso/TSA and FCS/TSA create phosphoacetylated 
histones at the VL30 promoter, RA/TSA does not. Nevertheless, RA/TSA treatment is equally 
efficient in boosting expression, suggesting that binding of the retinoic acid receptor to the 
RAR-RXR binding site is an independent mechanism to induce VL30 element expression. 
Previous studies clearly demonstrated that the DNA sequence serving as the retinoic acid 
response element is distinct from the response elements important for VL30 induction upon 
numerous other stimuli such as transformation, epidermal growth factor (EGF), TPA, cAMP, 
and anoxic stress which are all activating either the p38 or the ERK pathway. Two DNA 
sequence cassettes have been identified to be involved in the transmission of those stimuli: 
the first encodes an AP1 transcription factor binding site followed by a CREB/JUN binding 
site (French, 1997), the second consists of a 36bp long stretch referred to as VLTRE 
containing a CREB/JUN and a REL/NFκb binding site. These cassettes are good candidates 
for binding sites for transcription factors recruiting the kinase necessary for H3S10 
phosphorylation. So far, two possible kinases have been identified as histone H3 kinases, 
Rsk2 which is activated through the ERK pathway and MSK1/2 which is activated through 
the ERK and p38 pathway, making it the prime candidate for mediating H3S10ph of VL30 
associated chromatin. To test if MSK1/2 is indeed involved in VL30 promoter phosphorylation 
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we took advantage of the protein kinase inhibitor H89. This compound was used at a 
concentration (10µM) that was shown to efficiently block histone H3 phosphorylation without 
affecting transcription factor phosphorylation (Thompson, 1999). However, others could 
demonstrate that H89 also inhibited other protein kinases such as PKA, S6K1 and ROCK-II 
(Davies, 2000). 
As shown in Figure 14A, inhibition of MSK1/2 via H89 abolished the formation of a 
phosphoacetylation mark upon Aniso/TSA treatment in arrested Swiss 3T3 fibroblasts, 
suggesting that MSK1/2 is the responsible kinase for H3 phosphorylation of VL30 elements. 
Equally important, H89 treatment also prevented transcriptional induction upon Aniso/TSA 
treatment (14B), indicating that H3S10p/K14ac does not only correlate with transcriptional 
induction mediated by Aniso/TSA treatment, but is necessary for proper VL30 expression. 
As phosphorylation is a reversible process, one or more specific phosphatases must exist to 
counteract kinase activity. So far, only one phosphatase has been identified to play a role in 
the removal of H3S10 phosphorylation: PP2A has been shown to be the responsible 
phosphatase to counteract MSK1/2 kinase activity in the context of p21 regulation, another 
recently discovered phosphoacetylation target gene (Simboeck 2008, PhD thesis). However, 
PP2A was found to specifically regulate p21 expression, not other phosphoacetylation target 
genes, demonstrating that PP2A is not the only phosphatase involved in the 
dephosphorylation of H3S10. We were curious, if VL30 elements were also regulated by 
PP2A, therefore we treated logarithmically growing Swiss 3T3 cells with ocadaic acid alone 
or together with TSA or Anisomycin. Ocadaic acid is a phosphatase inhibitor specifically 
inhibiting PP2A, but not PP1, when used at low concentrations (50nM). As summarised in 
Figure 14C, ocadaic acid did not influence VL30 expression, precluding PP2A as the 
responsible phosphatase involved in VL30 regulation. 
Finally we want to suggest the following model for VL30 regulation, which integrates many of 
the previous findings about VL30 induction: external stimuli activate the p38 (stress) or the 
ERK (growth signal) pathway leading to activation of the downstream kinase MSK1/2 which 
is recruited to VL30 elements via DNA response elements. This results in phosphorylation of 
H3S10. Together with the induction of hyperacetylation a phosphoacetylation mark is created 
leading to full transcriptional activation. An alternative, independent pathway is mediated by 
the binding of RAR/RXR to the RAR-RXR binding site upon retinoic acid treatment and 
induction of hyperacetylation (Figure 15). 
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Figure 12. Activation of the p38 or ERK MAP kinase pathway together with HDAC inhibition creates 
phosphoacetylated histones. 
(A) Swiss 3T3 fibroblasts were grown in DMEM containing 10% FCS (log) or arrested in DMEM containing 0.1% 
FCS for 72h (arr) and subsequently treated for 2h with 166nM TSA (TSA), 189nM Anisomycin (Aniso), TSA and 
Anisomycin (TSA + Aniso), 20% FCS (FCS), FCS and TSA (FCS + TSA), 10nM all-trans-Retinoic acid (RA) or RA 
and TSA (RA + TSA). Histones were isolated and histone modification levels were surveyed via Western Blot 
analysis. Antibodies were directed against pan-acetylated histone H4 (H4ac), S10p/K14ac double modified 
histone H3 (H3S10p/H3K14ac) and the c-terminal part of histone H3 (c-H3) which served as loading control. 
Acetylation levels of histone H4 were higher in logarithmically growing cells, than in arrested cells. HDAC 
inhibition by TSA increased H4ac in arrested cells; Anisomycin, and Retinoic acid had no influence. 
Phosphoacetylated histone H3 (H3S10p/H3K14ac) was present at low abundance upon stimulation of the p38 
pathway with Anisomycin (Aniso) or the ERK pathway with FCS (log; FCS). Additional incubation with TSA lead to 
efficient creation of double modified histones; Retinoic acid showed no impact on phosphoacetylation of bulk 
histones. 
(B) Arrested Swiss 3T3 fibroblasts were treated for 1h with 166nM TSA (TSA), 189nM Anisomycin (Aniso) or both 
compounds (Aniso + TSA), chromatin was harvested and subjected to ChIP experiments. To survey the levels of 
phosphoacetylated histones associated with VL30 elements, an antibody against H3S10/K14ac was used for 
precipitation and primers annealing at VL30 LTRs were used to estimate the amount of associated VL30 DNA via 
semi-quantitative PCR. An unspecific IgG was used as control. Phosphoacetylated histones were associated with 
VL30 LTRs specifically upon treatment with Anisomycin together with TSA.  
(C) Treatment of arrested Swiss 3T3 fibroblasts for 3h with chemicals as in (A). ChIP experiments using 
unspecific IgGs and an antibody recognising phosphoacetylated histones showed association of double modified 
histones with VL30 LTRs upon FCS and TSA treatment, Aniso and TSA treatment, but not upon RA and TSA 
treatment.  
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Figure 13. Expression levels of VL30 elements upon p38, ERK or retinoic acid receptor activation and 
HDAC inhibition. 
Arrested Swiss 3T3 fibroblasts were treated for 2 or 6h with the indicated chemicals at concentration as in Figure 
11A. To survey VL30 mRNA levels, mRNA was isolated, reversely transcribed and quantified via Real Time PCR. 
Values obtained with VL30 specific primers were normalised to levels of the housekeeping gene HPRT. Values 
represent the mean of three independent experiments. ± SD. n=3. 
VL30 transcript levels were moderately increased upon treatment with either TSA, FCS, Aniso or RA ((A – D) dark 
grey bars) but showed a marked increase upon combined treatment with FCS, Aniso and RA together with TSA 
for 6h ((B – D) black bars). 
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Figure 14. MSK1/2 is most likely the kinase responsible for H3 phosphorylation of VL30 elements; PP2A 
seems not to be the relevant phosphatase to remove the phospho-mark. 
(A) To test if MSK1/2 might be the relevant kinase for phosphorylation of VL30 associated chromatin, we 
compared phosphoacetylation levels in untreated, Aniso + TSA treated (1h) and Aniso + TSA treated (1h) Swiss 
3T3 cells which have been incubated with 10µM H89 15min prior to addition of Aniso + TSA. ChIP experiments 
were performed as in Figure 11. Inhibition of MSK1/2 with H89 prohibited the creation of a phosphoacetylation 
mark upon Aniso + TSA treatment. 
(B) Treatment of cells is in (A), quantification of VL30 mRNA levels as in Figure 12. Precluding 
phosphoacetylation of VL30 elements with H89 also abolished transcriptional induction of VL30 elements upon 
Aniso + TSA treatment. ± SD. n=3. 
(C) Logarithmically growing Swiss 3T3 fibroblasts were incubated with TSA, Aniso or Aniso + TSA alone (grey 
bars) or together with 50nM Okadaic acid (black bars) for 5h. VL30 transcript levels were determined as in Figure 
12. n=3, ± SD. TSA and Aniso moderately increased VL30 transcription, Aniso + TSA further enhanced 
expression. Additional administration of Ocadaic acid had no influence.  
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Figure 15. Model for transcriptional activation of VL30 elements. 
(A) Numerous stimuli can activate VL30 expression. Notably most of the compounds identified so far can activate 
the MAPK pathway (dark red).  
(B) Model for the induction of VL30 expression. Activation of the p38 or ERK MAPK signaling pathway leads to 
phosphorylation of VL30 associated chromatin (red circle) mediated by MSK1/2. Induction of hyperacetylation 
(green circle) creates a phosphoacetylation mark, triggering full transcriptional activation. RAR/RXR binding to the 
LTR induced by retinoic acid together with induction of hyperacetylation is an alternative mechanism to activate 
VL30 expression. 
___________________________________________________________________________ 
  89 
4.6. The influence of HDAC inhibition on transposition frequency 
 
Regulating the expression of a transposable element is one way to regulate its activity. 
However, transposition is a complex process including many more steps and each of them 
can be targeted by regulatory mechanisms. After transcription, RNA has to be exported to 
the cytoplasm, translated, the gene product has to be shuttled into the nucleus and finally a 
reversely transcribed mRNA has to be integrated into the genomic DNA. That way, altering 
RNA stability, translation, nuclear shuttling, editing template RNA or effecting integration 
efficiency has severe impact on the rate of successful transposition. 
We could show in Chapter 3.1. that treatment of cells with the HDAC inhibitor TSA had 
severe effects on the chromatin state including changes in histone acetylation and 
methylation patterns. As the chromatin state is not only regulating gene transcription but also 
constitutes the substrate for the last step of transposition – integration – we raised the 
hypothesis that changed histone modification patterns might influence the efficiency of 
transposition independent of TE transcription. In the simplest model, opening of the 
chromatin might render the DNA more accessible and susceptible for the integration 
machinery. To test this hypothesis we took advantage of an experimental system recently 
used to investigate the influence of the RNA editing APOBEC enzymes on transposition 
efficiency (Esnault, 2005). Different retroelements carrying its set of functional genes 
essential for autonomous retrotransposition were marked with a neo reporter gene placed in 
reverse orientation. Upon transfection, TEs were transcribed and spliced, removing the intron 
located inside the neo gene in forward orientation. The mRNA served as source for reverse 
transcription and integration into the genome resulted in the creation of a genomic 
retroelement interrupted by a functional neo gene. This was used as selection marker and 
that way we could select for cells with successful transposition of a transposable element 
delivered from an episome (Figure 17A). To test the influence of histone modifying enzymes 
on this process, we transfected U2OS cells with different marked transposable elements or a 
control plasmid (MusD and IAP as representatives for LTR elements; L1.Md and L1.2B as 
representatives for LINEs; pEGFP-N2 as control plasmid) and treated them with TSA for 24h 
after transfection. For quantification of transposition frequency we followed the protocol 
presented in Figure 17B. Concomitantly we performed control experiments to determine the 
effect of TSA on (1) the transfection efficiency of cells and (2) the expression of the marked 
TEs after transfection. Figure 16 shows that TSA treatment for 24 or 48h after transfection 
was connected to a modest increase in the percentage of GFP positive cells, when U2OS 
cells were transfected with a plasmid containing EGPF driven by the CMV immediate early 
promoter (Figure 16A and C). However, the detected increase was rather small and also 
might originate from the enhanced expression of EGPF when cells were treated with TSA 
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(Figure 16B and D). This lead us to the conclusion, that TSA treatment did not have a major 
impact on transfection efficiency. The expression of the marked TEs was surveyed as 
described in Figure 17C: after transfection, cells were treated with TSA for 24h, RNA was 
isolated, reversely transcribed and subjected to Real Time PCR analysis. Using primers 
directed against the neo gene of the marked TE we measured the abundance of TE derived 
transcripts. In the case of the marked IAP, we also used IAP specific primers, leading to 
identical results (data not shown). Additionally, untransfected cells were included in the 
analysis, where we could not detect any transcripts (data not shown). Values obtained with 
the neo-specific primers were then normalised to expression of the housekeeping gene 
GAPDH.  
As presented in Figure 17D, treatment of TSA lead to an increase in marked TE mRNA 
abundance of about two to three times. The increase in mRNA abundance is accompanied 
with a two to four fold increase in transposition events (Figure 17D, compare black to grey 
bars). These data suggest that TSA treatment leads to enhanced expression of marked TEs, 
which in turn results in increased transposition rates. Therefore, changes on histone 
modification patterns as induced by TSA seem not sufficient to influence TE transposition 
rates. 
___________________________________________________________________________ 
  91 
 
Figure 16. Effect of HDAC inhibition on transfection efficiency. 
To test the impact of HDAC inhibition on transfection efficiency, U20S cells were transfected with the pEGFP-N2 
plasmid containing a cassette encoding the EGFP gene driven by the CMV immediate early promoter. After 
transfection, cells were incubated with 66nM TSA for 24 or 48h, harvested, fixed with 85% ethanol and subjected 
to fluorescent-activated cell sorting (FACS) analysis. (A) and (C) show FACS blots of untreated cells and cells 
incubated for 24 or 48h with TSA after transfection. The portion of GFP positive cells is 27% increased upon TSA 
treatment 24h post transfection and 15% 48h post transfection. Green dots: GFP positive cells; red dots: GFP 
negative cells; black dots: dead cells. Classification of GFP positive cells into lowly (M3), medium (M2) and highly 
expressing (M3) subpopulations revealed that TSA administration lead to elevated expression of the EGFP 
protein ((B) and (D)) in transfected cells. 
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Figure 17. TSA treatment has no major impact on the transposition frequency of retrotransposons. 
(A) Representation of a retroelement marked with the neo reporter gene placed in reverse orientation with its own 
promoter (Pr). Besides the neo cassette, each marked retroelement carries its set of functional genes, allowing 
autonomous retrotransposition. Only upon retrotransposition including the steps of transcription, splicing, reverse 
transcription and integration the neo gene becomes functional. (B) Experimental procedure for the detection of 
retrotransposition. After transfection, cells were treated with 66nM TSA for 24h to determine the effect of HDAC 
inhibition on transposition frequency determined by quantification of G418 resistant clones. (C) To monitor the 
influence of HDAC inhibition on the expression of transfected plasmids, mRNA abundance was measured via 
Real Time PCR. Primers were directed against the neo gene cassette and values were normalised against levels 
of the housekeeping gene GAPDH. (D) Analysis of the activity of murine LTR elements MusD and IAP, the murine 
non-LTR element L1.Md and the human non-LTR element L1.2B in U2OS cells upon TSA treatment. Grey bars 
represent transposition events as determined by counting G418 resistant clones. The numbers of clones in TSA 
treated cells are given relative to the numbers of clones determined in untreated cells. Black bars display the 
abundance of mRNA derived from transfected plasmids. Values for mRNA levels upon TSA treatment are given 
as relative numbers based on the mRNA levels determined in untreated cells. Values represent mean values of at 
least three independent experiments. ± SD. TSA treatment is enhancing transposition frequencies as well as 
transcription of tested retrotransposons. 
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5. Discussion 
 
5.1. Different epigenetic modifications are interconnected 
 
The goal of this work was to define the role of histone acetylation in the regulation of TEs in 
murine somatic cells. It is well known that histone acetylation is generally correlated with 
gene transcription; this has been demonstrated on the genome wide level (Kurdistani, 2004; 
Koch, 2007; Fischer, 2008) as well as for numerous individual genes and LTR retroviruses 
such as e.g. HIV (He, 2002; Lusic, 2003). Altering histone acetylation levels either via genetic 
inactivation of individual HATs and HDACs or via chemical inhibition of HDACs leads to 
changes in the expression pattern of defined genes in a cell type specific manner (Zhang, 
1998; Howe, 2001; Foglietti, 2006; Zupkovitz, 2006; Senese, 2007; Knutson, 2008). This is of 
clinical relevance, since cancer cells seem to be more sensitive to such changes than normal 
cells and application of HDACi has been demonstrated to induce cell cycle arrest or 
apoptosis in cancer cells (Marks, 2005). However, the exact mode of action is only poorly 
understood; although some important genes for cell cycle progression (e.g. p21) or apoptosis 
are often targeted upon HDACi treatment, effects also seem to be cell type specific.  
The vast majority of work on histone acetylation and transcription throughout the last years 
has been dedicated to gene regulation in different cancer cells (Yang, 2007), throughout 
development (Kalkhoven, 2004; Brunmeir, 2008) or to the silencing of retroviruses such as 
HIV (He, 2002; Lusic, 2003); to our knowledge no extensive study has been performed so far 
to analyse the interrelation between histone acetylation and regulation of endogenous 
retroelements. As already mentioned above, tight regulation of TE expression is crucial for 
genomic integrity and exploring the impact of histone acetylation on TE regulation is highly 
relevant: HDACis are already in clinical trials as anti-cancer drugs and they are also 
promising agents for the treatment of patients with HIV, bipolar disorders or 
neurodegenerative diseases (Lehrman 2005; Sharma 2006; Sadri-Vakili 2006; Hahnen 
2008). Therefore possible side effects have to be studied carefully. 
To perform this study, we exploited an experimental system where histone acetylation was 
altered in murine fibroblasts; either by the knock out of the major histone deacetylase 
HDAC1 or by chemical inhibition of all class I and II HDACs via TSA. For comparison, Aza-
dC treated cells with decreased DNA methylation levels were included in the analysis. Before 
we specifically addressed questions dealing with the effects of those perturbations on TE 
regulation, we wanted to monitor global effects on histone modification patterns and the 
expression of the targeted proteins. This analysis lead to some general conclusions: (1) 
HDAC1 function is not essential for the maintenance of most chromatin modification patterns 
analysed. (2) General HDAC and DNMT inhibition has far reaching consequences on the 
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cellular chromatin and DNA modification landscape, influencing not only directly targeted 
modifications, but also interfering with histone methylation patterns. 
Ad (1) Although HDAC1 is the major histone deacetylase in fibroblasts delivering more than 
30% of total HDAC activity (see also J. Jurkin, diploma thesis), the knock out shows only a 
very mild phenotype including the hyperacetylation of the single lysine residue H4K8 and the 
deregulation of few target genes (Y. Zhang, FMI Basel). Most likely HDAC2, the close 
homologue present in the same multiprotein complexes as HDAC1 and which is upregulated 
upon HDAC1 knock out, can take over the vast majority of functions. This is consistent with 
the finding that the knock out of HDAC1 or HDAC2 in several tissues does not result in 
obvious phenotypes, most likely due to redundancy between the two homologues. In 
contrast, deletion of both genes leads to severe phenotypes in all analysed cell types 
(Brunmeir, 2008). Still, under several circumstances the loss of HDAC1 alone is sufficient to 
cause phenotypic changes: loss of HDAC1 during embryogenesis leads to embryonic 
lethality before day E10.5 (Lagger, 2002), ES cells and primary fibroblasts without HDAC1 
show reduced proliferation rates (Lagger, 2002; R. Grausenburger, PhD thesis, 2006) and 
loss of HDAC1 in a teratocarcinoma or epithelial cancer model system affects 
cancerogenesis and cellular differentiation (D. Meunier, S. Lagger, unpublished observation, 
G. Machat, diploma thesis, 2008). This points towards a model, where most cellular tasks 
(including all basic cellular functions) are redundantly fulfilled by HDAC1 and HDAC2, but 
certain cell type specific functions are only properly executed when both homologues are 
present.  
Ad (2) Inhibition of all class I and II HDACs with TSA leads to major changes in chromatin 
modification patterns: acetylation levels are increased at histone H3 and H4 proteins, as a 
secondary effect H3K4m4 and H3K27m3 are enriched. Models to mechanistically explain 
this phenomenon have been mentioned above. A decrease in DNA methylation as caused by 
Aza-dC treatment procures even more complex changes: histone acetylation as well as the 
activating histone methylation mark H3K4m3 and the repressive marks H3K9m3, H3K27m3, 
H4K29m2 and H4K20m3 are enriched. Notably these are only the changes we detected with 
our limited number of antibodies; unbiased techniques such as mass spectrometry would 
certainly disclose additional deformations in chromatin modification patterns. However, with 
these quantitative methods we do not gain information about qualitative changes as for 
example the genomic distribution of chromatin modifications. ChIP-chip experiments, which 
are currently conducted in several laboratories are addressing this open question and might 
be helpful to better understand the crosstalk between different histone modifications as well 
as DNA methylation. 
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5.2. TE expression and histone acetylation 
 
Having monitored global changes mediated by TSA and Aza-dC treatment on a variety of 
histone modifications, we went on and narrowed our focus on the initial topic of interest i.e. 
the interrelation between histone acetylation and TE regulation. Determining histone 
acetylation levels of a representative selection of TEs in a HDAC-/- background, upon TSA 
and Aza-dC treatment and correlating these data with the expression of TEs revealed the 
following findings: (1) only a limited number of TEs can be activated by either TSA or Aza-dC 
treatment. In the prevalent model of TE silencing, transcription in somatic cells is restrained 
by DNA methylation (Yoder, 1997; Walsh, 1998) with some contribution of histone 
methylation (Martens, 2005) and small RNAs (Kanellopoulou, 2005), in germ cells by DNA 
methylation and piRNA related mechanisms (Bourc’his, 2004; Carmell, 2007; Aravin, 2007). 
Relieving DNA methylation in somatic fibroblasts strongly enhances the expression of IAP 
and VL30 LTR elements demonstrating that losing repression is sufficient to activate 
transcription of some, but not all TEs. Activating factors for other TEs might be absent in this 
cell type, impeding high expression; alternatively other repressive mechanisms could still be 
present. (2) Enhanced expression correlates with increased acetylation levels. This is 
obvious for VL30 elements, which are highly expressed upon TSA and Aza-dC treatment, 
and IAP elements which are highly expressed after treatment with Aza-dC: both LTR 
elements exhibit hyperacetylation when transcribed. SINEs are also hyperacetylated in TSA 
treated fibroblasts, but this comes along with only mild effects on transcription; therefore we 
want to suggest that SINEs are acetylated as parts of genes, which are under the influence 
of histone acetylation. (3) TSA treatment leads to hyperacetylation of H4 proteins 
independent of transcriptional activity. H4 specific HATs seem to readily acetylate lysine 
residues of H4 when the dominant HDACs are inhibited, suggesting their regular presence at 
TEs and silent genes. In contrast, acetylation of H3 seems coupled with transcription, 
pointing towards a model where H3 acetylation might stimulate the recruitment of the 
transcription machinery or alternatively H3 specific HATs are recruited together with the 
transcription machinery. Interestingly Koch and colleagues recently showed that although 
H4ac and H3ac are both enriched around the transcriptional start site, only H3ac can be 
used as a highly predictive marker for gene activity (Koch, 2008). One might speculate that 
differential HAT recruitment reflects a functional difference between H3 and H4 acetylation. 
In addition to their role in transcription where both modifications act synergistically, H4 
acetylation / deacetylation could have other biological tasks. 
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5.3. DNA sequence does matter 
 
The TEs activated by TSA or Aza-dC are derived from several genomic loci. Examining IAP 
and VL30 transcripts in untreated and treated fibroblasts clearly shows that expressed TEs 
originate from numerous loci dispersed throughout the genome. However, upon different 
stimuli, certain groups of elements are preferentially expressed. We could show that 
elements preferentially expressed harbour characteristic DNA sequence features within the 
LTR, the regulatory region of the element. IAPs are more efficiently activated with Aza-dC, 
when they carry additional binding sites for the transcription factor C/EBPalpha. Strikingly, 
Ishihara and colleagues, who characterised IAP elements active upon irradiation of mouse 
acute myeloid leukaemia (AML) cells, isolated elements with especially long stretches of 
C/EBPalpha binding sites (Ishihara, 2004) (Table 3, AB099818). In contrast, IAP elements 
responsible for recent integration events in the mouse germline (Maksakova, 2006) harbour 
only one TF binding site (Table 3, X04120 and AxinFu). 
VL30 elements treated with Aza-dC or TSA are preferentially expressed when driven by a 
LTR with a subtype I U3 region. Several years ago Nilsson and Bohm already proposed a 
model that the enhancer design of VL30 elements determines tissue specific expression and 
the response to external stimuli (Nilsson, 1994). Our data clearly support this model. 
In summary, upon release of silencing, expression is mainly determined by intrinsic features 
of the elements, e.g. transcription factor binding sites and external factors e.g. the availability 
of corresponding transcription factors. The impact of cellular components on expression is 
exemplified by the finding that VL30 elements expressed upon TSA are distinct in different 
fibroblasts cell lines: whereas in logarithmically growing fibroblasts subtype I elements are 
especially responsive to external stimuli, in arrested Swiss 3T3 we found predominant 
transcription of elements with LTR subtype IV U3 region (data not shown). 
 
5.4. VL30 – a special case 
 
In mammals, transcriptional release in TE silencing has been reported repeatedly: loss of 
proteins involved in DNA methylation, the siRNA and piRNA pathways and to a certain 
degree histone methylation lead to a deregulation of TEs expression. SINE elements can be 
activated via stress and Adenovirus infection (Panning, 1993; Liu, 1995), LINEs by benzo(a) 
pyrene (Stribinskis, 2006). In cancer cells, TE silencing is impaired probably due to altered 
DNA methylation patterns (Rauch, 2008; Wilson, 2007) and several human diseases are 
associated with a relaxation of TE repression (Colmegna, 2006).  
Still, the regulation of VL30 expression is unique among mammalian retrotransposons; a 
multitude of stimuli is able to highly induce transcription in several cell systems such as 
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fibroblasts, keratinocytes, haematopoietic and neuronal cells (French, 1997; Tzavaras, 2003; 
Noutsopoulos, 2007). Furthermore VL30 elements are the first mammalian TEs responsive 
to HDAC inhibition. Freshly integrated retroelements including retroviruses and LINEs have 
been reported to exhibit sensitivity to HDAC inhibition; however this responsiveness is lost 
after few generations when other, HDAC insensitive mechanisms (most likely DNA 
methylation) take over the silencing function (Pannell, 2000). Derepression of endogenous, 
not recently integrated TE elements with HDACis has not been reported so far to our 
knowledge. VL30 elements seem to exist in a default state which is “ready for transcription” 
and external stimuli can easily flip the switch to “active transcription”. 
Why does the host not antagonise this loose repression more vehemently? Why does it allow 
VL30 expression, but is tightly controlling expression of other TEs? One possible answer is 
that VL30 elements are simply ahead in the arms race between host and parasite. 
Alternatively, the evolutionary pressure on the host is relatively low: as long as other TEs, 
which are required for intracellular mobility of VL30 elements – VL30 elements are absolutely 
dependent the enzymatic machinery of other LTR elements as they do not encode functional 
proteins – are efficiently silenced, VL30 elements do not constitute a danger to the host and 
therefore expression does not have to be tightly controlled. 
Finally, a third scenario is plausible: Song and colleagues recently showed that VL30 RNA 
can interact with the PSF protein and modulate PSF mediated repression of target genes 
(Song, 2004; Song, 2005). Therefore VL30 elements have acquired physiological functions in 
murine cells and might be necessary for the regulation of certain host genes. This finding 
suggests that VL30 could be a symbiont rather than a parasite to the host. 
 
5.5. VL30 expression is synergistically regulated by histone acetylation and phosphorylation 
 
Another novel and important finding of our study is the positive impact of histone H3 
phosphorylation on VL30 transcription. Since several years, mechanistic links between 
histone acetylation and histone phosphorylation caused by different stimuli, including stress 
and growth factors, have been established. For example, immediate early genes such as c-
myc, c-fos, c-jun (Cheung, 2000; Clayton, 2000; L,i 2001), but also an increasing number of 
others (Hauser, 2002; Winter, 2008; E. Simboeck, PhD thesis, 2008) depend on the 
induction of histone H3 phosphoacetylation. Simultaneous H3 phosphorylation and 
acetylation provides a recognition mark for 14-3-3 proteins which translate this histone code 
into a biological outcome i.e. gene transcription (Winter, 2008; Walter, 2008). 
In a series of experiments we could show that VL30 expression is synergistically activated by 
stimuli leading to histone phosphorylation (FCS, anisomycin) and histone acetylation (TSA); 
full transcriptional activity is correlated with the creation of phosphoacetylated histone 
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proteins at the VL30 LTR. Usage of the inhibitor of the nucleosomal response H89 indicates 
that the creation of this dual histone mark is necessary for activation caused by FCS/TSA or 
Anisomycin/TSA and that MSK1/2 might be the responsible kinase responsible for 
phosphorylation. The phosphatase counteracting MSK1/2 activity in the non-induced state is 
not identified yet, first experiments with the inhibitor ocadaic acid indicate, that it is a different 
phosphatase than PP2A. We also do not know by now which HAT is responsible for histone 
acetylation. The contribution of the different HDACs in the maintenance an inactive state is 
also unclear. However, results from several experiments suggest the involvement of other 
HDACs beside HDAC1 and HDAC2. First, loss of HDAC1 in fibroblasts does not change 
VL30 transcript levels. Second, RNAi mediated knock down of HDAC1, HDAC2 or HDAC1 
and HDAC2 in primary fibroblasts has no influence on VL30 transcript levels as determined 
via RT-Real Time PCR (preliminary result, data not shown). Third, treatment of fibroblasts 
with MS-275 (5µM; 24h), an HDI with limited specificity against HDAC1 (Khan, 2008), results 
in an only 2 fold enrichment of VL30 transcripts, a modest increased as compared to the 30 
fold enrichment we observed when cells were treated with the general HDI TSA (data not 
shown). 
In summary we collected data supporting a model that VL30 transposable elements are 
novel phosphoacetylation target genes. Transcriptional activation can be mediated via stress 
or growth factor induced activation of the p38 or ERK MAPK pathway and subsequent 
phosphorylation of promoter associated histone proteins by MSK1/2 together with acetylation 
of histones. This pathway is one of at least two possible ways to activate VL30 elements; 
phosphoacetylation independent mechanisms involving retinoic acid receptor signalling exist 
in parallel. 
Still many details about the exact mechanism of VL30 regulation via dual histone 
modification are unclear. As mentioned above, we do not know the responsible HAT(s), 
HDAC(s) and phosphatase(s) and if the phosphoacetylation mark is read by 14-3-3 proteins 
as it is the case for the HDAC1 and p21 genes. 
 Activation of specific VL30 subtypes in different cell lines could originate from differential 
enhancer design of elements. We speculate that the availability of transcription factors 
necessary for the recruitment of factors (kinase, HAT, phosphatase, HDAC) to the regulatory 
regions might be the determining factor for the different regulation of VL30 subgroups in 
different cell lines. This is a testable hypothesis. 
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5.6. Transposition rates of several TEs are not influenced by HDAC inhibition in mouse 
fibroblasts 
 
The link between increased transcription and transposition is evident; production of an 
adequate amount of mRNA is an essential premise for all subsequent steps in the lifecycle of 
a TE. Similar to expression, upcoming events such as mRNA processing, export, translation, 
reverse transcription, nuclear import, integration including DNA cleavage and repair of the 
double strand brake, greatly depend on host factors. This delivers the host additional points 
of action to encounter transposon activity. An example for post-transcriptional regulation is 
the deamination of cytidine residues of nascent DNA molecules during reverse transcription 
leading to hypermutation of retroviruses and TEs (Mangeat, 2003; Esnault, 2005; Dutko, 
2005; Chiu, 2006). Genetic screens in yeast have uncovered numerous other host factors 
either restricting or enhancing transposon activity (Scholes, 2001; Griffith, 2003; Aye, 2004; 
Irwin, 2005; Nyswaner, 2008). Strikingly, a substantial fraction of the genes identified has a 
role in chromatin biology; for instance, members of the PAF1 complex involved in histone 
H2B ubiquitination, the histone chaperone ASF1 and most importantly SIN3 and RPD3, 
major components of the yeast HDAC complex were found to restrict Ty1 activity. 
Interestingly, SIN3/RPD3 do not act at the transcriptional level as they have no influence on 
Ty1 mRNA levels. In addition to increasing transposition rates, they also change target site 
selection of the LTR retrotransposon (Nyswaner 2008). 
In an experimental setup, where we monitored retrotransposition of tagged IAPs, MusD and 
L1 LINE elements from episomes into the genome, we detect only minor differences in the 
frequency of retrotransposition events when cells were treated with TSA. Transposition 
events were increased between two and four times upon TSA treatment, however we also 
observed a two to three fold enrichment of the transcript. Therefore we think that the 
increase in retrotransposition events is due to enhanced transcription. The finding that TSA 
treatment does not have a major influence on the retrotransposition frequency of murine LTR 
and non LTR retroelements is quite surprising considering the finding described above that 
HDAC complexes greatly influence TE activity in yeast. In addition to complex changes in the 
histone modification landscape, TSA treatment of cancer cells also results in the deregulation 
of a multitude of genes, presumably including several host factors important for 
retrotransposition. Therefore it is still possible that TSA treatment leads to qualitative 
changes of TE activity (i.e. target site selection); this aspect could be analysed via cloning of 
integration sites; or HDAC inhibition leads to an equal deregulation of activating and 
restricting histone modifications / host factors. 
___________________________________________________________________________ 
  100 
___________________________________________________________________________ 
  101 
6. References 
 
Agalioti T, Chen G, Thanos D. Deciphering the transcriptional histone acetylation code for a 
human gene. Cell. 2002 Nov 1;111(3):381-92.  
Akhtar A, Becker PB. Activation of transcription through histone H4 acetylation by MOF, an 
acetyltransferase essential for dosage compensation in Drosophila. Mol Cell. 2000 
Feb;5(2):367-75. 
Allan J, Cowling GJ, Harborne N, Cattini P, Craigie R, Gould H. Regulation of the higher-
order structure of chromatin by histones H1 and H5. J Cell Biol. 1981 Aug;90(2):279-88. 
Allfrey VG, Mirsky AE. Structural Modifications of Histones and their Possible Role in the 
Regulation of RNA Synthesis. Science. 1964 May 1;144(3618):559 
Allis CD, Chicoine LG, Richman R, Schulman IG. Deposition-related histone acetylation in 
micronuclei of conjugating Tetrahymena. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8048-
52. 
Aravin AA, Hannon GJ, Brennecke J. The Piwi-piRNA pathway provides an adaptive defense 
in the transposon arms race. Science. 2007 Nov 2;318(5851):761-4. Review. 
Aye M, Irwin B, Beliakova-Bethell N, Chen E, Garrus J, Sandmeyer S. Host factors that affect 
Ty3 retrotransposition in Saccharomyces cerevisiae. Genetics. 2004 Nov;168(3):1159-76. 
Bannister AJ, Kouzarides T. Reversing histone methylation. Nature. 2005 Aug 
25;436(7054):1103-6. Review. 
Becker PB. Nucleosome sliding: facts and fiction. EMBO J. 2002 Sep 16;21(18):4749-53. 
Review.  
Benson G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids 
Res. 1999 Jan 15;27(2):573-80. 
Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, Hiebert SW. Deletion of 
histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. 
Mol Cell. 2008 Apr 11;30(1):61-72. 
Birchler JA, Kavi HH. Molecular biology. Slicing and dicing for small RNAs. Science. 2008 
May 23;320(5879):1023-4. Epub 2008 May 8. 
Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ 
cells lacking Dnmt3L. Nature. 2004 Sep 2;431(7004):96-9. Epub 2004 Aug 18. 
Bradbury EM. Reversible histone modifications and the chromosome cell cycle. Bioessays. 
1992 Jan;14(1):9-16. Review.  
Branciforte D, Martin SL. Developmental and cell type specificity of LINE-1 expression in 
mouse testis: implications for transposition. Mol Cell Biol. 1994 Apr;14(4):2584-92. 
Brownell JE, Allis CD. Special HATs for special occasions: linking histone acetylation to 
chromatin assembly and gene activation. Curr Opin Genet Dev. 1996 Apr;6(2):176-84. 
Review. 
Brunmeir R, Lagger S, Seiser C. HDAC1/HDAC2-controlled embryonic development and cell 
differentiation. Int. J. Developmental Biology. In Press. Review 
Butler PJ, Thomas JO. Changes in chromatin folding in solution. J Mol Biol. 1980 Jul 
15;140(4):505-29. 
Cano E, Hazzalin CA, Kardalinou E, Buckle RS, Mahadevan LC. Neither ERK nor JNK/SAPK 
MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-
jun induction. J Cell Sci. 1995 Nov;108 ( Pt 11):3599-609. 
Carmell MA, Girard A, van de Kant HJ, Bourc'his D, Bestor TH, de Rooij DG, Hannon GJ. 
MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male 
germline. Dev Cell. 2007 Apr;12(4):503-14. Epub 2007 Mar 29. 
Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. 
Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal 
growth factor stimulation. 
Mol Cell. 2000 Jun;5(6):905-15. 
Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, Heidmann T, Greene 
WC. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl 
Acad Sci U S A. 2006 Oct 17;103(42):15588-93. Epub 2006 Oct 9.  
___________________________________________________________________________ 
  102 
Clayton AL, Rose S, Barratt MJ, Mahadevan LC. Phosphoacetylation of histone H3 on c-fos- 
and c-jun-associated nucleosomes upon gene activation. EMBO J. 2000 Jul 17;19(14):3714-
26. 
Colmegna I, Garry RF. Role of endogenous retroviruses in autoimmune diseases. Infect Dis 
Clin North Am. 2006 Dec;20(4):913-29. Review. 
Costain WJ, Rasquinha I, Graber T, Luebbert C, Preston E, Slinn J, Xie X, MacManus JP. 
Cerebral ischemia induces neuronal expression of novel VL30 mouse retrotransposons 
bound to polyribosomes. Brain Res. 2006 Jun 13;1094(1):24-37. Epub 2006 May 30. 
Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some 
commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105  
Davis CM, Constantinides PG, van der Riet F, van Schalkwyk L, Gevers W, Parker MI. 
Activation and demethylation of the intracisternal A particle genes by 5-azacytidine. Cell 
Differ Dev. 1989 Jul;27(2):83-93.  
Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene. 
2007 Aug 13;26(37):5433-8. Review. 
Dewannieux M, Dupressoir A, Harper F, Pierron G, Heidmann T. Identification of 
autonomous IAP LTR retrotransposons mobile in mammalian cells. Nat Genet. 2004 
May;36(5):534-9. Epub 2004 Apr 25. 
Dormann HL, Tseng BS, Allis CD, Funabiki H, Fischle W. Dynamic regulation of effector 
protein binding to histone modifications: the biology of HP1 switching. Cell Cycle. 2006 
Dec;5(24):2842-51. Epub 2006 Dec 15. 
Dupressoir A, Heidmann T. Germ line-specific expression of intracisternal A-particle 
retrotransposons in transgenic mice. Mol Cell Biol. 1996 Aug;16(8):4495-503. 
Dutko JA, Schäfer A, Kenny AE, Cullen BR, Curcio MJ. Inhibition of a yeast LTR 
retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol. 2005 Apr 
12;15(7):661-6. 
Eickbush TH. Telomerase and retrotransposons: which came first? Science. 1997 Aug 
15;277(5328):911-2. 
Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, 
Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous 
retroviruses. Nature. 2005 Jan 27;433(7024):430-3. 
Fennelly J, Harper K, Laval S, Wright E, Plumb M. Co-amplification to tail-to-tail copies of 
MuRVY and IAPE retroviral genomes on the Mus musculus Y chromosome. Mamm 
Genome. 1996 Jan;7(1):31-6. 
Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich 
NP. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. 
Nature. 1999 Sep 9;401(6749):188-93.  
Fischer JJ, Toedling J, Krueger T, Schueler M, Huber W, Sperling S. Combinatorial effects of 
four histone modifications in transcription and differentiation. Genomics. 2008 Jan;91(1):41-
51. Epub 2007 Nov 8.  
Fischle W, Wang Y, Allis CD. Binary switches and modification cassettes in histone biology 
and beyond. Nature. 2003 Oct 2;425(6957):475-9. 
Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, 
Mechtler K, Schotta G, Jenuwein T. Jmjd2b antagonizes H3K9 trimethylation at pericentric 
heterochromatin in mammalian cells. Genes Dev. 2006 Jun 15;20(12):1557-62. Epub 2006 
May 31. 
Foglietti C, Filocamo G, Cundari E, De Rinaldis E, Lahm A, Cortese R, Steinkühler C. 
Dissecting the biological functions of Drosophila histone deacetylases by RNA interference 
and transcriptional profiling. J Biol Chem. 2006 Jun 30;281(26):17968-76. Epub 2006 Apr 21. 
Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa 
JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen 
P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. Epigenetic differences arise 
during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005 Jul 
26;102(30):10604-9. Epub 2005 Jul 11. 
French NS, Norton JD. Structure and functional properties of mouse VL30 retrotransposons. 
Biochim Biophys Acta. 1997 May 2;1352(1):33-47. Review. 
___________________________________________________________________________ 
  103 
Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase 
Dnmt1 associates with histone deacetylase activity. Nat Genet. 2000 Jan;24(1):88-91. 
Gaudet F, Rideout WM 3rd, Meissner A, Dausman J, Leonhardt H, Jaenisch R. Dnmt1 
expression in pre- and postimplantation embryogenesis and the maintenance of IAP 
silencing. Mol Cell Biol. 2004 Feb;24(4):1640-8. 
Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T, Jacob ST. 5-Aza-deoxycytidine 
induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that 
requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. 
Mol Cell Biol. 2005 Jun;25(11):4727-41. 
Giet R, Prigent C. The non-catalytic domain of the Xenopus laevis auroraA kinase localises 
the protein to the centrosome. J Cell Sci. 2001 Jun;114(Pt 11):2095-104. 
Girard A, Hannon GJ. Conserved themes in small-RNA-mediated transposon control. Trends 
Cell Biol. 2008 Mar;18(3):136-48. Epub 2008 Feb 20. Review.  
Gonzalgo ML, Jones PA. Rapid quantitation of methylation differences at specific sites using 
methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 
1997 Jun 15;25(12):2529-31. 
Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki 
T, Takahashi T, Inagaki M. Identification of a novel phosphorylation site on histone H3 
coupled with mitotic chromosome condensation. J Biol Chem. 1999 Sep 3;274(36):25543-9. 
Griffith JL, Coleman LE, Raymond AS, Goodson SG, Pittard WS, Tsui C, Devine SE. 
Functional genomics reveals relationships between the retrovirus-like Ty1 element and its 
host Saccharomyces cerevisiae. Genetics. 2003 Jul;164(3):867-79. 
Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997 Sep 
25;389(6649):349-52. Review. 
Hauser C, Schuettengruber B, Bartl S, Lagger G, Seiser C. Activation of the mouse histone 
deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol. 
2002 Nov;22(22):7820-30. 
Hahnen E, Hauke J, Tränkle C, Eyüpoglu IY, Wirth B, Blümcke I. Histone deacetylase 
inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs. 
2008 Feb;17(2):169-84. Review. 
Haigis MC, Guarente LP. Mammalian sirtuins--emerging roles in physiology, aging, and 
calorie restriction. Genes Dev. 2006 Nov 1;20(21):2913-21. Review. 
He G, Margolis DM. Counterregulation of chromatin deacetylation and histone deacetylase 
occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the 
HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol. 2002 May;22(9):2965-73. 
Horie K, Saito ES, Keng VW, Ikeda R, Ishihara H, Takeda J. Retrotransposons influence the 
mouse transcriptome: implication for the divergence of genetic traits. Genetics. 2007 
Jun;176(2):815-27. Epub 2007 Apr 15. 
Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of 
endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene. 2008 
Jan 10;27(3):404-8. Epub 2007 Jul 9. 
Howe L, Auston D, Grant P, John S, Cook RG, Workman JL, Pillus L. Histone H3 specific 
acetyltransferases are essential for cell cycle progression. Genes Dev. 2001 Dec 
1;15(23):3144-54. 
Huang J, Fan T, Yan Q, Zhu H, Fox S, Issaq HJ, Best L, Gangi L, Munroe D, Muegge K. Lsh, 
an epigenetic guardian of repetitive elements. Nucleic Acids Res. 2004 Sep 24;32(17):5019-
28. Print 2004. 
Inoue T, Hiratsuka M, Osaki M, Oshimura M. The molecular biology of mammalian SIRT 
proteins: SIRT2 in cell cycle regulation. Cell Cycle. 2007 May 2;6(9):1011-8. Epub 2007 May 
30. Review. 
Irwin B, Aye M, Baldi P, Beliakova-Bethell N, Cheng H, Dou Y, Liou W, Sandmeyer S. 
Retroviruses and yeast retrotransposons use overlapping sets of host genes. Genome Res. 
2005 May;15(5):641-54. Epub 2005 Apr 18. 
Ishihara H, Tanaka I, Wan H, Nojima K, Yoshida K. Retrotransposition of limited deletion 
type of intracisternal A-particle elements in the myeloid leukemia Clls of C3H/He mice. J 
Radiat Res (Tokyo). 2004 Mar;45(1):25-32. 
___________________________________________________________________________ 
  104 
Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, 
Dausman J, Lee P, Wilson C, Lander E, Jaenisch R. Loss of genomic methylation causes 
p53-dependent apoptosis and epigenetic deregulation. Nat Genet. 2001 Jan;27(1):31-9.  
Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates 
silent retroviral genomes in different tissues. Proc Natl Acad Sci U S A. 1985 
Mar;82(5):1451-5. 
Januchowski R, Dabrowski M, Ofori H, Jagodzinski PP. Trichostatin A down-regulate DNA 
methyltransferase 1 in Jurkat T cells. Cancer Lett. 2007 Feb 8;246(1-2):313-7. Epub 2006 
Apr 19. 
Jenuwein T, Allis CD. Translating the histone code. Science. 2001 Aug 10;293(5532):1074-
80. Review.  
Jiang L, Smith JN, Anderson SL, Ma P, Mizzen CA, Kelleher NL. Global assessment of 
combinatorial post-translational modification of core histones in yeast using contemporary 
mass spectrometry. LYS4 trimethylation correlates with degree of acetylation on the same 
H3 tail. J Biol Chem. 2007 Sep 21;282(38):27923-34. Epub 2007 Jul 24. 
Jurka, J., Kapitonov, V.V., Pavlicek, A., Klonowski, P., Kohany, O., Walichiewicz, J.  
Repbase Update, a database of eukaryotic repetitive elements.  Cytogenetic and Genome 
Research 110:462-467 
Lusic M, Marcello A, Cereseto A, Giacca M. Regulation of HIV-1 gene expression by histone 
acetylation and factor recruitment at the LTR promoter. EMBO J. 2003 Dec 15;22(24):6550-
61. 
Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol. 2004 Sep 
15;68(6):1145-55. Review. 
Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston DM, 
Rajewsky K. Dicer-deficient mouse embryonic stem cells are defective in differentiation and 
centromeric silencing. Genes Dev. 2005 Feb 15;19(4):489-501. 
Kazazian HH Jr. Mobile elements and disease. Curr Opin Genet Dev. 1998 Jun;8(3):343-50. 
Review. 
Kimura A, Matsubara K, Horikoshi M. A decade of histone acetylation: marking eukaryotic 
chromosomes with specific codes. J Biochem. 2005 Dec;138(6):647-62. 
Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, 
Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested 
M. Determination of the class and isoform selectivity of small-molecule histone deacetylase 
inhibitors. Biochem J. 2008 Jan 15;409(2):581-9.  
Koshland D, Strunnikov A. Mitotic chromosome condensation. Annu Rev Cell Dev Biol. 
1996;12:305-33. 
Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. Liver-specific 
deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 2008 
Apr 9;27(7):1017-28. Epub 2008 Mar 20. 
Koch CM, Andrews RM, Flicek P, Dillon SC, Karaöz U, Clelland GK, Wilcox S, Beare DM, 
Fowler JC, Couttet P, James KD, Lefebvre GC, Bruce AW, Dovey OM, Ellis PD, Dhami P, 
Langford CF, Weng Z, Birney E, Carter NP, Vetrie D, Dunham I. The landscape of histone 
modifications across 1% of the human genome in five human cell lines. Genome Res. 2007 
Jun;17(6):691-707. 
Korber P, Luckenbach T, Blaschke D, Hörz W. Evidence for histone eviction in trans upon 
induction of the yeast PHO5 promoter. Mol Cell Biol. 2004 Dec;24(24):10965-74. 
Kuff EL, Lueders KK. The intracisternal A-particle gene family: structure and functional 
aspects. Adv Cancer Res. 1988;51:183-276. Review. 
Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene 
expression. Cell. 2004 Jun 11;117(6):721-33. 
Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, 
Hauser C, Brunmeir R, Jenuwein T, Seiser C. Essential function of histone deacetylase 1 in 
proliferation control and CDK inhibitor repression. EMBO J. 2002 Jun 3;21(11):2672-81. 
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle 
M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, 
LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, 
___________________________________________________________________________ 
  105 
Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic 
N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton 
J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, 
French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, 
McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, 
Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, 
Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, 
Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx 
PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, 
Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, 
Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, 
Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, 
Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, 
Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, 
Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, 
Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, 
Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, 
Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, 
Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen 
F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, 
Blöcker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, 
Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp 
M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, 
Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif 
S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, 
McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz 
J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, 
Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, 
Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, 
Osoegawa K, Shizuya H, Choi S, Chen YJ; International Human Genome Sequencing 
Consortium. Initial sequencing and analysis of the human genome. Nature. 2001 Feb 
15;409(6822):860-921 
Lee KK, Workman JL. Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev 
Mol Cell Biol. 2007 Apr;8(4):284-95. Review.  
Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal 
histone 3 lysine 4 demethylation. Nature. 2005 Sep 15;437(7057):432-5. Epub 2005 Aug 3. 
Lee MG, Wynder C, Bochar DA, Hakimi MA, Cooch N, Shiekhattar R. Functional interplay 
between histone demethylase and deacetylase enzymes. Mol Cell Biol. 2006 
Sep;26(17):6395-402. 
Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs 
RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. Depletion of latent HIV-1 
infection in vivo: a proof-of-concept study. Lancet. 2005 Aug 13-19;366(9485):549-55.  
Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in 
embryonic lethality. Cell. 1992 Jun 12;69(6):915-26. 
Liang G, Chan MF, Tomigahara Y, Tsai YC, Gonzales FA, Li E, Laird PW, Jones PA. 
Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive 
elements. Mol Cell Biol. 2002 Jan;22(2):480-91. 
Liu CL, Kaplan T, Kim M, Buratowski S, Schreiber SL, Friedman N, Rando OJ. Single-
nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol. 2005 
Oct;3(10):e328. Epub 2005 Aug 30. 
Liu WM, Chu WM, Choudary PV, Schmid CW. Cell stress and translational inhibitors 
transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res. 1995 
May 25;23(10):1758-65. 
Lorch Y, Zhang M, Kornberg RD. Histone octamer transfer by a chromatin-remodeling 
complex. Cell. 1999 Feb 5;96(3):389-92. 
___________________________________________________________________________ 
  106 
Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the 
nucleosome core particle at 2.8 A resolution. Nature. 1997 Sep 18;389(6648):251-60.  
Macdonald N, Welburn JP, Noble ME, Nguyen A, Yaffe MB, Clynes D, Moggs JG, 
Orphanides G, Thomson S, Edmunds JW, Clayton AL, Endicott JA, Mahadevan LC. 
Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 
14-3-3. Mol Cell. 2005 Oct 28;20(2):199-211. 
Mahadevan LC, Willis AC, Barratt MJ. Rapid histone H3 phosphorylation in response to 
growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell. 1991 May 
31;65(5):775-83. 
Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by 
human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003 Jul 
3;424(6944):99-103. Epub 2003 May 28.  
Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. 
Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS 
Genet. 2006 Jan;2(1):e2. 
Marks PA, Jiang X. Histone deacetylase inhibitors in programmed cell death and cancer 
therapy. Cell Cycle. 2005 Apr;4(4):549-51. Epub 2005 Apr 28. Review. 
Martens JH, O'Sullivan RJ, Braunschweig U, Opravil S, Radolf M, Steinlein P, Jenuwein T. 
The profile of repeat-associated histone lysine methylation states in the mouse epigenome. 
EMBO J. 2005 Feb 23;24(4):800-12. Epub 2005 Jan 27. 
Mietz JA, Grossman Z, Lueders KK, Kuff EL. Nucleotide sequence of a complete mouse 
intracisternal A-particle genome: relationship to known aspects of particle assembly and 
function. J Virol. 1987 Oct;61(10):3020-9. 
Milutinovic S, D'Alessio AC, Detich N, Szyf M. Valproate induces widespread epigenetic 
reprogramming which involves demethylation of specific genes. Carcinogenesis. 2007 
Mar;28(3):560-71. Epub 2006 Sep 28. 
Miller WJ, McDonald JF, Nouaud D, Anxolabéhère D. Molecular domestication--more than a 
sporadic episode in evolution. Genetica. 1999;107(1-3):197-207. 
Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, 
Olson EN. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, 
growth, and contractility. Genes Dev. 2007 Jul 15;21(14):1790-802. 
Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH. Somatic mosaicism in 
neuronal precursor cells mediated by L1 retrotransposition. Nature. 2005 Jun 
16;435(7044):903-10.  
Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin 
structure and transcription. Cell. 2002 Feb 22;108(4):475-87. Review. 
Nilsson M, Bohm S. Inducible and cell type-specific expression of VL30 U3 subgroups 
correlate with their enhancer design. J Virol. 1994 Jan;68(1):276-88. 
Noutsopoulos D, Markopoulos G, Koliou M, Dova L, Vartholomatos G, Kolettas E, Tzavaras 
T. Vanadium induces VL30 retrotransposition at an unusually high level: a possible 
carcinogenesis mechanism. J Mol Biol. 2007 Nov 16;374(1):80-90. Epub 2007 Sep 11. 
Nyswaner KM, Checkley MA, Yi M, Stephens RM, Garfinkel DJ. Chromatin-associated genes 
protect the yeast genome from Ty1 insertional mutagenesis. Genetics. 2008 Jan;178(1):197-
214. 
Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are 
essential for de novo methylation and mammalian development. Cell. 1999 Oct 29;99(3):247-
57. 
Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi M, Ekström TJ, Szyf M. 
Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA 
demethylation in human cancer cell lines. Biochem Pharmacol. 2007 May 1;73(9):1297-307. 
Epub 2007 Jan 5. 
Pannell D, Osborne CS, Yao S, Sukonnik T, Pasceri P, Karaiskakis A, Okano M, Li E, 
Lipshitz HD, Ellis J. Retrovirus vector silencing is de novo methylase independent and 
marked by a repressive histone code. EMBO J. 2000 Nov 1;19(21):5884-94. 
___________________________________________________________________________ 
  107 
Panning B, Smiley JR. Activation of RNA polymerase III transcription of human Alu repetitive 
elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the 
products of E4 open reading frames 3 and 6. Mol Cell Biol. 1993 Jun;13(6):3231-44. 
Peaston AE, Evsikov AV, Graber JH, de Vries WN, Holbrook AE, Solter D, Knowles BB. 
Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos. Dev 
Cell. 2004 Oct;7(4):597-606. 
Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schöfer C, Weipoltshammer K, 
Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. Loss of the 
Suv39h histone methyltransferases impairs mammalian heterochromatin and genome 
stability. Cell. 2001 Nov 2;107(3):323-37. 
Prak ET, Kazazian HH Jr. Mobile elements and the human genome. Nat Rev Genet. 2000 
Nov;1(2):134-44. Review. 
Puschendorf M, Stein P, Oakeley EJ, Schultz RM, Peters AH, Svoboda P. Abundant 
transcripts from retrotransposons are unstable in fully grown mouse oocytes. Biochem 
Biophys Res Commun. 2006 Aug 18;347(1):36-43. Epub 2006 Jun 27. 
Ramakrishnan V. Histone H1 and chromatin higher-order structure. Crit Rev Eukaryot Gene 
Expr. 1997;7(3):215-30. Review. 
Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP. High-
resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl 
Acad Sci U S A. 2008 Jan 8;105(1):252-7. Epub 2007 Dec 27. 
Ribet D, Harper F, Dupressoir A, Dewannieux M, Pierron G, Heidmann T. An infectious 
progenitor for the murine IAP retrotransposon: emergence of an intracellular genetic parasite 
from an ancient retrovirus. Genome Res. 2008 Apr;18(4):597-609. Epub 2008 Feb 6. 
Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax 
group proteins. Annu Rev Genet. 2004;38:413-43. Review. 
Rougeulle C, Chaumeil J, Sarma K, Allis CD, Reinberg D, Avner P, Heard E. Differential 
histone H3 Lys-9 and Lys-27 methylation profiles on the X chromosome. Mol Cell Biol. 2004 
Jun;24(12):5475-84. 
Sadri-Vakili G, Cha JH. Histone deacetylase inhibitors: a novel therapeutic approach to 
Huntington's disease (complex mechanism of neuronal death). Curr Alzheimer Res. 2006 
Sep;3(4):403-8. Review. 
Saito ES, Keng VW, Takeda J, Horie K. Translation from nonautonomous type IAP 
retrotransposon is a critical determinant of transposition activity: implication for 
retrotransposon-mediated genome evolution. Genome Res. 2008 Jun;18(6):859-68. Epub 
2008 May 2. 
Sarg B, Helliger W, Talasz H, Koutzamani E, Lindner HH. Histone H4 hyperacetylation 
precludes histone H4 lysine 20 trimethylation. J Biol Chem. 2004 Dec 17;279(51):53458-64. 
Epub 2004 Sep 28. 
Scholes DT, Banerjee M, Bowen B, Curcio MJ. Multiple regulators of Ty1 transposition in 
Saccharomyces cerevisiae have conserved roles in genome maintenance. Genetics. 2001 
Dec;159(4):1449-65. 
Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T. A 
silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive 
heterochromatin. Genes Dev. 2004 Jun 1;18(11):1251-62. Epub 2004 May 14. 
Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, Leib-Mösch C. 
Comprehensive analysis of human endogenous retrovirus transcriptional activity in human 
tissues with a retrovirus-specific microarray. J Virol. 2005 Jan;79(1):341-52. 
Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, Bernard L, Draetta 
GF, Alcalay M, Seiser C, Chiocca S. Role for histone deacetylase 1 in human tumor cell 
proliferation. Mol Cell Biol. 2007 Jul;27(13):4784-95. Epub 2007 Apr 30. 
Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-
Koseki Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H. The SRA protein 
Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007 
Dec 6;450(7171):908-12. Epub 2007 Nov 11. 
___________________________________________________________________________ 
  108 
Sharma RP, Rosen C, Kartan S, Guidotti A, Costa E, Grayson DR, Chase K. Valproic acid 
and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a 
clinical population. Schizophr Res. 2006 Dec;88(1-3):227-31. Epub 2006 Sep 25. 
Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone 
demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004 Dec 
29;119(7):941-53.  
Smit AF. Identification of a new, abundant superfamily of mammalian LTR-transposons. 
Nucleic Acids Res. 1993 Apr 25;21(8):1863-72. 
Smit AF. Interspersed repeats and other mementos of transposable elements in mammalian 
genomes. Curr Opin Genet Dev. 1999 Dec;9(6):657-63. Review. 
Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD. Conservation of deposition-related 
acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci U S A. 1995 
Feb 14;92(4):1237-41. 
Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, Mahadevan 
LC, Arthur JS. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of 
histone H3 and HMG-14. EMBO J. 2003 Jun 2;22(11):2788-97. 
Song X, Wang B, Bromberg M, Hu Z, Konigsberg W, Garen A. Retroviral-mediated 
transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an 
immunodeficient mouse model. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6269-73. Epub 
2002 Apr 16. 
Song X, Sui A, Garen A. Binding of mouse VL30 retrotransposon RNA to PSF protein 
induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. Proc Natl 
Acad Sci U S A. 2004 Jan 13;101(2):621-6. Epub 2004 Jan 2. 
Song X, Sun Y, Garen A. Roles of PSF protein and VL30 RNA in reversible gene regulation. 
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12189-93. Epub 2005 Aug 3. 
Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000 Jan 
6;403(6765):41-5. 
Stribinskis V, Ramos KS. Activation of human long interspersed nuclear element 1 
retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res. 
2006 Mar 1;66(5):2616-20. 
Suka N, Luo K, Grunstein M. Sir2p and Sas2p opposingly regulate acetylation of yeast 
histone H4 lysine16 and spreading of heterochromatin. Nat Genet. 2002 Nov;32(3):378-83. 
Epub 2002 Oct 15. 
Takabatake T, Ishihara H, Ohmachi Y, Tanaka I, Nakamura MM, Fujikawa K, Hirouchi T, 
Kakinuma S, Shimada Y, Oghiso Y, Tanaka K. Microarray-based global mapping of 
integration sites for the retrotransposon, intracisternal A-particle, in the mouse genome. 
Nucleic Acids Res. 2008 Jun;36(10):e59. Epub 2008 May 1. 
Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast 
transcriptional regulator Rpd3p. Science. 1996 Apr 19;272(5260):408-11.  
Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC. The nucleosomal 
response associated with immediate-early gene induction is mediated via alternative MAP 
kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 1999 Sep 
1;18(17):4779-93. 
Thorne AW, Kmiciek D, Mitchelson K, Sautiere P, Crane-Robinson C. Patterns of histone 
acetylation. Eur J Biochem. 1990 Nov 13;193(3):701-13. 
Trewick SC, McLaughlin PJ, Allshire RC. Methylation: lost in hydroxylation? EMBO Rep. 
2005 Apr;6(4):315-20. 
Turner BM. Decoding the nucleosome. Cell. 1993 Oct 8;75(1):5-8. Review. 
Turner BM. Histone acetylation and an epigenetic code. Bioessays. 2000 Sep;22(9):836-45. 
Review. 
Tzavaras T, Eftaxia S, Tavoulari S, Hatzi P, Angelidis C. Factors influencing the expression 
of endogenous reverse transcriptases and viral-like 30 elements in mouse NIH3T3 cells. Int J 
Oncol. 2003 Oct;23(4):1237-43. 
van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb-group 
protein EED involves histone deacetylation. Nat Genet. 1999 Dec;23(4):474-8. 
___________________________________________________________________________ 
  109 
Walsh CP, Chaillet JR, Bestor TH. Transcription of IAP endogenous retroviruses is 
constrained by cytosine methylation. Nat Genet. 1998 Oct;20(2):116-7. 
Walter W, Clynes D, Tang Y, Marmorstein R, Mellor J, Berger SL. 14-3-3 interaction with 
histone H3 involves a dual modification pattern of phosphoacetylation. Mol Cell Biol. 2008 
Apr;28(8):2840-9. Epub 2008 Feb 11. 
Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, 
Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, 
Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, 
Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, 
Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley 
RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, 
Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, 
Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, 
Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs 
RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, 
Gregory S, Guigó R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs 
A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, 
Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler 
E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, 
Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, 
Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, 
McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, 
Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson 
JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-
Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov 
A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, 
Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, 
Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, 
Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, 
Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, 
Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, 
Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, 
Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES.; 
Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the 
mouse genome. Nature. 2002 Dec 5;420(6915):520-62.  
Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim 
Biophys Acta. 2007 Jan;1775(1):138-62. Epub 2006 Sep 1. Review. 
Winter S, Simboeck E, Seiser C. Open Chromatin (Review). Genes, Genomes and 
Genomics. 2007; 209-225 
Winter S, Simboeck E, Fischle W, Zupkovitz G, Dohnal I, Mechtler K, Ammerer G, Seiser C. 
14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional 
activation. EMBO J. 2008 Jan 9;27(1):88-99. Epub 2007 Dec 6. 
Xing J, Witherspoon DJ, Ray DA, Batzer MA, Jorde LB. Mobile DNA elements in primate and 
human evolution. Am J Phys Anthropol. 2007;Suppl 45:2-19. Review. 
Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. Histone H3 phosphorylation by 
IKK-alpha is critical for cytokine-induced gene expression. Nature. 2003 Jun 
5;423(6940):655-9.  
Yang XJ, Seto E. HATs and HDACs: from structure, function and regulation to novel 
strategies for therapy and prevention. Oncogene. 2007 Aug 13;26(37):5310-8. Review. 
Yang XJ, Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to 
mice and men. Nat Rev Mol Cell Biol. 2008 Mar;9(3):206-18. Review. 
Ymer S, Tucker WQ, Sanderson CJ, Hapel AJ, Campbell HD, Young IG. Constitutive 
synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near 
the gene. Nature. 1985 Sep 19-25;317(6034):255-8. 
Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic 
parasites. Trends Genet. 1997 Aug;13(8):335-40. Review.  
___________________________________________________________________________ 
  110 
You JS, Kang JK, Lee EK, Lee JC, Lee SH, Jeon YJ, Koh DH, Ahn SH, Seo DW, Lee HY, 
Cho EJ, Han JW. Histone deacetylase inhibitor apicidin downregulates DNA 
methyltransferase 1 expression and induces repressive histone modifications via recruitment 
of corepressor complex to promoter region in human cervix cancer cells. Oncogene. 2008 
Feb 28;27(10):1376-86. Epub 2007 Sep 10.  
Yu F, Zingler N, Schumann G, Strätling WH. Methyl-CpG-binding protein 2 represses LINE-1 
expression and retrotransposition but not Alu transcription. Nucleic Acids Res. 2001 Nov 
1;29(21):4493-501. 
Zhang W, Bone JR, Edmondson DG, Turner BM, Roth SY. Essential and redundant 
functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p 
acetyltransferase. EMBO J. 1998 Jun 1;17(11):3155-67. 
Zupkovitz G, Tischler J, Posch M, Sadzak I, Ramsauer K, Egger G, Grausenburger R, 
Schweifer N, Chiocca S, Decker T, Seiser C. Negative and positive regulation of gene 
expression by mouse histone deacetylase 1. Mol Cell Biol. 2006 Nov;26(21):7913-28. Epub 
2006 Aug 28. 
 
 
 
 
 
CURRICULUM VITAE 
 
Name:   Reinhard Brunmeir 
Date of Birth:  18.05.1977 
Place of Birth:  Wels, Austria 
Nationality:  Austrian 
 
Education: 
 
2004 – 2007  PhD thesis at the Max F. Perutz Laboratories, Department of Medical 
Biochemistry, Medical University of Vienna, Vienna Biocenter, Austria. 
Supervisor: Prof. Dr. Christian Seiser (Prof. Dr. Manuela Baccarini) 
2002 Diploma thesis at the Max F. Perutz Laboratories, Department of 
Medical Biochemistry, Medical University of Vienna, Vienna Biocenter, 
Austria. Supervisor: Prof. Dr. Christian Seiser 
1996 – 2003  Studies of Genetics, University of Vienna 
1995 – 1996 Military Service 
1987 – 1995 Stiftsgymnasium Wilhering 
1983 – 1987 Primary School Stroheim 
 
Scholarship: 
 
2004 – 2005 Schering Stiftung scholarship for PhD students 
 
Publications: 
 
Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, 
Hauser C, Brunmeir R, Jenuwein T, Seiser C.  
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor 
repression.  
EMBO J. 2002 Jun 3;21(11):2672-81. 
 
Brunmeir R*, Lagger S*, Seiser C. 
HDAC1/HDAC2-controlled embryonic development and cell differentiation.  
Int. J. Developmental Biology. 2008. In Press. Review.  
*equal contribution 
 
 
